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Abstract
This thesis investigates potential classes of compound for use as 
immunohistochemical markers. A range of ligands and their corresponding metal 
complexes have been screened for their ability to catalytically reduce silver ions in a 
Timm’s type reaction.
Chapter two focuses on the preparation and testing of bidentate tertiary phosphine 
metal complexes. The functionalised ligands, l,2-bis-diphenylphosphino-4-methoxy- 
benzene, l-diphenylphosphino-2[(diphenylphosphino)-methyl]-4-methoxybenzene and the 
corresponding platinum complexes have been prepared. Platinum complexes of 1,2- 
bis[diphenylphosphinoethane] were also synthesised. These platinum complexes were 
found to reduce the silver in times ranging from 5 minutes to in excess of 30 minutes.
Chapter three focuses on the preparation of marker systems based on platinum and 
palladium complexes of weso-tetraarylporphyrins. 5,10,15,20-Tetra(4- 
hydroxyphenyl)porphyrin and 5,10,15 -tri-(4-tolyl)-20-(4-hydroxyphenyl)porphyrin have 
been prepared from the corresponding anisole and 3,4,5-trimethoxybenzoic acid phenyl 
ester derivatives. A number of symmetrical and unsymmetrical porphyrins bearing aryl 
phosphate esters derived from diethyl-4-formylphenyl phosphate and diethyl-4-formyl-2- 
methoxyphenyl phosphate have been prepared. The reaction of 5,10,15,20-tetra-(4- 
hydroxyphenyl)porphyrin or 5,10,15,20-tetra-(4-hydroxy-3-methoxyphenyl)porphyrin with 
chloro diethylphosphate in the presence of either sodium hydride or triethylamine failed to 
afford the corresponding tetra-phosphorylated products. The reaction between 5,10,15,20- 
tetra-(4-hydroxyphenyl)porphyrin palladium and chlorodiethylphosphate in the presence of 
triethylamine afforded a mixture of phosphorylated products. None of the prepared 
complexes displayed the ability to reduce silver ions in a Timm’s type reaction.
Chapter four describes the design and synthesis of 4-phenyl-2,2’:6’,2”-terpyridines 
functionalised with a PEG chain terminating with a reactive group suitable for bio­
conjugation. 4’-[(2-(2-[2-(l,3-Dioxo-l,3-dihydro-isoindol-2-yl)-ethoxy]-ethoxy)-ethoxy)- 
phenyl]- 2,2’:6’,2” -terpyridine was prepared using two methods starting from either 4- 
hydroxybenzaldehyde or (4-hydroxyphenyl)-2,2’:6’,2”-terpyridine. Base hydrolysis 
converted the phthalimde moiety to the free amine which was subsequently treated with
l,5-difluoro-2,4-dinitrobenzene. This ligand was not water soluble. The addition of two 
morpholinomethyl pendent groups via a Mannich reaction did not dramatically increase the 
solubility in water. A number of transition metal complexes were prepared and tested.
Chapter five presents a novel one-pot synthesis of ‘mixed’ A-arylated 1,4,7- 
triazacyclononane (tacn) ligands. Using this methodology tacn ligands functionalised with 
two nitrophenyl groups and either a benzaldehyde (L32A), benzoic acid ( L 32Ba ) ,  benzyl ester 
( L 32Benzyi), alcohol ( L 32a ic) ,  tolyl ( L 32t )  or napthoquinone ( L 32q )  groups have been prepared 
in yields ranging between 39 and 64 %. Hydrogenation of L 32t  afforded L 32t r .  Reaction 
with Ni(II) perchlorate afforded the air stable complex [Nin(L3 2 TR)][C104]2, which was 
found to catalyse the reduction of aqueous silver ions via  a Timm’ type reaction in 3 
minutes. Attempts to attach both a porphyrin and a terpyridine sub-unit are also presented.
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Chapter 1 - Introduction
1.1 Overview
Diagnosing disease is the first step in treatment. This can be achieved by the use of 
either invasive or non-invasive techniques. This work describes the preparation of markers 
suitable for use as immunohistochemical imaging agents. This technique is performed on 
tissue samples taken from the body.
1.2 Introduction
The environment that surrounds us contains a vast array of infectious agents such as 
viruses, fungi, protozoa and multicellular parasites. All of these can bring about disease and 
if go unchecked can ultimately result in the death of the host. However, most infections are 
only short lived owing to the immune system which has evolved to combat infectious 
agents. The human immune system is composed of approximately 10 cells that protect 
against foreign invaders.
Substances that are foreign to the human body, for example bacteria, viruses and 
other infectious agents are known as antigens (derived from the term antibody generator) 
and are recognised by the white blood cells (leucocytes) as invaders. The immune response 
consists of two phases, firstly the recognition of an antigen and secondly a reaction to 
eradicate it. There are two classes of immune response being the innate or non-adaptive 
immune responses and adaptive immune responses. These immune responses are created by 
leucocytes. There are several different types of leucocytes, the most important being 
lymphocytes, which identify the foreign object and phagocytes, which destroy invaders 
(figure 1 .1 ).
Type o f Lymphocyte Role
B lymphocyte or B-cells Make antibodies which are then released into the bloodstream
T lymphocytes or T-cells Make molecules similar to antibodies. These remain attached to the 
plasma membrane and are known as T-cell antigen receptors 
(TCRs).
Figure 1.1: Types of lymphocytes and their role.
The lymphocytes synthesise soluble glycoproteins, known as immunoglobulins (Ig) 
which can bind to antigens. Some immunoglobulins are carried on the surface of B-cells 
where they act as receptors for specific antigens (T-cell antigen receptors, TCRs) whilst 
others circulate in the blood and tissue fluids (antibodies, Ab). There are five classes of 
immunoglobulin molecules; IgG, IgA, IgM, IgD and IgE, differing in size, charge, amino 
acid composition and carbohydrate content (figure 1.2). Each B-cell only produces one type
2
Chapter 1 - Introduction
of antibody and the immune system relies on there being so many different types so at least 
one will bind to the antigen. The human body can produce an estimated 100 million 
different antibodies enabling the recognition of all kinds of antigens.
Class o f Ig % Role
IgG 76 The major serum Ig. Some can cross cell membranes (e.g. from 
mother to foetus through the placenta).
IgA 15 Antibody responsible for protecting the body surfaces (e.g. 
mucous membrane of the gut). Is also found in mother’s milk
IgM 8 The first antibody that is produced in response to an infection
IgD 1 Thought to be involved in regulation of antibody synthesis
IgE 0.002 Maybe responsible for exaggerated immunological reaction to dust 
and pollen in allergy sufferers
Figure 1.2: The five classes of immunoglobulins.
The immunoglobulins are made up of four polypeptide chains which are held 
together by covalent and non-covalent interactions. All of the immunoglobulins consist of 
two identical heavy chains (molecular weight range of 50,000-75,000) and two identical 
light chains (molecular weight ~ 25,000). However, antibodies are not all the same. The 
first 100 amino acids at the N-terminus of the polypeptide chains varies from one antibody 
to another, this region is known as the hypervariable or variable region and generates 
binding regions of differing shape and charge (figure 1.3). Hence antibodies are highly 
specific and will only bind to one particular antigen.
ntigen-specifk bivalent binding___
sites
Ami no-terminal 
end .
-S -S-
c c
Key
1 = 1 Heavy chain
C = Light chain
m Variable region
S -S Disulfide bridge
Carboxy-terminal
end
Figure 1.3: A schematic diagram of a typical Ig antibody.
Monoclonal antibodies are pure antibodies of a defined specificity and can be mass- 
produced in laboratories from a single clone and that recognises only one antigen. They are
3
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typically made by fusing a normally short-lived, antibody producing B cell to a fast 
growing cell. The resulting hybrid cell, multiplies rapidly creating a clone that produces 
large quantities of the same antibody. The high specificity of monoclonal antibodies makes 
them powerful biological tools in medical diagnostics. However, to utilize them fully 
requires a means of detecting them at low concentration. This is usually achieved by 
labelling the antibody in a number of ways, such as enzyme labelling or biotin labelling. 
The technique of using labelled antibodies as specific probes for the localisation of tissue 
constituents (e.g. antigens) is known as immunohistochemistry or immunocytochemistry) 
The first attempts to label an antibody were made in 1934 using ordinary dyes. 
However, this type of label could not be visualised under the microscope. In 1941 Coons 
and his co-workers developed a method of locating tissue constituents by labelling a 
specific antibody with a fluorescent dye and visualising it using a fluorescence microscope.
1.3 Antibody Labelling
13.1 Direct Method
This is a one step reaction where a primary antibody is labelled directly with a 
marker (figure 1.4-(i)). It was first introduced in the 1941 when a primary antibody 
(specific to a particular antigen) was labelled with fluoroscein isocyanate. 3  Since then many 
other labels have been used to directly label antibodies, such as enzymes, 4 - 6  gold particles7
•  510along with other fluorochromes. ’ The direct labelling method is one-step and simple. 
However, it is limited since it provides no immunological amplification of the colour signal 
relative to the number of antigenic sites. It can also be an expensive technique since the 
primary antibody must be raised specifically each time.
13.2 Indirect Method
Modification of the direct method was made in 195510 whereby a second layer of 
antibody molecule (secondary) was introduced (figure 1.4-(ii)). A primary antibody is 
raised against the antigen to be identified, is not itself labelled but is conjugated to a 
secondary, non-specific antibody which carries the label. This increases the sensitivity and 
allows antigens to be visualised by a lower concentration of primary antibody.
4
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P
Direct
0 )
JO
Indirect
(ii)
Key
primary antibody
secondary antibody
marker
y \  tissue antigen
Figure 1.4: Schematic diagram illustrating the (i) direct and (ii) indirect antibody labelling methods.
1.4 Types of Label
1.4.1 Fluorochromes
The first fluorescent dye to be attached to an antibody was fluoroscein isocyanate3,10 
but this was later replaced by the more stable isothiocyanate derivative.11 Fluoroscein 
isothiocyanate is still widely used today and emits a bright apple green colour when excited 
at a wavelength of 490 nm (figure 1.5). Other examples of fluorescent markers include the 
rhodamine derivatives which fluoresce red (figure 1.5). The orange to red luminescence of 
rhodamine derivatives is in stark contrast to the green of fluoroscein, hence these two types 
of fluorochrome are commonly used together in double immunofluoroscence staining.
FITC 
Excitation = 494 nm 
Emission =  520 nm 
(green)
TRITC 
Excitation 544 nm 
Emission =  570 nm 
(red)
(j) (ii)
Figure 1.5: Labels used in immunofluoroscence: (i) fluoroscein-5- isothiocyanate (FITC) and (ii)
tetramethylrhodamine-5-isothiocyanate.
Advantages:
• Provides an instantly visible label, with excellent contrast when used against dark, 
non-fluorescent backgrounds.
• Are available in a variety of colours so can be used in double labelling techniques.
5
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Disadvantages:
• Conjugates are unstable; they are not resistant to dehydration and solvent-based 
mountants used in microscopy.
• Fluorescence tends to fade, although newer fluorochromes have overcome this 
problem (e.g. Oregan Green ™ (Molecular Probes).
• Endogenous fluorescence (auto fluorescence) is common in aldehyde fixed tissue.
1.4.2 Enzymes
The instability of immunofluorescence led to the development of a more permanent 
type of preparation using enzymes. The catalytic activity of an enzyme can be used to 
convert substrate molecules into chromogenic or fluorescent products which can then be 
detected via microscopy (figure 1.6 ). Any endogenous enzyme must be inhibited so that it 
cannot react with the substrate. Immunoenzyme methods can be used on any type of sample 
preparation providing permanent results. Horseradish peroxidase (HRP) was the first 
enzyme to be conjugated to an antibody; 4 ,5  followed later by alkaline phosphatase (AP) 6  
and glucose oxidase. Many antibodies are available from commercial suppliers already 
labelled with HRP and AP.
Enzyme Label Substrate (chromogen) Colour reaction
Horseradish peroxidase (HRP) Diaminobenzidine (DAB) 
3-Amino-9-ethylcarbazole (AEC)
Brown
Reddish
Alkaline phosphatase (AP) Naphthol AS-MX/ fast red TR salt 
and fast blue BB 
New Fuchsin
Red and Blue 
Red
Glucose oxidase Nitro-blue tetrazolium Blue-black
Figure 1.6: Commonly used enzymes and their substrate/chromogen.
1.4.2.1 Horseradish Peroxidase (HRP)
Peroxidase is a stable, highly active enzyme. HRP is derived from the roots of the 
horseradish. It has a molecular weight of 40,000 and catalyses the reaction of its substrate, 
hydrogen peroxide with certain organic, electron-donating substrates to yield highly 
coloured products. Diaminobenzidine12 is the most common chromogen used in the 
immunoperoxidase technique, it polymerises upon oxidation with H2 O2  producing a brown 
colour. The DAB stain can be further enhanced by a variety of agents such as osmium . 13 It 
has the advantage that it is stable in organic solvents, however it has been shown to be
6
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carcinogenic. 14 Non-carcinogenic alternatives such as 3-amino-9-ethylcarbazole15 have 
been introduced but these provide less satisfactory results.
Advantages
•  Polymerisation of DAB is rapid and the deposited coloured product is visible within
a few minutes.
• Polymerised DAB adheres firmly at the site of the histochemical reaction.
• DAB can be amplified by either metals or physical developers.
Disadvantages
• Peroxidase is endogenous to many biological tissues.
• Many non-peroxidate enzymes and pseudoperoxidate factors (e.g. haem containing 
proteins) can catalyse the reaction.
• The reaction destroys the enzyme and both H2 O2  and DAB are chemically unstable 
and toxic.
• The chemistry of DAB polymerisation and its reaction with metals is poorly 
understood.
• The quality of DAB varies between suppliers making reproducibility difficult.
1.4.2.2 Alkaline Phosphatase (AP)
There are two forms of alkaline phosphatase in mammals, one form present in a 
variety of tissues and the other form found only in the intestines. The AP isoenzymes have 
an optimal activity between pH 8  to 10 and cleave the associated phosphomonoester groups 
from a wide variety of substrates (figure 1.7). AP was first introduced for quantitative work 
with the enzyme-linked immunosorbent assay (ELISA) technique, providing a soluble, 
coloured end-product of reaction that could be measured with a spectrophotometer. The 
enzyme can also react with a chromogen (azo dye) to produce a coloured precipitate 
suitable for immunocytochemistry. 1 6 The isoenzyme most commonly used in 
immunocytochemistry is derived from calf intestine and has a molecular weight of 140,000. 
All of the isoenzymes except the intestinal one can be inhibited (blocked) , 1 7 therefore 
methods depending on AP as a label are not suitable for immunostaining intestinal tissue.
R -O H
R - o - p - o
o
11
r Enz—()—n —^
O
11
H O —P —O + Enz
O
11
1 1OH OH OH
Enz
Figure 1.7: Enzymatic action of alkaline phosphatase.
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Advantages
• AP displays a broad substrate specificity.
• Endogenous enzyme is easily inhibited.
• Highly coloured end-products can be viewed by light microscopy.
• AP is a useful alternative when specimens have a high endogenous peroxidase
activity e.g. in bone marrow or the spleen.
Disadvantages
• Cannot be used in intestinal tissue.
• Coloured end products cannot be made electron dense or amplified with physical 
developers.
• Some end products are alcohol soluble therefore aqueous mountants are required.
1.4.3 Colloidal gold
The use of colloidal gold particles in immunocytochemistry was first introduced in
7 71971. It was originally developed for use with an electron microscope and remains the 
label of choice in this field since it is made in convenient well-defined sizes and is rendered 
immunoreactive by adsorbing antibodies. Colloidal gold can be seen under a light 
microscope as reddish particles but only when highly concentrated conjugates are applied. 
Such suspensions are unstable. Alternatively, a diluted conjugate concentration can be used 
and enhanced by silver amplification producing a black colouration. 18
Advantages
• Colloidal gold is electron dense and can be easily prepared in different sizes (3- 
1 0 0  nm ) ; 1 9 therefore multiple labelling of various binding sites can be 
performed.
• The amplification with silver produces one of the most sensitive 
immunocytochemical methods. None of the reagents are toxic and high 
dilutions of antibodies can be used thus increasing the sensitivity.
Disadvantages
• The particular nature of colloidal gold limits penetration into fixed tissues, 
although smaller gold particles (1-3 nm) have been developed e.g. Nanogold™ 
(1.4 nm) . 2 0
• Protein A, which is used to bind the gold particles to the antibody, has a high 
affinity for both binding sites of antibodies (Fab and Fc),21 this may lead to cross 
linking and a loss of specificity.
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• The amplification with silver requires great expertise and the silver reduction is 
less pronounced than other amplified markers.
1.5 Silver Amplification
Silver has been used in photography since the early nineteenth century. A 
photographic emulsion contains silver halide crystals. On exposure to photons (light), a thin 
layer of metallic silver forms on the surface of these crystals. The development can be 
achieved by two different types of developer solutions, a chemical developer which is made 
up of a reducing agent and dissolves the silver halide crystals or a physical developer which 
contains a source of ionic silver in addition to the reducing agent. With both types of 
developing solutions the end-product is a black deposit of pure silver.
1.5.1 The Use of Silver in Biology
In 1911, Liesegang2 2  and later in 1921, Liesegang and Rieder2 3  applied the 
principles of photographic ‘physical development’ to histology. This technique known as 
‘physical development’ is now often referred to as autometallography. The 
autometallographic technique (AMG) is based on the ability of small clusters of gold and/or 
silver atoms, mercury bismuth and zinc sulfide/selenide molecules to catalyse the reduction 
of silver ions from a developing solution into silver metal. 2 4  This technique was originally 
developed as a new way of increasing the staining intensity of silver impregnated tissue. 2 3  
In 1935 Roberts published a photochemical method for the in situ detection of trace 
amounts of gold deposited in gold-exposed animals. In his method, the tissue-bound gold 
was enlarged to microscopic dimensions by the deposition of silver.
1.5.2 Timm’s Sulfide Silver Staining Method
In 1958, Timm2 6  generalised a finding by the photographic scientist Zeiger2 7  that 
silver sulfide accumulations in photographic emulsions could be silver-enhanced by 
physical development. Timm noted that the metal sulfides were always more catalytic, with 
respect to silver reduction, than their respective metals. 2 6  The method described by Timm 
launched a breakthrough for physical development in biology. The methodology has been 
since modified by Danscher2 8  and has been used to visualise a variety of metals in brains 
and other tissues. Among these are the trace metals essential for life, such as Zn, Cu, Fe, 
Co, and Ni, as well as toxic metals such as Hg, Cd, Pb, As, Bi, Au and Ag. The principal of 
the technique is based on sulfide-precipitation of metals in tissue, followed by a physical
9
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development. During the latter stage the metal sulfides catalyse the reduction of silver ions 
by reducing agents.
1.5.3 Physical Developers
In biology, physical developers have been important in the detection and 
visualisation of both endogenous and exogenous sites of metal incorporation in biological 
tissue. 3 0  Endogenous metals such as mercury and silver can be visualised directly by 
physical developers3 1 ,3 2  whereas many others are converted to insoluble sulfides which 
have been shown to rapidly deposit reduced silver from physical developers. 2 2 , 2 6 ,2 8 ,2 9 ,3 3 ' 3 8  
Exogenous metals which are introduced as markers of histochemical, 
immunohistochemical, in situ hybridisations and immunoblot reactions have also been 
identified using physical developers. Examples of these markers include colloidal 
gold1 8 ,3 9 ,4 0  and polymerised DAB (a weak catalytic effect on physical developers4  M3) 
although a greater amplification is observed in the presence of non-noble transitional 
elements. 4 4 ,4 5
Physical developers contain a reducing agent and a soluble silver salt. The most 
basic physical developer, for example a solution of silver nitrate and hydroquinone, is very 
unstable and the deposition of metallic silver occurs almost immediately upon exposure to 
light. Today, physical developers contain buffers to control the pH. ‘Protective colloids’ 
such as gum arabic and gelatine are also added which inhibit the ‘direct collision’ of the 
silver ions and reducing molecules. Several formulations of physical developers have been 
developed to overcome the problems associated with self-nucleation upon exposure to light.
1.53.1 Danscher
Danscher3 2 ,4 6  has shown that the availability of silver ions can be controlled by 
using organic silver salts e.g. silver lactate as opposed to inorganic salts. Such salts ionise 
less efficiently in solution and hence slow down the reaction. The developer solutions are at 
an acidic pH of 3-3.5. This has been found to slow down the development process and is 
controlled by buffers such as citric acid/citrate or boric acid/borate. Gum arabic is used as 
the sticky, protective colloid and slows down the collision rates between silver ions and 
reducer molecules.
Disadvantages: Whilst the inclusion of gum arabic lessens the need for total light 
exclusion, silver lactate is photolabile. Hence solutions should be protected from light, 
although this is often impractical in a histological setting. In addition a low pH may damage 
the tissue.
10
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1.5.3.2 Galiyas
The physical developer formulated by Galiyas employs colloidal solutions of 
tungsten in order to protect the silver ions from both the light and coming into contact with 
the reducer molecules. This delays the blackening of the solutions for up to 30 minutes. The 
developer is weakly acidic (pH 5) which makes it suitable for many applications. Despite 
the relative light insensitivity of this solution, it does have disadvantages.
Disadvantages: Silver nitrate is used as the source of silver ions; it is not very robust and is 
poorly affected by contamination. The developer solution is not simple to make and is 
made up of three separate solutions. One of these needs to be freshly prepared prior to use.
1.533 Newman and Jasani
This is a neutrally-buffered, light insensitive physical developer. 4 7  It is made, just 
before use, by mixing together equal amounts of separate buffered silver and reducer 
solutions. Silver nitrate is used as the ionic source of silver ions. The silver ions and reducer 
molecules are kept apart by the introduction of silver ion chelators into both the silver stock 
and the reducer stock. When high molarity of tris[hydroxymethyl]aminomethane (Tris 
buffer) is combined with sodium sulfite and sodium thiosulfate, it prevents the unreduced 
silver ions being taken up by background tissue and controls the rate at which the reduced 
silver is deposited at the target site. Alcohol buffered pyrogallol is used as opposed to 
hydroquinone as the reducing agent. Pyrogallol is a very powerful reducing agent; it is 
soluble in alcohols and is chemically stable. In addition it has been shown that the addition 
of alcohols to a pyrogallol developer reduces self-nucleation and doubles the time it takes 
for light to affect the solution. 4 7  The solutions are found to be very stable with a bench life 
of up to two years, although adjustments in the pH are necessary. Upon exposure to light, 
the physical developer remains clear for at least 55 minutes at room temperature, much 
longer than previous formulations.
1.6 Design and Development of an Improved Marker System
The limitation of the current immunohistochemical techniques for the detection of 
antigens is the choice of chemical marker. Little investigation has been made in the 
development and design of alternative marker systems. Enzyme labels provide the greatest 
versatility of the immunohistochemical methods. Currently the enzyme labels horseradish 
peroxidase and alkaline phosphatase are detected by a chemical reaction which produces a
11
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highly coloured end-product. AP is often the enzyme of choice as it displays a broad 
substrate specificity and the endogenous enzyme is easily inhibited.
1.7 Proposal
Our approach is based on an indirect antibody labelling method to identify the site 
of interest (figure 1.8). This technique involves both primary and secondary antibodies. 
Primary antibodies are specific and will only bind to their corresponding antigen, whereas 
secondary antibodies bind to the non-specific site of the primary antibody. The secondary 
antibody has an alkaline phosphatase enzyme label attached to it. Thus, the secondary 
antibody carrying this label may be localised to specific antigens expressed by cells of 
interest. When a marker substrate is added to the system it will undergo enzymatic cleavage 
causing it to precipitate onto the cell surface. Commonly, aqueous silver ions are added 
which are catalytically reduced by the marker and are deposited onto the surface of the cell. 
Since the secondary antibody is bound to alkaline phosphatase, cells that express the 
antigen of interest may be identified by this method.
  redox active
ligand system
lysable polar 
function to 
impart
solubility i.e. 
phosphate
LYSISri
® I +CiD
catalytically active
complex
precipitated
wash with aqueous 
solution of silver ions
Ag+ —  Ag(m) I y IMAGE
^^WWVWWVWVAAAAAAAAAAAAAAAAAnAAAAAAAAAAAAAAAAA/
I
Kev
A Primary antibody
A Secondary antibody
Antigen
• Reporter molecule: 
alkaline phosphatase
tSXAA. Cell surface
A Precipitated silver metal
Figure 1.8: Schematic diagram of proposed system.
1.8 Aims
We intend to prepare new marker compounds which contain a lysable enzyme 
substrate and are catalytically active for the reduction of silver ions i.e. can be silver- 
enhanced. Incorporation of a functionalised ligand backbone will allow an initially water 
soluble metal complex to become water insoluble and precipitate on the cell surface upon 
enzymatic cleavage of the functional moiety, thus localising the redox catalyst at the site of 
interest. When the tissue section is washed with a physical developer, the redox-active
12
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compound will reduce silver ions to silver metal which will be deposited locally at the site 
of interest.
The metal-based marker substrate should be:
• Water soluble to allow administration to tissue sample.
• Incorporate a lysable substrate of alkaline phosphatase i.e. phosphomonoester.
• Form kinetically inert complexes.
• Must not have an affinity for non-target substances.
The marker should be:
• Insoluble in histological preparations i.e. water at pH 6-9.5, ethanol, xylene.
• Strictly localised at the target site.
• Strongly adhere to the target site.
• Support redox catalysis i.e. be amplifiable with a physical developer to enable
visualisation via light microscopy.
Little is known about the exact chemistry of silver reduction in a physical developer
(a Timm’s type reaction). The aim of this thesis is to investigate potential classes of
compounds as suitable, alternative marker systems.
13
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Introduction
This chapter presents the preparation of platinum complexes of bidentate tertiary 
phosphines. The prepared compounds were screened to establish whether they were 
suitable catalysts for the reduction of silver in a Timm’s type reaction.
2.1 The Chelate Effect
Chelating ligands are those with two or more donor atoms available to 
simultaneously attach to a metal ion. The stability constants of metal complexes containing 
chelating ligands are found to be higher than for their analogous non-chelate counterparts. 
An example is given in figure 2.1 (where en is the bidentate ligand ethylenediamine).
[Cu(OH2)6]2t + 2NH3  .  -  -  [Cu(0H2 )4 (NH3)2]+ + 2H20  (1)
p2 = 107 7; AH°= -46 kJ m o l1; AS°= -8.4 J K '1 m o l1; at 
298 K AG °= -46.47 kJ mol'1
[Cu(OH2)6]2+ + en ■ ......—  [Cu(OH2 )4 (en)]2+ + 2H20  (2 )
p, = 1010-6; AH°= -54 kJ mol'1; AS °= +23 J K '1 mol'1; at 
298 K, AG °= -61.17 kJ mol’1
Figure 2.1: Illustration of the chelate effect.
The replacement of two coordinated water molecules by one ethylene diamine 
molecule forms a complex with a larger stability constant than the complex formed in the 
analogous reaction with two ammonia molecules. The difference in the stability constants 
can be seen in the enthalpy and entropy values for the two reactions. Both reactions have 
similar enthalpy values so the difference in stability constants is mostly attributed to the 
entropy value.
2.2 Hard-Soft Acid-Base Classification (HSAB) 1
The stability constant of a metal complex also depends upon the nature of both the 
ligand and the metal ion. It has been found that certain types of ligand donor atoms form 
stronger complexes with certain metal ions i.e. have higher stability constants. This gives 
rise to a broad classification of metal ions according to the type of ligand they form the 
strongest complexes with. The smaller, highly charged metal ions are known as hard acids 
and form the strongest complexes with the smaller electronegative donors or hard bases. 
Whereas, the larger more polarizable metal ions are known as soft acids and form the
18
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strongest complexes with the larger, less electronegative donor atoms or soft bases. For 
example, tertiary phosphines are classified as soft bases and will therefore form the 
strongest complexes with metal ions such as Pt2+, Pd2+ and Rh+. Other examples are 
illustrated in figure 2.2
(hard) Borderline (soft)
Metal ions Metal ions Metal Ions
Mn2+, Sc3+, Cr3+, Fe3+ Fe2+, Co2+, Ni2+, Cu2+ Ag+, Pd2+, PF+, Rh+
Ligands Ligands Ligands
r2o , r o h , o h ', so42', cr Br, py r 2s , r 3p , co, c n \  r
Figure 2.2: Examples of hard and soft metal ions and ligands.
2.3 Square Planar Complexes
The energy level diagram for a square planar complex can be derived from that of 
an octahedral complex by removing two of the mutually trans ligands out to infinity. For d8 
ions a square planar geometry is favoured when the crystal field splitting (A) is greater than 
the pairing energy of placing two electrons in a single orbital. A square planar geometry is 
common to metals with a d8 electron configuration (e.g. Pt2+, Pd2+) when bound to a strong 
(high) field ligand (figure 2.3).
dz2 dx2.yi
4xy *-fyz 2g
• z
III,, ,x\\\
dx2- f
A > PE
M - d
4 - d
4xZ dyz
Octahedral Tetragonal 
distortion
Square-planar 
Low-spin d8
Figure 2.3: Energy diagram illustrating the effect of a square planar crystal field on the energies of d orbitals.
A strong field ligand is one which imposes a large crystal field splitting (A) whereas 
a weak (low) field ligand imposes a smaller crystal field splitting. Examples of strong field
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ligands include CO, PR3 and NO2 ', these ligands are good 71-acceptors. Halides and OH' are 
examples of weak field ligands. The oxidation state and position of the metal in the periodic 
table also affect the crystal field splitting. A higher oxidation state and a higher atomic 
weight increase the crystal field split. For example, a phosphine-platinum complex will be 
square planar.
2.4 Phosphine Ligands
Tertiary phosphines (PR3 ), in particular mono and diphosphines are some of the
2 5 1 wmost extensively used ligands in both inorganic and organometallic chemistry. ' The most 
widely reported diphosphine ligands are of the type Ph2 P(CH2 )«PPh2  where n=  1 (dppm) 
and n = 2 (dppe). These ligands are able to coordinate in a monodentate, chelating or 
bridging mode to a metal centre through the lone pair of electrons on the phosphorus atom.
• zr 0
There are also reports of diphosphine ligands where n is greater than two or where the 
phosphorus atoms are linked by an aromatic system9,10 (figure 2.4).
Ph2P " ^ P P h 2 Ph2p// ^PPh2
Ph2P PPh2
dppm dppe dppb
Figure 2.4: Examples of diphosphine ligands; l,2-bis(diphenylphosphino)methane (dppm), 1,2- 
bis(diphenylphosphino)ethane (dppe) and l,2-bis(diphenylphosphino)benzene (dppb).
Metal-phosphine complexes are of immense industrial importance in the area of 
homogeneous catalysis. One of the most studied catalytic systems is the rhodium (I) 
complex [Rh(PPh3 )3 Cl] (Wilkinson’s catalyst11) which is used as a hydrogenation catalyst. 
Other metal-phosphine complexes, particularly those of Ru, Rh and Pd play a crucial role in 
homogeneous catalysis for a wide range of transformations.
2.5 Phosphine Properties
An important feature of phosphine ligands is the ability to alter their properties by 
systematically changing the nature of the R group substituents. This allows for the fine 
tuning of both the electronic and steric properties of the ligand.
2.5.1 Electronic Considerations
The phosphine metal bond is synergic in nature (figure 2.5) which enables the 
phosphine ligand to act as both a o base and n acid, thus enabling them to stabilise metals in 
low oxidation states.
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_____
metal d o r b i t a l m  ——  p n acceptor orbital
a
Figure 2.5: Schematic diagram illustrating the synergic nature of the M-P bond.
a -Bonding: Donation of the lone pair of electrons on the phosphorus atom to the metal 
results in a bonding. If the R group is electron releasing (e.g. in PBu^) then the ligand acts 
predominantly as a a type donor i.e. the lone pair of electrons on the phosphorus is the 
major component of the resulting P-M bond. The strength of the o bond depends on the 
Lewis acidity of the metal where a more electropositive metal results in a stronger a  bond. 
The a bonding ability can be equated to pKa values, where a higher pKa value indicates 
more dominant o bonding (figure 2.6).
Tertiary phosphine pKa Tertiary phosphine pKa
P*Bu3 11.40 P(4-MeC6H4)3 3.84
PCy3 9.65 PPh3 2.73
P(4-MeOC6H4)3 4.75 P(4-FC6H4)3 1.97
Figure 2.6: Basicities of selected tertiary phosphines12
it-bonding: As R becomes more electronegative the 7t-acceptor properties of the phosphine 
ligand increase. The n character arises from back-donation from the metal to the phosphine. 
The classical view is that the electron density is donated from the metal d-orbital into the 
vacant phosphorus ^/-orbital.13 An alternative view however, is that the electron density is 
donated from the metal d-orbitals into the P-R a* (antibonding) orbitals.14'17
2.5.2 Steric Effects
Steric factors frequently dominate, particularly with bulky ligands. These effects 
contribute towards the stereochemistry, reactivity and structure of metal-phosphine 
complexes. The steric bulk of a coordinated phosphine can be measured using Tolman’s 
cone angle.4 This is defined as the angle (0) at the metal atom of the cone swept out by Van 
der Waals radii of the groups attached to the phosphorus upon rotation of the M-P bond 
(figure 2.7).
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■
V
Figure 2.7: Tolman’s cone angle (0).
Values of 0 are dependent on the interatomic distance between M and P. The cone 
angle can be used to explain the lability of phosphine complexes, where in general a larger 
cone angle results in a more labile phosphine ligand. Examples of the cone angles for 
tertiary phosphines are illustrated in figure 2 .8 .
Tertiary phosphine Cone Angle Tertiary phosphine Cone Angle
PMes3 212 PPh3 145
P(o-Tol)3 194 PPr3 132
P*Bu3 182 PC13 124
Pcy3 170 PMe3 118
Figure 2.8: Table of cone angles (0) for selected tertiary phosphines.
2.6 Methods of Preparation
There are three main methods for the preparation of bi and polydentate tertiary
1 Sphosphines (figure 2.9):
i. Reaction o f organometallic reagents and halophosphines: Grignard reagents are 
mainly used for the preparation of alkylphosphines and organolithium reagents are 
used for the preparation of arylphosphines. Organolithium reagents are more 
reactive than Grignard reagents and are therefore added to the halophosphine at low 
temperatures.
ii. Nucleophilic substitutions using metal phosphides: Alkali-metal
diphenylphosphides (MPPI1 2) can be prepared in a number of ways; by the cleavage 
of a phenyl group in triphenylphosphine by lithium, sodium or potassium, from 
chlorodiphenylphosphine and the alkali metal or from diphenylphosphine and 
butyllithium. The leaving group on the organic precursor is usually a halide, tosylate 
or mesylate.
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iii. Reduction o f phosphine oxides and sulphides: This presents a useful method for the
preparation of optically active tertiary phosphines. Powerful reductants such as 
UAIH4  and HSiCl3 are required to reduce the P=0 bond owing to its strength.
More recent methods for the preparation of both symmetrical and unsymmetrical 
tertiary phosphines include hydrophosphinations1 9 ,2 0  and metal catalysed 
phosphinations 2 1 5 2 2
PCI3  + 3RMgX or 
3RLi
R3 P(0) + SiHCl3
PM3  + 3RX
PH3  + C=C or C=0
Figure 2.9: Common methods for the preparation of tertiary phosphines.
2.7 Aims
Previous work within our group has illustrated that bidentate phosphine complexes 
of platinum (II) show potential as catalysts for the reduction of silver in a Timm’s type 
reaction. The aim of this work was to synthesise simple bidentate phosphine ligand 
complexes (figure 2 .1 0 ) which are functionalised, such that they can be modified to an 
enzyme substrate (e.g. alkaline phosphatase). The activity of these complexes was 
compared with a series of platinum complexes based on bis(diphenylphosphino)ethane.
MeO MeO
[Pt(2.4>] [Pt(2.7)J
Figure 2.10: Target Ligands
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Results and Discussion
2.8 Synthesis of l,2-Bis-diphenyIphosphino-4-methoxy-benzene [2.4]
The diphosphine ligand [2.4] was synthesised in four steps (figure 2.11), from the 
commercially available nitro compound, 4-bromo-3-nitroanisole in an overall yield of 8  %.
Me<X ^NOi _ M e O ^ ^ ^ /N H 2
Br 79% 30 % ^  Br
[2 . 1 1  I2-2!
6 8 %
M e0Y ^ / PPh2 d M e0\ ^ ^ / P P h 2
^ > P h 2 ’ 47%
[2.41 12-31
Figure 2.11: The synthesis of [2.4]. Reagents and conditions: (a) Fe, EtOH, HC1; (b) i) NaN02, HC1, ii) KI; 
(c) PPh2H, Pd(PPh3)4, toluene, Et3N; (d) i) «-BuLi, ii) PPh2Cl.
Initial attempts to reduce the nitro function to the amine using an iron/acetic acid 
mixture2 3  proved unsatisfactory. Although product [2.1] was formed, it was contaminated 
with unreacted starting material and unwanted by-products. Alternatively, a solution of 4- 
bromo-3-nitroanisole in ethanol, in the presence of iron and concentrated hydrochloric 
acid2 4  afforded 2-bromo-5-methoxyaniline [2.1] in 79 % yield, without the need for further 
purification (figure 2.11). The appearance of two sharp peaks in the IR spectrum at 3502 
and 3407 cm' 1 confirm the presence of the primary amine. Other spectroscopic data is 
consistent with that in the literature. 2 4
The amine [2.1] was converted to [2.2] through the nucleophilic attack of iodide on 
the aryl diazonium salt intermediate. Thus a solution of [2.1] in aqueous sodium nitrite and 
concentrated hydrochloric acid was added to a solution of potassium iodide, with stirring 2 5  
to give 2-bromo-3-iodoanisole [2.2] in 30 % yield (figure 2.11). Experimental data was 
consistent with that previously reported. 2 5
Since the early work of Heck2 6  in the 1960’s, palladium catalysed coupling 
reactions have become significant in the formation of carbon-carbon and carbon- 
heteroatom bonds. 2 7 ' 2 9  Work by Stelzer has shown that bromo-phenylphosphine can be 
synthesised in high yields from or/Zzo-bromoiodobenzene and diphenylphosphine by a Pd° 
catalysed P-C coupling. 3 0  Using Pd(PPh3 ) 4  as the catalyst, (2-bromo-5-methoxy-phenyl)-
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diphenyl-phosphine [2.3] was prepared in a 6 8  % isolated yield as a cream solid (figure
2.11). It is noteworthy that the presence of the anisole substituent has an influence on the
efficiency of the cross-coupling reaction. The ortho-para activating nature of this group
deactivates the meta position towards nucleophilic attack, which contributes to the lower
yield relative to that of bromophenyl phosphine.
During this work it was observed that under the conditions of Stelzer, poor yields of
[2.3] were obtained with most of the PI1 2PH remaining unreacted. Product [2.3] was
identified by a singlet in the 3 1 P{1H} NMR spectrum ( 8  -3.6 ppm), which is consistent with
that observed for (2-bromo-phenyl)diphenyl phosphine ( 8  -3.5 ppm) Addition of further
catalyst increased the amount of product formed, thus suggesting the deactivation or
poisoning of the catalyst during the course of the reaction. In order to avoid this
reoccurring, an excess of Pd(Ph3 P) 4  was used, yielding only the desired product in a
1 1 ^reasonable yield ( 6 8  %). The H and C NMR spectra are consistent with those reported
-5A
for (2 -bromo-phenyl)diphenyl phosphine.
The diphosphine [2.4] was generated by the halogen-exchange of [2.3] with w-butyl 
lithium followed by quenching with chlorodiphenylphosphine (figure 2.11). Washing with 
petrol afforded the air sensitive ligand [2.4] as an oil (47 %).
The chemical shift difference between the two inequivalent phosphorus centres is 
small giving rise to a second order 3 1 P{!H} NMR spectrum. This prevents the direct 
measurement of 3Jpa-pb- Using gNMR3 1 the values have been calculated to be 8 a = -11.08, 
8 b = -15.70 with 3Jab as 152 Hz and V1 /2 = 2 Hz (where V1 /2 = the line width at V2 height). 
These values are comparable to those reported in the literature for the two adjacent 
diphenyl phosphines in 1,2-bisdiphenylphosphine. 3 2  The NMR spectrum is consistent 
with the structure.
2.9 Synthesis of l-Diphenylphosphino-2[(diphenylphosphmo)-methyl]-4- 
methoxy benzene [2.7].
[2.7] A
Figure 2.12: Target ligand [2.7] and phosphine A.
It was initially proposed that the phosphine compound [2.7] could be prepared from 
the phosphonium salt of 4-bromo-3-(bromomethyl)-l-methoxybenzene, upon treatment 
with base (figure 2.13). The synthesis of the phosphonium salt was envisaged to be
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achieved by refluxing the dibromide with diphenylphosphine in THF using a variation of 
the synthesis of A (figure 2.12) . 3 3
MeOMeO MeOBr PPhsH, THFNBS PPh
reflux Br
Figure 2.13: Attempted synthesis of phosphonium salt.
The reaction mixture was refluxed for a total of three weeks, and the course of the 
reaction monitored by 31P NMR spectroscopy. Three signals were observed in the 
spectrum, a major peak at 5 -40 ppm, (PPh2 H) and two minor resonances at 8  24 and -12 
ppm. Phosphonium salts are typically observed in the region of 20-30 ppm thus confirming 
the presence of a phosphonium species, whilst the signal at - 1 2  ppm can be assigned to a 
free triarylphosphine. Although it appeared that the desired species was formed, the slow 
conversion led us to devise an alternative methodology.
To this end, the diphosphine [2.7] was synthesised via a three step procedure from 
4-bromo-3-methylanisole (figure 2.14) in an overall yield of 7 %.
MeO MeO
37%Br
MeO
48%
[2.5]
X X
[2.6]
41 %
Me° T ^ T ^ p p h 2
^ ^ T P h 2
[2.7]
Figure 2.14: The synthesis of [2.7]. Reagents and conditions: (a) Li, ether; (b) ClPPh2; (c) i) w-BuLi, ii)
ClPPh2.
4-Lithio-3-methylanisole [2.5] was prepared by the lithiation of 4-bromo-3- 
methylanisole3 4  (figure 2.14). The organolithium species was subsequently used as an ether 
solution, the concentration of which was determined by a Gilman titration. 3 5
A solution of chlorodiphenylphosphine was added dropwise to the organolithium 
solution resulting in the precipitation of LiCl. The solution was filtered and dried in vacuo 
to give the crude product as a yellow oil. Recrystallisation from petrol afforded the air
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sensitive compound [2.6] as a white crystalline material (48 %). The 31P{1H} NMR 
spectrum shows a singlet at 5 -14.13 ppm indicating the formation of the mono phosphine. 
This resonance is observed upfield of product [2.4]. This can be accounted for by the 
presence of the anisole being para to the phosphine as opposed to meta {cf. p-MeO- 
C6H4 PPh2 5 (ppm) -12.03 36 and m- MeO-C6 H4 PPh2 5 (ppm) -3.8137).
Compound [2.7] was prepared in a two-step process, deprotonation of the terminal 
methyl group by «-butyllithium, followed by nucleophilic attack by the phosphine to afford 
the crude product as a viscous oil. Recrystallisation from hot methanol afforded the air 
sensitive compound [2.7] as a white solid in a 41 % yield. The first order 31P{1H} NMR 
spectra shows a pair of doublets exhibiting a roof effect at 8a -12.31 and 8b -  18.06 with 
Vab as 13.67 Hz.
2.10 Platinum complexes Pt[2.4] and Pt[2.7]
Addition of a 1: 1 ratio of the free ligands [2.4] or [2.7] to Pt(COD)Cl2 in DCM 
afforded the corresponding platinum (II) complexes Pt[2.4] and Pt[2.7] as white air stable 
compounds in 60 and 51 % yields respectively (figure 2.15).
MeOMeO
[Pt(2.4>] [Pt(2.7>]
Figure 2.15: The platinum complexes of [2.4] and [2.7].
2.10.1 [Pt(2.4)]
The 31P{1H} NMR spectrum shows an AB pattern which is coupled to 195Pt (30 %), 
with 8a (40.54 ppm), 8b (37.72 ppm), Vpa-pt (3629 Hz) and 3Jpb-pt (3584 Hz). The signals are 
shifted downfield with respect to the free ligand, indicative of coordination. Assignment of 
a cis or trans geometry at the platinum centre are based upon values of ^ (P t195-31?) of 
approximately 3500 or 2500 Hz respectively.38,39,40 The coupling constants between the 
phosphorus and the metal nuclei is dependent on the electron density in the P-M bond. The 
observed coupling constants are therefore in agreement with a cis conformation. The *H 
NMR spectrum also shows a downfield shift of the aromatic proton peaks. In the mass 
spectrum a molecular ion peak is observed at 707.07 Da/e [-C1] consistent with one 
coordinated ligand, there is also a minor peak at 507 corresponding to oxidised free ligand.
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The IR spectrum confirms the presence of P-phenyl bonds with a stretching vibration 
observed at 1433 cm'1.
2.10.2 Pt[2.7]
Due to the small quantity of product synthesised full characterisation of the complex 
was not possible. An ESI MS was obtained showing the molecular ion at 723.06 Da/e (-C1). 
Again there is a minor peak at 522 corresponding to oxidised free ligand.
2.11 Platinum Complexes of Bis-Diphenylphosphmoethane.
A series of phosphine complexes with a range of coordinating ligands were 
prepared to establish whether there are any trends in catalytic behaviour towards the 
reduction of silver. Diphenylphosphinoethane (dppe) is a versatile ligand which forms 
complexes with a variety of metals in either a bridging or chelating manner. 4 1  The 
availability, along with the ease of preparation of air stable platinum complexes, made dppe 
a suitable choice for the constant bidentant ligand. Complexes [2.8]-[2.14] were synthesised 
by previous literature methods (figure 2.16) 4 2 - 4 6
P h !hcp. ClVp' NC1
Ph Ph
[2.8]
Ph.
Ph/
[2.13]
Ph ^hPh 
r Ps ,p- ,
I  A J
p r c
Pfa/Ph PhPhj 
n  oi
2+
e
Ph
S\ / 
Pt
f  \ S/ i
[2.14]
Ph Ph PhPh
r ^ P\  P'^ 1 cCO —"C ap p. "  '\
ph Ph Phph 
[2.10]
Pv S- 
P S'
ph Ph
[2.11]
c:ph^h-ps APt P 'i
Pfa/Ph
[2.12]
Figure 2.16: The preparation of the complexes [2.8] -  [2.14]. Reagents and conditions: (a) dppe (1 eq), 
EtOH/H20 , reflux; (b) NaBH4; (c) sulfur, benzene; (d) Mel, DCM; (e) 1,2-ethanedithiol, DCM, Et3N; (f) 1,2-
benzenedithiol, DCM, Et3N.
The physical reducer solution, which is added to aqueous silver ions, is composed 
of sulfur containing compounds 4 7  This solution slowly reduces the silver ions to silver 
metal. Since the presence of the sulfur may aid the redox process it was thought that
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phosphine sulfur compounds may also reduce silver. Dithiolates have been shown to act as 
electron transfer mediators 46 and hence were included in the investigation.
No Complex 5p Jp.pt reference
(2.8] Pt(dppe)Cl2 41.84 3620.44 48
(2.9] Pt(dppe)2Cl2 a 49.50 2313.39 48,49
[2.10] Pt°(dppe)2 a 31.07 3730.6 50
[2.11] Pt(dppe)S4 49.55 2810.6 51
[2.12] Pt(dppe)I2 46.6 3367.55 52
[2.13] Pt(dppe)SCH2CH2S 46.34 2748.08 46
]2.14] Pt(dppe)SC<>H4S 45.53 2780.97 46
a recorded in D20
Figure 2.17:31P NMR data for the complexes [2.8]-[2.14].
2.12 Laboratory Testing of Complexes.
To establish whether the synthesised compounds are suitable for our application a 
series of screen tests were performed in the lab.
2.12.1 Testing for Catalytic Activity.
A simple test using the physical developer developed by Newman and Jasani47 was 
set up. This involved the addition of 1-5 mg of compound to 2 mL of the physical 
developer. The rate of deposition of silver metal, observed by the darkening of the solution 
was recorded.
2.13 Preparation of the Physical Developer
The physical developer is comprised of two stock solutions. For both solutions, 
glassware was cleaned with chromic acid, 0.1 M hydrochloric acid and distilled water. The 
silver and reducer solutions can be stored separately in the refrigerator for up to one year, 
although adjustments to the pH may be required.
2.13.1 Silver Stock Solution
To prepare the silver solution the chemicals (figure 2.18) are added sequentially to a 
stirred volume of water less than the final required volume (approx 150 mL for 200 mL), 
making sure each chemical has fully dissolved before adding the next. The pH is monitored 
using an accurately calibrated pH electrode. The solution is decanted into a volumetric flask 
and made up to the correct volume with distilled water.
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Stock For 200 mL pH Final conc.
tris[hydroxymethyl]aminomethane 
(Tris base)8
36.3 g 11.33 1.5 M
Silver nitrate 600 mg 11.18 0.3 %
Acetic acid (glacial) 11.4 mL (approx) 7.41 -
Distilled water To 200 mL 7.4 -
8 manufactured by Boehringer Mahnhein.
Figure 2.18: The silver stock solution
2.13.2 Reducer Stock Solution
This solution is initially prepared as two separate solutions 
and 2.20) which are later combined to give the final reducer stock, 
in the same manner as the silver stock solution.
Solution A
For 200 mL pH Final conc.
Citric acid (H20 ) 1.05 g 2.35 0.025 M
Sodium Sulphite (anhydrous) 1.00 g 4.42 0.5 %
Sodium thiosulphate (5.H20 ) 0.25 g 4.34 0.125%
Pyrogallol 3.00 g 4.39 1.5%
Polyethylene glycol 1500 20.0 g 4.74 10%
Sodium citrate (2.H20 ) approx 0.70 g 5.11 -
Distilled water (up to) 100 mL 5.00 50%
Figure 2.19: Solution A of the reducer stock solution.
Solution B
For 200 mL pH Final conc.
Glycerol 20 mL - 10%
Ethanol 80 mL - 40%
Final volume 200 mL 5.791
Figure 2.20: Solution B of the reducer stock solution.
(A and B, figures 2.19 
Solution A is prepared
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2.14 Complex Testing
Figure 2.21 summarises the screen tests performed.
Compound Colour Solubility in the physical developer First noticeable darkening
Pt(COD)Cl2 Cream Insoluble instant
Pt(COD)I2 yellow Insoluble instant
Dppe white Insoluble No reaction
[Pt(2.4)] White Insoluble 14 minutes
|Pt(2.7)] White Insoluble 15 minutes
[2.8] white Insoluble 20 minutes
[2.91 white Insoluble No reaction
[2.101 yellow N/A N/A
[2.111 yellow Insoluble 6 minutes
[2.121 yellow Insoluble 5 minutes
[2.131 white Insoluble No reaction
[2.141 white Insoluble No reaction
Figure 2.21: Results of laboratory testing of complexes.
2.15 Conclusion
The ligands/complexes [2.4]/ [Pt(2.4)J and [2.7]/ [Pt(2.7)J were functionalised with 
an anisole moiety. In the future, demethylation to the phenol would allow the introduction 
of a phosphate group and hence render the compounds suitable substrates of alkaline 
phosphatase. The platinum (II) complexes [Pt(2.4)J and [Pt(2.7)] show potential as 
catalysts for the reduction of silver in a Timm’s type reaction with noticeable darkening 
(precipitation of silver) of the physical developer solution occurring in 14 and 15 minutes 
respectively. Subsequent silver precipitation is gradual over a period of 30 minutes. The 
redox activity of various platinum dppe complexes [2.8] -  [2.14] were also investigated. 
The complexes [Pt(dppe)2 ]2+ and the dithiolate complexes [Pt(dppe)SCH2 CH2 S] and 
[Pt(dppe)SC6 H4 S] showed no redox activity for the reduction of silver ions. The complexes 
Pt(dppe)Cl2 , Pt(dppe)S4  and Pt(dppe)l2  showed redox activity in times of 20, 6 and 5 
minutes respectively. Since the bidentate phosphine remains constant we can postulate that 
the variable ligands (e.g. tetrasulfido, iodide, chloride etc.) play some role in the silver 
reduction mechanism. However, the chemistry for the reduction of silver ions in a Timm’s 
type reaction is poorly understood.
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Experimental 
General Procedure
All experiments were carried out under an atmosphere of dry nitrogen using 
standard Schlenk line techniques. All solvents were dried and degassed by reflux over 
standard drying agents under a nitrogen atmosphere. Dichloro(l,5- 
cyclooctadiene)platinum(II),54 Pt(dppe)Cl2 ,45 PtII(dppe)2 ,48 Pt°(dppe)2 ,43 Pt(dppe)S4 ,44 
Pt(dppe)l2 ,42 Pt(dppe)(SCH2 CH2 S)46 and Pt(dppe)(SC6 H4 S)46 were prepared according to 
literature methods. Non-synthesised reagents were purchased from Aldrich, Avocado or 
Lancaster and were used as received. Where appropriate, chemicals were dried over 
molecular sieves and freeze-thaw degassed. The NMR spectra were recorded on a Bruker 
Avance AMX 400 instrument at 400 MHz (JH) and 100 MHz (13C), JEOL Lamda Eclipse 
300 at 121.65 MHz (31P); *H and 13C chemical shifts are quoted in ppm relative to residual 
solvent peaks and 31P chemical shifts are quoted in ppm relative to external 85 % H3 PO4  (5 
0). Coupling constants are quoted in Hertz. Mass spectra were obtained in El (electronic 
ionisation mode). IR spectra were obtained using a Jasco FTIR 110 series spectrometer.
[2.1] 2-Bromo-5-methoxyaniline
MeCk .NH2
Br
This was prepared according to a literature procedure by Tidwall.24 4-Bromo-3-nitroanisole 
(14.03 g, 60.5 mmol), iron powder (10.14 g, 181.6 mmol), ethanol (200 ml) and 
concentrated hydrochloric acid (28.9 ml of a 32 % solution) were added to a round 
bottomed flask. The reaction mixture was heated to reflux for 4 h. The solution was 
allowed to cool to room temperature and sodium carbonate was added until no more 
bubbling occurred. Ether (100 ml) was added and the reaction mixture was washed with 
water (3 x 100 ml), brine (100 ml) and dried over anhydrous magnesium sulfate. The 
solvent was evaporated in vacuo to give 2-bromo-5-methoxyaniline [2.1] as a red oil, 
without the need for further purification (9.61 g, 79 %); 8H(400 MHz; CDCI3 ) 7.38, (1H, d, 
J  8.0), 7.30 (d, 1H, J  2.93), 6.7 (dd, 1H, J  8.80, 2.93), 3.9 (br s, 2H, NH2\  3.69 (s, 3H, 
OC//3 ); 8C(100 MHz; CDCI3 ) 160.0, 144.5, 133.2, 105.3, 100.9, 100.0, 55.7; IR (NaCl, 
cm'1) 3041, 2990, 2966, 3244, 1624, 1580, 1447, 1425, 1321, 1277, 1190, 1150, 1046, 
1007,948 and 843. m/z (APCI) 203 [M+l],
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[2.2] 4-Bromo-3-iodoanisole
  'yc
This was prepared according to a literature procedure by Tanida. Into a mixture of [2.1] 
(9.61 g, 47.6 mmol), concentrated hydrochloric acid (22.3 ml) and cracked ice (14.7 g) was 
added a solution of sodium nitrite (3.66 g) in water (14.7 ml) at 0 °C. The reaction mixture 
was stirred for 25 min, the deep orange solution which resulted was filtered. This solution 
was slowly added at 5 °C, to a solution of potassium iodide (27.1 g, 163.6 mmol) in water 
(89 ml). The reaction mixture was left to stand overnight at room temperature. The violet 
oil which separated, was extracted with ether (3 x 100 ml), washed with 10 % aqueous 
sodium hydroxide (2 x 100 ml), water (2 x 100 ml) and 5 % aqueous sodium sulfite (100 
ml) and dried over anhydrous sodium sulfate. The solvents were removed in vacuo to give 
the crude product as a dark red oil. The residue was distilled at 130 °C on a Kugelrohr 
apparatus to afford [2.2] as a yellow oil. (3.85 g, 30 %); 8h (400 MHz; CDCI3 ) 7.15 (d, 1H J  
8.7), 6.2 (d, 1H, J  2.8), 6.1 (dd, 1H, J  2.8, 8.7), 3.65 (s, 3H, OC//3); m/z (APCI) 314 
[M+l]. Other data are consistent with the literature. 2 5
[2.3] (2-bromo-5-methoxy-phenyl)-diphenyl-phosphine
Me° Y ^ Y P P h 2
This was prepared in a method analogous to that of Stelzer, 3 0  where 4-bromo-3-iodoanisole 
[2.2] replaces 2-bromoiodobenzene. To a solution of [2.2] (3.81 g, 12.18 mmol) and 
diphenylphosphine (2.5 g, 13.43 mmol) in toluene (31 ml), triethylamine (1.5 g, 14.82 
mmol) was added. After the addition of Pd(PPh3 ) 4  (0.087 g, 0.07 mmol), the mixture was 
stirred at 90 °C for 4 h, resulting in a purple solution. The toluene was removed in vacuo to 
give a brick red solid which was dissolved in dichloromethane (30 ml), washed with water 
(30 ml) and dried over anhydrous magnesium sulfate. The solvents were removed in vacuo 
to give a pale orange solid, which was washed with hot methanol to afford [2.3] as a cream 
solid (3.23 g, 6 8  %); 8H(400 MHz; CDC13) 7.37 (dd, 1H, J  8.72, 3.96 ), 7.21 (m, 10H), 
6.62 (dd, 1H, J 8 .6 6 , 3.05), 6.2 (t, 1H, J2.92), 3.43 (s, 3H); 5C (100 MHz, CDC13) 158.8, 
140.0 (d, Jcp 12.5), 135.7 (d, JCP 10.7), 134.2 (t, Jc? 20.9), 133.7 (d, JCP 2 2 .8 ), 129.0 (d, 
Jc? 16), 128.7 (d, Jq? 7.1), 120.5, 1 2 0 . 1  (d, Jc? 29.9), 115.5, 55.2; 8 P{H} (121.65 MHz; 
CDCI3 ) -3.33.
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[2.4] 1,2-Bis-dipheny lphosphino-4-methoxy-benzene)
This was prepared in a method analogous to that of Tunney and Stille, 2 1  where (2-bromo-5- 
methoxy-phenyl)-diphenyl-phosphine replaces (2-bromophenyl)diphenylphosphine. To a 
cooled (-78 °C) solution of [2.3] (2.63 g, 7.08 mmol) in THF (77 ml) was added dropwise a 
solution of w-BuLi in petrol (4.4 ml of a 2.21 M solution) and was stirred for 30 min at -78 
°C. To this chlorodiphenylphosphine (3.2 ml, mmol) was added dropwise, and the 
temperature was raised to room temperature then stirred overnight. Water (15 ml) was 
added to quench the solution, dichloromethane (20 ml) added, washed with saturated NaCl 
(30 ml) and dried over magnesium sulfate. The solvent was removed in vacuo to yield the 
crude product as an opaque yellow oil. Petrol (30 ml) was added, instantly forming a cream 
precipitate. The petrol solution was filtered off and cooled to -35 °C. The petrol solution 
was removed from the solid that had formed to afford [2.4] as an oil (1.58 g, 47 %); 8 h (400 
MHz, CDC13) 7.31 (m, 1H), 7.20-7.25 (m, 20H), 6.75 (m, 1H), 6.45 (m, 1H), 3.50 (s, 
3H); 5C (100 MHz, CDC13) 160.2, 137.7 (d, JCp 11.5), 137.0 (d, JCp 11.5), 136.8, 136.1 
(Jcp 6.9), 134.1-133.4, 132.7 (JCp 18.1), 128.7-128.1, 119.5 (JCp 8.4), 114.5, 54.9; 5P{H} 
(121.65 MHz, CDCI3 ) 8 a = -11.08,8B = -15.70 with 3J AB as 152 H z .
Pt[2.4] l,2-Bis-diphenylphosphino-4-methoxy-benzene Platinum (II)
MeO
To a solution of (1,5 cyclooctadiene)dichloro platinum(II) (0.72 g, 1.92 mmol) in DCM (15 
ml)was added to a solution of l,2-bis-diphenylphosphino-4-methoxy-benzene [2.4] (0.97 g,
2.04 mmol) in DCM (20 ml) and stirred overnight. Ether (25 ml) was added dropwise to the 
solution to precipitate out the complex as a crude solid. Recrystallisation in hot 
dichloromethane (10 ml) yielded the pure complex Pt[2.4] as an off-white solid (0.90 g, 60 
%); 5h (400 MHz, CDC13) 7.7 (m, 10H, Ai-H) 1A-1.5 (m, 11H, Ai-H ), 7.1 (m, 1H, Ai-H ), 
6.95 (d, 1H, J9.57, Ai-H), 3.7 (s, 3H, OCH3); 5P{H} (121.65 MHz, CDC13) 8 Pa 40.54 (JPa.pt 
3629), 8 pb 37.72 (Jn .n 3584); IR (KBr, cm'1) 3005, 2945, 2885, 2825, 1579, 1473, 1433, 
1332, 1307,1272,1227,1182,1096, 1006, 830, 750,695 m /z(ES) 707.07.
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[2.5] 4-Lithio-3-methylanisole
This was prepared according to a literature procedure by Mckinstry. 3 4  An oven dried, 250 
mL, three-necked, round-bottomed flask was fitted with a pressure equalising dropping 
funnel, condenser and glass stopper and was purged with argon. Lithium powder alloyed 
with Na (2.86 g) was added and washed with petroleum ether (15 ml x 3), then ether (156 
ml) was added. A solution of 4-bromo-3-methylanisole (11.2, 55.7 mmol) in ether (50 ml) 
was slowly added dropwise. The solution was heated with the aid of a heat gun, to bring it 
to reflux. The yellow solution was stirred at room temperature for an additional 2 h. 
Titration against standardised 0.1 M HC1 confirmed that the reaction had been a success. 
(2.69 g, 37%).
[2.6] (4-Methoxy-2-methyl-phenyl)-diphenyI-phosphine
Under argon, a solution of chlorodiphenyphosphine (1.229 g, 6 . 6  mmol) in ether (20 ml) 
was added dropwise to a cooled (-78 °C) solution of [2.5] (0.021 moles in ether (2.69 g, 21 
mmol). The solution was allowed to stir at room temperature for 2.5 h to give a cream 
coloured precipitate in a pale yellow solution. The ether solution was filtered off and 
removed in vacuo to a give the crude material as a yellow opaque oil. Petrol (20 ml) was 
added to the oil, instantly forming a cream solid, the petrol was filtered off and was left 
overnight to yield the pure product [2.6] as small white crystals (3.08 g, 48 %); 8h (400 
MHz, D2 0) 7.05-7.20 (m, 10H), 6.65 (t, 1H, J3.25), 6.60 (dd, 1H, J8 .33 , 4.41), 6.50 
(dd, 1H, J  8.46, 2.48), 3.60 (s, 3H, OMe), 2.20 (s, 3H, Me); 8 C (100 MHz, CDC13) 23.5 
(d, JCP 30.7, CH3), 55.1 (OCH3), 111.3 , 117.4, 128.0 (d, Jcp 6 .6 ), 132.2 (d, Jcp 19.2),
138.5,145.3 (d, Jcp 28), 161.5; 8 P{H} (300 MHz; D2 0) -14.13 .
[2.7] l-Diphenylphosphmo-2[(diphenylphosphino)-methyl]-4-methoxybenzene
To a cooled solution (-78 °C) of [2.6] (0.42 g, 1.37 mmol) in THF (20 ml) was added «BuLi 
(0.63 ml of a 2.12 M solution in petrol) and was stirred for 45 min. 
Chlorodiphenylphosphine (0.3 ml) was added and the temperature was allowed to rise to
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room temperature and the stirring continued overnight. The solution was quenched with 
water (10 ml) and extracted with DCM (10 ml). The organic phase was washed with 
saturated NaCl (20 ml) and dried over magnesium sulfate. The solvent was removed in 
vacuo to give a viscous liquid. The crude product was recrystallised in hot methanol twice 
to give the pure product [2.7] as a white solid (0.27 g,41 %); 8h(300 MHz, CDCI3 ) 3.3 (s,
This was prepared in a similar manner to [Pt(2.4)J. The applied reagents were [2.7] (0.1 g,
0.20 mmol) and Pt(COD)Cl2  (0.08g, 0.20 mmol) to afford [Pt(2.7)] as a white solid (0.07g, 
51 %); m/z (ES) 723.06 [-C1].
3H, OC//3 ), 3.7 (s, 2H, CH2), 6.57 (d, 1H, J8.58, Ai-H), 6.7 (dd, 2H, J8 .58, 4.62, Ai-H ),
7.3 (m, 2 1 H, Ai-H), 8 P{H} (121.65 MHz, CDC13) -12.311,- 18.062 (VAB 13.67 Hz).
Pt[2.7]
Ph
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Chapter 3
Markers based on porphyrin ligands
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Introduction
This chapter presents the preparation of markers based on functionalised meso-tetra- 
arylporphyrins. Platinum and palladium complexes were prepared and their catalytic 
activity towards the reduction of silver in a Timm’s type reaction was investigated.
3.1 Background
The porphin nucleus is comprised of four pyrrole rings joined by four methane 
bridges, giving rise to highly conjugated macrocycle. There are nominally 22% electrons but 
only 18 of these are included within the delocalisation therefore conforming to Hiickel’s 4n 
+ 2  rule for aromaticity.
Porphin
Figure 3.1: The Basic Porphin Framework
Porphin is the parent compound of the substituted derivatives known as porphyrins. 
The two most common patterns of substitution are at the pyrrole (P substitution) and the 
methane {meso substitution) positions. All naturally occurring porphyrins are substituted at 
the pyrrole positions whilst the meso substituted porphyrins are purely synthetic.
3.2 Occurrence of Porphyrins
Porphyrins and the related compounds are of great importance in the natural world. 
They constitute the prosthetic group of hemes (found in hemeoglobins and myoglobins) 
which are responsible for oxygen transport and storage in tissues. Reduction of one of the 
pyrrole units in porphin gives rise to a class of derivatives known as chlorins. These are 
found in chlorophylls which are found abundantly in green plants and play an important 
role in photosynthesis. Porphyrins and their derivatives are highly coloured compounds 
exhibiting very high extinction coefficients, they are often found in abundance in natural 
pigments.
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Me
Me
Heme
/H^C02C h  o  
:2oH3 9o A 0
Chlorophyll-a
Figure 3.2: The structures of Heme (iron (II) protoporphyrin IX) and chlorophyll-a
Both metallated and metal-free forms widely occur in nature. For example, Fe (II) is 
the metal found in hemes1 (e.g. iron (II) protoporphyrin IX) whilst Mg (II) is found in the 
chlorophylls. Isomers of coproporphyrin (I and III type) and protoporphyrin IX are found 
in nature in their metal free states. They are found in small traces in tissue fluids and in 
larger quantities in certain pathological conditions.
3.3 Metal Derivatives
The metal complexes of porphyrins are of great importance in nature, often essential 
to the life of animal and plant organisms. The metal-porphyrin motif is found in many 
enzymes (e.g. cytochrome P450), vitamins (e.g. vitamin B 1 2), photosynthetic agents (e.g. 
chlorophyll) and oxygen transfer agents (e.g. haemoglobin). Synthetic metalloporphyrins 
are utilised in other areas such as medicine and in electronic devices.
Metalloporphyrins are porphyrin derivatives where the lone pair of electrons on the 
central nitrogen atom is shared with a metal, alongside this the two hydrogen atoms on the 
pyrrole NH are replaced, thus two more lone pairs are donated to the valence shell of the 
metal. The donation of a-electrons from the four nitrogen atoms to the central metal gives 
rise to complexes of high stability.
H2(Por) + MX2 M(Por) + 2HX
+ m 2+
metallation
demetallation 
- 2H+
H2(Por) M(Por)
Figure 3.3: Formation of the equatorial coordination group of a monometallic porphyrin M(Por).
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A wide variety of metal porphyrin derivatives are known by the reaction of the free 
base porphyrin with the appropriate metal salt in a high boiling solvent. 4 ,5  The most 
commonly found coordination types found in metalloporphyrins are square (4 coordinate), 
square pyramidal (5 coordinate) and octahedral ( 6  coordinate). In cases where the 
coordination number exceeds four, the coordination sphere is completed by the 
coordination of axial ligands. The size of the porphyrin cavity can accommodate metal ions 
of radii 0.60 -  0.65 A . 4  Where the metal ion is too small, the porphyrin buckles (S4  
distortion) to accommodate the ion. For large ions, the metal sits either above or below the 
porphyrin equatorial plane.
equatorial plane 
axial positions
Figure 3.4: Illustration of the social and equatorial planes in a porphyrin
3.4 Porphyrin Properties
3.4.1 UV/Vis Spectra
In 1883 an intense absorption band at 400 nm was observed in hemeoglobin by 
Soret. 6  This intense absorption (e ~ 400 000 cm'1), now known as the Soret band, is 
exhibited in all fully conjugated tetrapyrroles and is characteristic of the macrocyclic 
conjugation. Porphyrins in their free-base form also exhibit four other bands (Q bands) in 
the region of 450-700 nm. The Soret band can be assigned to the aiu (31) to eg* (71*) 
transitions, whilst the Q band absorptions are ascribed to the two possible transitions from 
a2 u 00 to eg* (31*). Incorporation and alteration of the peripheral porphyrin substituents may 
result in minor changes in the wavelength of the absorptions.
3.4.2 Metalloporphyrins
In simple square planar porphyrin complexes, an altered UV/Vis spectrum is 
observed, with the retention of the Soret band and the appearance of two visible bands 
labelled a and p.
The absorption spectra of metalloporphyrins can be placed into three categories:
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i. Normal Spectrum
This is observed for all d° and d 1 0  ions. The porphyrin it orbitals do not significantly 
interact with the metal n orbital (pz or dxz, dyz). A bathochromic shift of the 
absorption bands is seen upon increasing atomic number. Complexes exhibiting a 
‘normal type’ spectrum are purple in colour.
ii. Hypso Spectrum
This is found in d6 -d9  metalloporphyrins. The metal dxz and dyz orbitals are of the 
correct symmetry to overlap with the porphyrin n levels, which results in 
backbonding from the metal to the porphyrin. Increasing the atomic number results 
in increased backbonding thus increasing the shift (e.g. Ni(II) < Pd(II) < pt (ii)). 
Thus the hypso spectrum is defined as ‘a normal spectrum with hypsochromic shifts 
to all bands’ . 5 The colour of these complexes is red to orange.
iii. Hyper Spectrum.
This is observed for d*-d5 ions. The spectrum consists of more-or-less shifted a, (3 
and Soret bands and one or more additional bands. 5 Most of the metal ions in this 
class can realise lower oxidation states within the porphyrin which then causes 
normal light absorption. Common examples of this type are exhibited in Fe (III) and 
Mn (III) porphyrins. Complexes of this class are brown or green in solution.
Porphyrins are well known for their robust nature exhibiting stability to both strong 
acids and bases. The extended 18 n electron system affects the range of remarkable
n
properties of these macrocycles. This extended n system present in porphyrins generates a
o
HOMO and LUMO that are separated by only 2 eV, thus giving rise to materials with 
interesting photophysical and conductivity properties. Porphyrins and metalloporphyrins 
have similar energies of the singlet and triplet excited states, high intersystem crossing 
yield and long triplet lifetimes making them of use as excellent photosensitisers.
3.5 Routes of Synthesis
The vast amount of research that has been carried out on porphyrins has led to 
numerous routes of preparation. These can be divided into two main categories; the 
transformation of naturally occurring porphyrins and the more widely used total synthesis. 
In the total synthesis the choice of method is dependent on the symmetry and the pattern of 
substitutions. Since the work undertaken has solely focused on /weso-tetraaryl porphyrins, 
only their syntheses shall be considered.
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Symmetrical tetra-aryl porphyrins can be prepared by the cyclocondensation of 
pyrrole and benzaldehyde. In many cases the porphyrin product is contaminated with the 
corresponding chlorin which can be either converted to the porphyrin using an oxidant (e.g. 
DDQ9) or separated by chromatography.
3.5.1 Rothemimd and Adler-Longo Methods
Tetraphenylporphyrin was first synthesised in 1936 by Rothemund, by reacting 
benzaldehyde and pyrrole in pyridine in a sealed bomb at 150°C for 2 h . 1 0 The yields were 
low and the severe conditions that were used meant that few substituted benzaldehydes 
could be converted to the corresponding porphyrin. Since then, other methods of 
synthesising porphyrins have been developed, but the simple method of Adler and Longo 
whereby benzaldehyde and pyrrole are reacted in refluxing propionic acid11 exposed to air, 
is one of the most widely used (figure 3.5). These conditions, which are milder than 
previous, allow for a wider range of substituted benzaldehydes to be used. This preparation 
enables large-scale synthesis in yields of up to 20 %. The main drawback of this synthesis 
is the formation of tarry by-products (polymerised pyrrole), chlorin contamination and its 
unsuitability when acid sensitive benzaldehydes are used.
propionic acid
J  H 
+
ON
H
reflux, 30 min
Figure 3.5: The Adler-Longo method, exemplified for meso-tetraphenylporphyrin [H2(TPP)]
3.5.2 Lindsey Method
10Lindsey developed a methodology that allowed porphyrins from sensitive
13benzaldehydes to be prepared in higher yields than the previous methods (30-40 % ). This 
synthesis proceeds via the porphyrinogen by the reversible reaction of a benzaldehyde and 
pyrrole. The reaction is performed at room temperature under an inert atmosphere in 
dichloromethane in the presence of boron trfluoride etherate. Addition of a stoichiometric 
amount of oxidant, typically 2,3-dichloro-5,6-dicyano-l,4-benzoquinone (DDQ), oxidises 
the porphyrinogen (A) to porphyrin (B) (figure 3.6).
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Oxidation
HNNHH
25 °C
DDQ
Q
H
Porphyrinogen
(A) Porphyrin (TPP)
Figure 3.6: The Lindsey method, exemplified for /weso-tetraphenylporphyrin
In order to obtain maximal yields, high dilutions are required13 since the reaction 
has been found to be sensitive to concentration. This limits the reaction only being carried 
out on a small scale. In cases where the porphyrin product does not crystallise out (Adler 
method), the Lindsey method presents an attractive alternative since the production of tarry 
by-products is limited thus simplifying isolation and purification.
3.5.3 Unsymmetrical Tetra-aryl porphyrins
Unsymmetrical substituted aryl-porphyrins are often prepared with groups which 
are suitable for further modification. Simple porphyrins of type A3 B are useful precursors 
to more elaborate systems.
3.5.4 Mixed Aldehyde/ Statistical Approach
The preparation of porphyrins which have an A3 B substitution pattern can be 
achieved by the condensation of two different benzaldehydes with pyrrole. The 
condensation of a single benzaldehyde with pyrrole affords a symmetrical tetra substituted 
porphyrin. When two different aryl-aldehydes are reacted with pyrrole, up to six different 
porphyrins are formed (figure 3.7) . 12
The stoichiometry of the benzaldehydes used alters the ratio of the products, and by 
using the appropriate ratios, a mixture containing a majority of the A4  and A3 B porphyrins 
can be achieved. 1 2 ,1 4  This method, although simple, often requires elaborate and tedious 
separation techniques; the ease of this is dependent on the difference in polarity of the 
differing meso substituents. 15 Despite this, a statistical approach is commonly used to 
prepare A3 B type porphyrins. When performed using the Adler conditions isolated yields of 
A3 B porphyrins are seldom greater than 5 %.
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N H  H NN H  HNN H  H N
N H  HNN H  HN
Figure 3.7: The six possible porphyrin products from a mixed aldehyde condensation.
3.5.5 Other Methodologies
In addition to the above, other routes of synthesis are available particularly for the 
preparation of highly unsymmetrical porphyrin products. Many of these routes include 
substituted dipyrromethanes as the building blocks. 1 6 ,1 7  These synthetic methods allow 
more control over the pattern of substitution. One of the most successful routes is known as 
the ‘2 + 2 synthesis’ which was first devised by MacDonald1 8 and involved the use of a 
dipyrromethane with two formyl group a to the pyrrolic nitrogens and an unsubstituted 
dipyrromethane. The introduction of substituents at both the meso and p positions can be 
achieved by varying the substituents on the dipyrromethanes and the pyrrole precursors.
oxidant
Figure 3.8: MacDonald 2+2 condensation.
3.6 Aims and Objectives
Research in Cardiff has previously shown that group ten metal complexes of tetra- 
aryl porphyrins demonstrate the ability to reduce silver ions via a Timm’s type reaction. 19  
We proposed to synthesise aryl porphyrin systems based on group ten metals which feature 
a lysable enzyme substrate i.e. a phosphate moiety. Literature procedures for the 
phosphorylation of a species focus on the addition of a phosphate group to a hydroxyl
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containing compound2 0 ' 2 8  and in particular a phenol. We have devised two routes of 
preparation for phosphate containing porphyrins based on the relative ease of preparation of 
benzaldehyde precursors and the common practise of changing or introducing 
functionalities at the phenyl rings of a meso-tetra-arylporphyrin. This chapter outlines the 
attempted synthesis of both tetra and mono phosphorylated porphyrins from either the 
direct condensation of a benzaldehyde bearing a phosphate functionality with pyrrole or by 
the direct modification of a phenol porphyrin.
Results and Discussion
3.7 Synthesis of Phenol Substituted Porphyrins
3.7.1 Tetra Phenol Porphyrins (A4 )
Phenol derivatives of meso substituted porphyrins are often obtained from a 
protected species, most commonly the anisole. To this end, /weso-5,10,15,20-tetra (4- 
methoxyphenyl)porphyrin [3.1] was synthesised by the direct condensation of 4- 
methoxybenzaldehyde and pyrrole in refluxing propionic acid11 in a 2 0  % yield. 
Demethylation using boron tribromide at -80°C29 afforded meso-5,10,15,20-tetra-(4-
™  11
hydroxyphenyl)porphyrin ’ [3.2] as a purple solid in a 50 % yield (figure 3.9). Successful 
demethylation was indicated by the disappearance of the methoxyl protons at 4.0 ppm in 
the !H NMR spectrum whilst an OH stretching vibration at 3311 cm' 1 appears in the IR 
spectrum.
OMeMeO.
NH HN
5 0 %20%
MeO OMe
[3.1]
,OHHO,
NH HN
HO OH
[3.2]
Figure 3.9: Reaction scheme for the synthesis of porphyrins [3.11 and [3.2]. Reagents and conditions: (a)
propionic acid, reflux, 0.5 h; (b) BBr3, -80 °C.
Both the methoxyphenyl and hydroxyphenyl porphyrins [3.1] and [3.2] were 
metallated using palladium (II) dichloride in refluxing benzonitrile5 for 6  h to afford the 
corresponding Pd2+ complexes [Pd(3.1)] and [Pd(3.2)] as pink solids in 23 and 53 % yields 
respectively. Both complexes show the expected palladium isotope pattern in the MALDI
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mass spectrum (838.25 and 782.2 Da/e). As anticipated, in the absorption spectra, subtle 
hypsochromic shifts to the bands was observed consistent with the insertion of palladium.
3.7.2 Mono-Phenol Tri-Aryl Porphyrins (A3 B)
5,10,15-Tri-(4-tolyl)-20-(4-methoxyphenyI)porphyrin [3.3] was synthesised by an 
adaptation of the method reported by Little3 2  from a statistical mixture of 4- 
tolylbenzaldehyde and 4-methoxybenzaldehyde in a 20:1 ratio in a 11 % yield. The desired 
mono-substituted product [3.3] precipitates out of the reaction mixture along with
5,10,15,20-tetra-(4-tolyl)porphyrin (figure 3.10). The two porphyrins along with small 
amounts of poly-substituted tetra-arylporphyrins can be separated by column 
chromatography. On a small scale preparation purification is easily achieved, however, 
when performed on a larger scale, separation of the fractions by chromatography has 
proved problematic. This can be attributed to a small difference in Ry values of the two 
products.
OMe
Cnh HN + NH HN
OMe[33]
1 1 %
Figure 3.10: Reaction scheme for the preparation of [3.3] using a ‘mixed aldehyde’ approach. Reagents and
conditions: propionic acid, reflux, 0.5 h.
3.8 Use of an Alternative Protecting Group
To overcome the encountered problems associated with the separation of the two 
produced porphyrins a protecting group for the phenol with increased polarity was 
introduced, namely 3,4,5-trimethoxybenzoic acid phenyl ester [3.4] (figure 3.11).
OMe
[3.4]
Figure 3.11: Alternative protecting group.
The benzyl ester [3.4] was prepared from 3,4,5-trimethoxybenzoic acid via the acid 
chloride in 81 % yield. The IR spectrum confirms the presence of both ester and aldehyde
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functional groups with C=0 stretching frequencies observed at 1737 and 1699 cm' 1 
respectively. The mass spectrum shows the molecular ion for M+ at 317 Da/e.
Figure 3.12: The symmetrical and unsymmetrical porphyrins [3.5J and [3.6J.
To investigate the feasibility of protecting the hydroxyl group with the benzyl ester, 
compounds [3.5] and [3.6] were prepared (figure 3.12). The symmetrical porphyrin [3.5] 
was prepared in a 26 % yield. Reaction with platinum (II) dichloride in benzonitrile 
afforded the platinum complex [Pt(3.5)] as an iridescent pink solid. In the *H NMR 
spectrum, an upfield shift is observed to both p-pyrrole and phenyl protons adjacent to the 
porphyrin ring and the disappearance of the internal NH protons is indicative of platinum 
binding. Consistent with the coordination of platinum, a hypsochromic shift of 20 nm is 
seen in the UV/Vis spectrum whilst the disappearance of the NH stretch at 3318 cm ' 1 is 
observed. The molecular ion is observed at 1648 Da/e in the mass spectrum.
Using a statistical mixture of 4-tolylbenzaldehyde and [3.4] (20:1) afforded the 
corresponding A3 B porphyrin [3.6] in 6  % yield (figure 3.12). Eluting with chloroform on a 
silica column removes the symmetrical product, and the now increased separation of Rp 
values (0.053 versus 0.55) allows [3.6] to be separated by simply increasing the polarity of 
the solvent system (10 % MeOH). The signals in the *H NMR spectrum attributed to the 
pyrrole protons are made up of more than one component and other signals in the aromatic 
region are observed in the correct ratio of 3:1, indicative of the unsymmetrical nature.
3.8.1 Removal of Ester Groups
Hydrolysis of the benzyl ester group in [3.6] was attempted on a small scale using 
potassium hydroxide in refluxing THF for 2 hours. To aid solubility 1,4-dioxane was 
added. It was found that the benzyl ester groups were not readily hydrolysed under these
50
Chapter 3 - Porphyrins
conditions as confirmed by the mass spectrum, where only the ion for unreacted starting 
material [3.6] is seen.
Ester cleavage was alternatively performed using hydrazine monohydrate in ethanol 
(figure 3.13). The reaction of [3.5] was left for two days and the course of the reaction was 
monitored by thin layer chromatography. Filtration of the reaction mixture removes a large 
quantity of unreacted porphyrin; the phenol porphyrin being readily soluble in ethanol. 
Analysis of the mass spectrum indicates an incomplete reaction with observed ions 
corresponding to tetra-(4-hydroxyphenyl)porphyrin (MS M+ = 679) and partially 
hydrolysed material (MS M+ = 1356). Under analogous reaction conditions, analysis of the 
mass spectrum of the reaction of [3.6] shows ions corresponding to both unreacted and 
phenolic porphyrin materials, again indicating an incomplete reaction.
OHHO,
MeO. O M e
5 3 %2 6 %
OHHO
[3.8][3.5]
OMe
O,
OMe
Where R =
OMe
Figure 3.13: Reaction scheme illustrating the use of 3,4,5-trimethoxyben2yl ester as a protecting group for the 
phenol. Reagents and conditions: (a) propionic acid, reflux, 0.5 h; (b) hydrazine monohydrate, EtOH, reflux.
The conditions have not been optimised, never-the-less this method does illustrate 
potential as an alternative route for the synthesis of mono-substituted hydroxyphenyl 
porphyrins on a large scale. It is less suited to the tetra-substituted as the conditions do not 
give good yields when compared to current alternatives (pyridine hydrochloride3 4  and 
BBr3 ). Preparation of tetra-substituted hydroxyphenyl porphyrins is still best achieved by 
demethylation using boron tribromide.
3.9 Alternative Route to Phenol Containing Porphyrins
Due to the problems encountered with the purification and the de-protection 
procedure described above, an alternative phenolic benzaldehyde was used, namely 4- 
hydroxy-3-methoxy benzaldehyde (vanillin). 5,10,15,20-Tetra-(3-methoxy-4-
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hydroxyphenyl)porphyrin ’ and the mono-substituted A3 B porphyrins (where B =
-IQ
phenyl and B = tolyl ) have been previously reported.
OMe
OH OMe
h u
-OMe
+ o NH
16%
MeO
MeO
[3.9]
Figure 3.14: Preparation of [3.91 v‘a Adler methodology. Reagents and conditions: propionic acid, reflux, 0.5
h.
Porphyrins which contain vanillin moiety precipitate out of the propionic acid 
reaction mixtures thus eliminating the need for a protecting group. Using Adler 
methodology, [3.9] was prepared in 16 % yield (figure 3.14). Metallation was carried out 
using both platinum and palladium to afford [Pt(3.9)] and [Pd(3.9)]. In the UV/Vis spectra 
hypsochromic shifts were observed to the bands, an increased shift was observed in the 
platinum complex owing to increased metal-porphyrin backbonding. 5 Porphyrins of the 
A3B type [3.10] and [3.11] were also prepared (figure 3.15); the obtained data was 
comparable to the literature. 3 8 ,3 9  The presence of both hydroxyl and methoxyl groups 
lowers the R f values (Rf =0.18) thus enabling ease of separation.
Figure 3.15: Preparation of unsymmetrical, vanillin containing porphyrins [3.10] and [3.11] using the ‘mixed 
aldehyde’ approach. Reagents and conditions', propionic acid, reflux, 30 min.
D R R R
R
[3.10] where R= Me, RF (CHC13) = 0.18 
( 4 % )
[3.11] where R= /-butyl, RF (CHC13) = 0.21 
( 2 %)
52
Chapter 3 - Porphyrins
3.10 Phosphorylation Methods
There are limited reports of porphyrins that incorporate a phosphate moiety in the 
literature. Porphyrins that have been functionalised at the meso position with a 
phosphate4 0 ,4 1  have been used for the high sensitivity assay for alkaline phosphatase 
activity, enzyme immunoassay and trace metal ion quantification etc. These compounds 
have been synthesised by reacting a mono, di or tri hydroxybenzaldehyde with pyrrole to 
form 5,10,15,20-tetrakis-(hydroxyphenyl)porphyrin, which is then further reacted with 
pyrophosphoric acid and phosphorus pentoxide to give the corresponding phosphate 
derivative (i.e. 5,10,15,20-tetrakis(phosphonooxyphenyl)porphyrin40). The addition of a 
phosphate group is best achieved on compounds which contain a hydroxyl group,
* 9n 98particularly a phenol. ' With this in mind two routes of preparation for phosphate 
containing porphyrins was devised:
i. Incorporation of phosphate group into benzaldehyde.
ii. Incorporation of phosphate group directly to porphyrin.
3.11 Incorporation of phosphate group into benzaldehyde
M?so-tetrakis(4-phosphonatophenyl)-porphyrin has been previously prepared4 2  by 
hydrolysis of the corresponding tetrakis diethyl ester (figure 3.16). Introduction of the 
phosphate group as the ester allows synthetic manipulations to be carried out in organic 
solvents, with the ethyl groups easily cleaved using trimethylsilyl iodide4 3  or bromide4 2  
thus yielding a water soluble tetraphosphate.
On OEt
O OEtEtO Os
TMSBr
EtO. P
X
O OEt
/ y
HO O•V XO OH
Figure 3.16: Preparation of Meso-tetrakis(4-phosphonatophenyl)-porphyrin as reported by De Napoli and
workers.42
3.11.1 Synthesis of Benzaldehydes
Diethyl-4-formylphenyl phosphate [3.12] was prepared from chloro diethyl 
phosphate and the sodium salt of 4-hydroxybenzaldehyde (figure 3.17) as previously
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reported4 4  to afford [3.12] as a yellow oil (60 %). The 3 1 P{1H} NMR spectrum shows a 
single signal at -6.48 ppm, which is consistent with values in the literature. 4 4  The phosphate 
ester of vanillin [3.16] was also synthesised in the same manner in a 77 % yield (figure 
3.17). Again, the 3 1 P{1H} NMR spectrum shows a signal at -6.09 ppm . 4 5
0'N a+
E tO -P -O E t
() H O H O H
(3.12J where R= H (60% )
13.16] where R= OMe (77 %)
Figure 3.17: Preparation of [3.12] and [3.16]. Reagents and conditions: (a) NaH, THF, inert atmosphere; (b)
chloro diethylphosphate
As well as the mono-phosphorylated benzaldehydes, efforts were made to prepare 
benzaldehydes that incorporated two phosphate esters. By doing so, the effect of increasing 
the number of phosphate groups in a porphyrin has on water solubility could be 
investigated. Reaction of 2,4-hydroxybenzaldehyde with sodium hydride and chloro 
diethylphosphate (figure 3.18) did yield a phosphate ester (8 p = -5.99 ppm). However, this 
may be a result of either mono or di substitution and the vast amount of unidentifiable 
phosphorus containing compounds (identified by P{ H}NMR spectroscopy) was cause 
for concern since the cholinesterase inhibitor activity of chloro diethylphosphate poses a 
real threat.
(Eto^oro^^^orcxoEt^
i) NaH
ii) C10P0(0Et)2
o r  "H O ' H
Figure 3.18: Attempted synthesis of a di-substituted phosphorylated benzaldehyde.
3.11.2 Synthesis of the Symmetrical Porphyrins [3.13] and [3.17]
The symmetrical tetra substituted porphyrin [3.13] was prepared (Adler 
methodology see figure 3.19), however the porphyrin material does not crystallise out of 
the propionic acid due to the increased polarity of the phosphate ester functions. Removal 
of the solvent and lengthy purification afforded the desired product in a low yield (3 %). 
The 3 1 P{1H} NMR spectrum shows a signal at -4.60 ppm for the phosphate ester which is 
slightly downfield of the aldehyde [3.12] presumably due to incorporation into the 
porphyrin system. The HRMS is consistent with the formation of the tetra substituted 
product.
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The symmetrical porphyrin [3.17] derived from diethyl 4-formyl-2-methoxyphenyl 
phosphate [3.16] was also synthesised (figure 3.19). The four methoxyl substituents modify 
the solubility in propionic acid which results in porphyrin precipitation. Purification on a
T1 1silica column gave [3.17] in an 8  % yield. A singlet at -5.8 ppm is seen in the P{ H} 
NMR spectrum and multiplets at 1.40 and 3.80 ppm are observed in the NMR spectrum 
consistent with the phosphate ester. The molecular ion was confirmed by MALDI MS 
(1343.74).
O n P E t
EtO O, P  OEt
E tO -P -O E t
[3.12] where R = H 
[3.16] where R = OMe O , OEtEtO, p
</ N
O OEt EtO O
[3.13[ where R = H (3% )
[3.17J where R = OMe (8 %)
Figure 3.19: Preparation of porphyrins [3.13] and [3.17]. Reagents and conditions: propionic acid, reflux, 0.5
h.
3.11.3 Synthesis of the Mono-Substituted (A3 B) Porphyrins [3.14], [3.15] and [3.18]
Three unsymmetrical porphyrins [3.14], [3.15] and [3.18] (A3 B type, where A = 
PhMe or PhCl) were prepared from the benzaldehydes [3.12] and [3.16] in 4, 2 and 0.5 % 
yields respectively (figure 3.20). The NMR spectral data is comparable to that of [3.13] and 
[3.17], whilst the unsymmetrical nature was confirmed by the 3:1 ratio of the aromatic 
protons.
O , p E t
EtO O
[3.14] where R= H, R ,= Me (4 %) 
[3.15J where R= H, R ,= Cl (2 %)
[3.18] where R= OMe, R]= Me (0.5 %)
Figure 3.20: Mono-substituted porphyrins [3.14], [3.15] and [3.18].
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The preparation of tetra-phenylporphyrins that incorporate a phosphate ester can be 
achieved by the reaction of a phosphate ester benzaldehyde with pyrrole in an Adler type 
methodology. Due to the nature and presence of four phosphate esters in [3.13], synthesis 
via the Lindsey method may have been more appropriate. The prepared porphyrins are 
obtained as pure compounds. However the extensive separation and purification of the 
unsymmetrical porphyrins is reflected in the low yields.
Recent research within our group has shown that tetra-phenyl porphyrins that 
contain diethyl phosphate esters are unable to withstand the harsh conditions (MCI2 , PhCN, 
200°C) which have been used to insert either platinum or palladium. 1 9 This discovery has 
led us to devise an alternative route for the preparation of metalled phosphate ester 
porphyrins.
3.12 Incorporation of phosphate group directly to porphyrin
3.12.1 Use of Sodium Hydride and Chloro Diethylphosphate
The phosphate containing porphyrin was envisaged to be prepared using the same 
method as previous; formation of the sodium salt followed by the treatment with chloro 
diethylphosphate.
3.12.1.1 Attempted Synthesis of 5, 10, 15, 20 Tetra ((4-diethyl phosphate) -  3 -  
methoxyphenyl) porphyrin [3.19]
Under an inert atmosphere, [3.9] was added to a suspension of four equivalents of 
sodium hydride in THF and stirred for 1.5 h. To this, four equivalents of chloro 
diethylphosphate were added and the mixture was stirred for a further 2 hours. The resultant 
NaCl was removed by filtration and the solvents were removed to give the crude product as
-I
a dark purple oily substance (figure 3.22). The P{ H} NMR spectrum shows a signal at 
-5.13 ppm which is consistent with that of [3.17] implying the formation of a phosphate 
containing porphyrin. Two further signals are also observed at 4.94 (ClP(0 )(0 Et)2 ) and 
-12.55 ppm ([(0 Et)2 P(0 )]2 0 ) . 4 6  Investigative experiments were performed on 4- 
hydroxybenzaldehyde using 1 molar equivalent and an excess of chloro diethylphosphate 
(figure 3.21). One equivalent of C1 0 P(0 Et) 2  results in only production of the phosphate 
ester (8 p = -5 ppm), whereas an excess produces the phosphate ester and pyrophosphate (8 p
= -12ppm ).
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O
EtO-P-OEt
O
EtO-P-OEt
OH
i) 1 equiv.
5P = -5 ppm
C10P(0Et)2
ii) XS
H O 
Sp = -5 ppm
O O 
EtO.jj M/OEt
EtO^ ^OEt
5P = -12 ppm
Figure 3.21: Experiments performed on 4-hydroxybenzaldehyde in the presence of either NaH or Et3N and 
DMAP with either i) 1 equivalent or ii) an excess of chloro diethylphosphate.
Reactions performed on phenol porphyrins with chloro diethylphosphate were on a
small scale so pyrophosphate formation may be a result of experimental error (i.e. an excess
of reagent added). However, the hydrolysis of chloro diethylphosphate can also lead to the
formation pyrophosphate and phosphoric acid. 4 7  In the MALDI MS the expected molecular
ion for the tetra-phosphorylated porphyrin (Mr 1343.167) and twice-phosphorylated
product (Mr 1071.31) are observed as weak intensity peaks. Peaks corresponding to
unreacted porphyrin [3.9] and mono-phosphorylated product are seen at 766.35 and 935.38
 ^1 1Da/e respectively (figure 3.22). It can be deduced from the P{ H} NMR spectrum, that 
the chloro diethylphosphate is consumed in the formation of the tetra diethyl pyrophosphate 
resulting in the mono-phosphorylated product predominantly being formed (figure 3.22).
OMe OMe
OHHO.
OMe OMe
i) NaH
MeO MeO
OHHO
MeO MeO
[3.9] P-19] where R1=R2=R3=R4= OPO(OEt)2
Figure 3.22: Attempted synthesis of [3.19] using NaH and C10P(0Et)2 , where Ri=R2=R3 =R4 = OPO(OEt)2. 
MS data shows the predominant presence of the product where Rj= OPO(OEt)2 and R2=R3=R4 = OH (Mr =
935.38 Da/e).
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3.12.1.2 Attempted Synthesis of Palladium Phosphorylated porphyrin
Eto. . oQs .OEt
O  OEtEtO O,p HHO,
[I .N — Pd— N
Os P E tOHHO
|Pd(3.2)J EtO O
Figure 3.23: Attempted phosphorylation of [Pd(3.2)J using NaH and C10P0(0Et)2
Despite the incomplete reaction, the diethylphosphate addition to a palladium 
porphyrin was attempted (figure 3.23). To this end, [Pd(3.2)J was added to four equivalents 
of sodium hydride in THF and left to stir. This was followed by four equivalents of chloro 
diethylphosphate. The 3 1 P{1H} NMR spectrum showed three signals at -12.94 
(pyrophosphate46), 0.44 (diethyl phosphoric acid48) and 5.041 ppm (ClP(0 )(0 Et)2 ), no 
signal is observed at -5 ppm. This implies that phosphate ester formation had not occurred 
and this was further reinforced by the 'H NMR spectrum and the MALDI MS, both of 
which are consistent with that of [3.2]. Under these conditions, the coordinated palladium 
(+2 ) centre is reduced to free palladium metal, an occurrence that was visibly observed 
during the course of the reaction by the formation of a dark grey “mirror” on the inside of 
the Schlenk tube. The standard potential of the Kh/H' couple is estimated to be -2.25 V49, 
making H‘ one of the most powerful reducing agents known. Despite employing NaH as a 
base, it appears that the formation of palladium hydride and the reduction to palladium 
metal is favoured over proton abstraction. Since the sodium salt of the phenol porphyrin is 
not produced, formation of the phosphate ester cannot proceed (figure 3.24).
(OEt>2P(OpH
(OEt)2P(OXXO)P(OEt)2
HO, ,OH HO, P H
i) NaH
XN — Pd— N
OHHO HO OH
Figure 3.24: Reaction of [Pd(3.2)| with NaH and chloro diethyl phosphate.
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3.12.2 Use of Triethylamine and Chloro Diethylphosphate
Phosphate esters can also be prepared by the reaction of either chloro 
diethylphosphate5 0  or phosphite4 5  in the presence of triethylamine. Reaction of 
chlorodiethyl phosphate in pyridine has also been reported. 51
An alternative phosphorylation methodology was applied by a modification of the 
literature procedures using chloro diethylphosphate in the presence of triethylamine with 
the addition of a catalytic amount of dimethylaminopyridine (DMAP). 4 -  (Diethyl 
phosphate) -  3 methoxybenzaldehyde [3.16] was prepared in this manner (60 %, figure 
3.25) the spectroscopic data being consistent with that in the literature. 4 5
o
E tO -P -O E t
[3.16]
Figure 3.25: Reagents and conditions: C10P0(0Et)2, DMAP (catalytic amount), Et3N, THF.
3.12.2.1 Attempted Synthesis of 5, 10, 15, 20 Tetra ((4-diethyl phosphate) -  3 -  
methoxyphenyl) porphyrin [3.19]
Porphyrin [3.9] was reacted with four equivalents of triethylamine and chloro
T i ldiethylphosphate in the presence of 0.1 equivalents of DMAP. Analysis of the P{ H} 
NMR spectrum indicates the presence of a phosphate ester with a singlet at -5.14 ppm. As 
with the reaction with NaH, signals are observed at -12.53 and 0.75 ppm which correspond 
to the pyrophosphate4 6  and phosphoric acid. 4 8  Under these conditions all of the chloro 
diethylphosphate is consumed as it is not observed in the NMR spectrum. A small AB 
quartet is observed in the spectrum (5 -9.96 and -11.11 where Jp.p 17.85 Hz), 
pyrophosphates typically exhibit geminal coupling constants in the region of 18-22 Hz. 
Therefore, it is reasonable to presume that this phosphorus containing species is due to the 
formation of an unsymmetrical pyrophosphate. The unsymmetrical nature may have arisen 
by either trans-esterification or hydrolysis of the chloro diethylphosphate (figure 3.26).
59
Chapter 3 - Porphyrins
„ 0 0 R,-U U.R3
r 2/ o ^ r 4
R,=R2 = 0Et, R3=R4 = OH 
R i=R3 = OEt, R2=R4 = OH 
Ri=R4 = OEt, R2=R3 = OH
OMe
HO,
OMe
NH HN
MeO
OHHO
MeO
Mass = 986.85
Figure 3.26: Possible structures of the unsymmetrical pyrophosphate formed during the attempted synthesis
of [3.19].
The MALDI mass spectrum does not show the expected molecular ion (M + 1) at 
1343. A large peak is seen at 799.55 Da/e (peak A, figure 3.27) due to unreacted starting 
porphyrin [3.9] and as with the reaction with NaH, an ion corresponding to the mono 
phosphorylated species is seen at 935.38 Da/e. (peak C, figure 3.27) As anticipated, IR 
stretches at 1259 and 1036 cm"1 are observed attributed to the P=0 bond.
BexK 10 (0 165) Cm (10) 
100-
TOF LD+ 
1 27e£799.2083
800.2238
HO,
HO o
OMeHO
KUO-
MeO
801 2401
OH
935.2580
936.2722
907.2084802.2178 937.2869
988.2489 1015.3721 1043.2823 1071.2689
-Ulk. m/z
760 780 800 820 840 860 880 900 920 940 960 980 1000 1020 1040 1060 1080 1100
Figure 3.27: MALDI mass spectrum of the products obtained in the reaction of [3.9] and chloro
diethylphosphate.
3.12.2.2 Synthesis of 5, 10, 15 Tri (4-terf-butylphenyl) 20 ((4-diethyl phosphate) -  3 -  
methoxyphenyl) porphyrin [3.20]
An analogous procedure was performed on porphyrin [3.11]. The presence of a 
phosphate ester was confirmed by a signal at -5.16 ppm in the 3 NMR spectrum. 
Signals ascribed to diethyl phosphoric acid, the symmetrical and unsymmetrical 
pyrophosphates are again observed. The MALDI mass spectrum shows ions corresponding
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to unreacted porphyrin material [3.11] (829.48 Da/e) and the expected molecular ion for 
[3.20] (965.53 Da/e) (figure 3.29).
3.12.2.2.1 Hydrolysis of Phosphorylated Products
All phosphate esters are subject to hydrolysis (figure 3.28), a fact that is of immense 
importance in biological systems. 4 7
+ h o h  +  h o h  + h o h
(RO)3PO ------- ► (RO)2P(0)OH  ► (R 0)P(0)(0H )2 --------► P(0)(0H )3
-RO H  -ROH . r o h
Figure 3.28: Hydrolysis of phosphate esters.
It is interesting to note, that in all the direct phosphorylation reactions molecular 
ions in the mass spectra are observed that correspond to hydrolysed product. For instance, 
in the reaction between [3.11] and chloro diethylphosphate in the presence of triethylamine, 
minor peaks are observed at 937.49 and 909.04 Da/e (peaks B and C in figure 3.29).
BexH6(0.100)Cm(6)
100n
TOF LD+ 
2.37e3965 5372
966.5677
929.5198
.830.5146
967.5559
831.5101 964.5502
828.5653
937.5406
815 4961 909.0401
Mi
m/z
750 775 800 825 850 875 900 925 950 975 1000 1025 1050 1075 1100 1125 1150 1175
Figure 3.29: MALDI mass spectrum of the reaction of (3.11] with chloro diethylphosphate in the presence of
Et3N.
It is reasonable to presume that these ions (B and C) are a result of the hydrolysis of 
either one or both ester groups (figure 3.30). The presence of water, under these conditions 
may result in hydroxide formation which attacks the phosphate ester groups. This 
occurrence is also observed in attempts to phosphorylate tetra (4-hydroxy-3-methoxy 
porphyrin [3.9] with both NaH and triethylamine.
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,0 OH
M*= 909.04 Da/eM+= 937.49 I>a/e
Figure 3.30: Possible structural assignments for MS ions at 937.49 and 909.04 Da/e shown in figure 3.29 as a
result o f the reaction of [3.11 ] with C10P(OEt>2.
3.12.2.3 Reaction of [Pd(3.2)] with Chloro Diethylphosphate
The palladium complex, [Pd(3.2)] was reacted with chloro diethylphosphate in the 
presence of triethylamine and DMAP under the same conditions as previous. No 
precipitation of palladium metal was observed during the course of this reaction. The 
product was purified by column chromatography followed by precipitation from 
chloroform/petroleum ether to give an orange solid [Pd(3.21)]. Evidence for the formation 
of the phosphate ester is seen in the 3 1 P{1H} NMR spectrum with a signal at -5.48 ppm. 
Pyrophosphate formation had also occurred but is removed by purification. The ]H NMR 
spectrum is complicated with splitting of the pyrrole signals thus indicating a mixture of 
products. In the MALDI MS molecular ions are observed at 1054.1 (A), 1190.1 (B) and
1326.1 (C) Da/e corresponding to the two, three and four diethylphosphate additions, 
resulting from an incomplete reaction (figure 3.31 and 3.32).
« CAR28F AL_0001» Vbjeger S pa: #1=>AdvBC(32p.5j0.1}=>NF0.7[BP = 357.2, 24288]
1190.1
189.1
1192.1
191.1
1054.1
1056.1 1326.1
1193.1
1194.1
053.1
1057.1
188.1 1329.1
[1330.1 1430.1
1427.1 1433.1
1158 1293.
Figure 3.31: MALDI mass spectrum of the mixture of products obtained form the reaction between [Pd(3.2>]
and chloro diethylphosphate.
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/ r\
,0 OEtOH HO,
N — Pd— N N — Pd— N sand/ or
PHHO,
HO HO
Y
M+= 1054.1 Da/e
N — Pd— N
O. pEt
>\ 
EtO O,HO,
OHHO
[Pd(3.2)]
[\ N — Pd— NN — Pd— N
°x PEl 
|Pd(3.21)| Et0^ \
EtON O 
O OEt
(> P E tEtO. p
6'  OEt EtO O
M+= 1326.1 Da/eM =  1190.1 Da/e
Figure 3.32: Mixture of products obtained in the reaction between [Pd(3.2)J and chloro diethylphosphate.
A second series of peaks are observed at 1158.1 (A’), 1294.1 (B’) and 1430.1 (C’) 
Da/e (figure 3.31). A possible explanation for this can be found in the mass spectrum of the 
starting porphyrin [Pd(3.2)] (figure 3.33). As well as the expected ion (782.1, A), a small, 
higher mass peak with a complex isotope pattern is observed at 886.1 Da/e (B). The second 
series of peaks appear to correspond to the two, three and four diethylphosphate additions 
to the species of mass 886.1 [M+H+]. The exact identification of this species was attempted 
using MSMS technique. However due to the low resolution of the peak, the results were 
inconclusive. The complex isotope pattern would suggest the presence of palladium in this 
unknown species. The difference in mass is 104, which could be attributed to a weakly 
coordinated axial benzonitrile molecule at the palladium centre. This however would be
o A
surprising, as in metal porphyrins with a d  or d configurations their filled dz orbitals 
normally repel any axial ligand approaching the metal ion. 5
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«  C AR27F AL_0001» Nfoyager Spec #1=>AdvB C( 640.^0.1 )=> N F0.7[B P = 7821,13136]
782.1
IDA
HO, OH
■81.1
I N -P d-N
«e.i
83.1
HO OH
[Pd(3.2)| 786.1
g  886.1
751.4 '-I 810
Figure 3.33: MALDI mass spectrum obtained for [Pd(3.2)j, with expansion of the higher mass peak at 886.1
Da/e.
3.13 Other work involving Porphyrin Systems
3.14 Fluorine Containing Porphyrins
In addition to porphyrin derivatives that contain an arylphosphate which is directly 
bound to the macrocyclic ring, investigations involving fluorinated porphyrins have also 
been carried out. We envisaged that the presence of fluoride atoms within the marker may 
form interactions with sites within a cell surface and hence enable the marker to more 
strongly adhere. The susceptibility of electron deficient arylfluorides to nucleophilic 
aromatic substitution can be utilised towards further modifications to the porphyrin 
structure.
Bedel-Cloutour and co-workers5 3  have reported hydrosoluble and 
monofunctionalised meso-tripyridinylarylporphyrins which possess functional groups 
susceptible to covalent coupling with amino acid side chains present in both bovine serum 
albumin (BSA) and monoclonal antibodies (figure 3.34). It has been shown that the 
mesomeric effect of the nitro group in 3-nitro-4-fluorobenzaldehyde is sufficient enough to 
initiate fluoride lability. 3 4  Hence porphyrins bearing a fluoride in the para phenyl position, 
both with (7) and without (2) a nitro substituent were prepared. 5 3  Following the 
quatemization of the pyridyl rings and metallation with indium, the porphyrin derivatives 1 
and 2 were coupled to bovine serum albumin in reasonable labelling efficiency (60 %, 75 
% ).53
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2 R, = F, R2 = H
i r , = f , r 2 = n o 2
Figure 3.34 .Porphyrin derivatives prepared by Bedel-Cloutour and co-workers.53
With these aspects in mind we set out to prepare porphyrin derivatives bearing one 
or more fluoride groups suitable for our own purposes. Meso-5,10,15,20-tetra-(4- 
fluorophenyl) porphyrin [3.22] (p-F-TPP) was prepared by the direct condensation of 4- 
fluorobenzaldehyde and pyrrole (14 %) (figure 3.35). This compound is highly insoluble in 
both organic and aqueous mediums (e.g. the molar solubilities of p-F-TPP at 30°C in 
pyridine, benzene and chloroform are 7.1 x 10' 5 M, 4.8 x 10' 5 M and 4.9 x 10' 5 M 
respectively) . 5 5
Figure 3.35: Preparation of fluorine containing porphyrins [3.22] and [3.23] via Adler method. Reagents and
conditions: propionic acid, reflux, 0.5 h.
Meso-5,\0,15,20-tetra-(4-fluoro-3-nitrophenyl)-porphyrin [3.23] (figure 3.35) was 
prepared from 4-fluoro-3-nitrobenzaldehyde [5.1] (synthesised as described in chapter 
5.5.1), yielding a black material (21 %) which is extremely insoluble in both organic and 
aqueous solvents. The IR spectrum shows absorbencies at 3418 cm" 1 (NH stretch), 1537 
(antisymmetric N =0 stretch) and 1348 cm" 1 (symmetric N=0 stretch) and 1266 cm' 1 (CF). 
The water insolubility of both fluorinated porphyrins [3.22] and [3.23] could be used to our 
advantage since we seek to prepare compounds/markers that become water insoluble upon 
the cleavage of an enzyme substrate.
Attempts were made to displace the para-f[uoride in [3.22] and [3.23] with a 
nucleophile in order to increase the solubility of these compounds. The reaction of [3.22]
R
R
R
[3.221 where R=H (14%) 
[3.23| where R= N 0 2 (21%)
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and [3.23] with nucleophiles such as terf-butylanliline, TV-methylglucamine, 
diethanolamine, benzylmercaptane and the disodium salt of 4-aminophenyl phosphate 
proved unsuccessful (figure 3.36).
NucNuc,
NucNuc
Nuc'
where R= H 
where R= N 0 2
Figure 3.36: Attempted displacement of/?ara-fluorides in [3.22] and [3.23] with a nucleophile (Nuc')
A series of asymmetric porphyrins were prepared by the method of Little et al as 
illustrated in figure 3.37. Whilst the presence of some of these functions imparted an 
element of solubility in organic solvents such as chloroform, purification and manipulations 
still presented difficulties that could not be overcome.
Ri R 2 r 3 R4
4-F-Ph 4-F-Ph 4-F-Ph 4-OMe-Ph
4-F-Ph 4-F-Ph 4-F-Ph 4_OH-Ph
4-F-Ph 4-F-Ph 4-F-Ph 4-OC12H25-Ph
4-F-Ph 4-F-Ph 4-F-Ph 4-OPO(OEt)2-Ph
Ph Ph Ph 4-F-Ph
Ph Ph Ph 4-F-3-N02-Ph
Figure 3.37: Table illustrating range of asymmetric porphyrins containing fluorine.
3.14.1 Af£50-tetra-(pentafluorophenyl)porphyriii
The /?ara-fluoride substituents in /we.s0 -tetra-(pentafIuorophenyl)porphyrin can be 
selectively displaced by nucleophiles such as amines, thiols and phenolate anions. 5 6 ,5 7
co
McKeown has shown that the reaction of weso-tetra-(pentafluorophenyl)porphyrin with 4 
equivalents catechol results in the displacement of the /rara-fluoride followed by the rapid 
intramolecular substitution of the neighbouring weta-fluoride.
Using the conditions developed by Lindsey, pentafluorobenzaldehyde and pyrrole 
were reacted to give [3.24] as a red solid (20 %) (figure 3.38). In the 19F NMR spectrum, 
three multiplets are observed corresponding to the ortho (-136.3 ppm, pair of doublets), 
meta (-161.1 ppm, multiplet) and para (-151.0, triplet) fluorides.
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H X )
[3.24]
Figure 3.38: Preparation of [3.24] via the Lindsey method. Reagents: i) BF3-etherate, DCM, N2; ii) DDQ.
The introduction of an iodide can be utilised towards further modifications either 
via nucleophilic attack or a coupling reaction (e.g. Heck, Suzuki, Sonogashira). Hence, 
veratrole and iodine monochloride were reacted in a one molar ratio to give iodo-3,4- 
dimethoxybenzene [3.25] (62 %) which was subsequently treated with boron tribromide2 9  
generating iodo-3,4-dihydroxybenzene [3.26] (74 %) (figure 3.39).
OMe BBl-3
OMe 74 % ^ ^ S ) H
[3.25] [3.26]
Figure 3.39: Preparation of [3.26] from [3.25].
The reaction between [3.24] with four equivalents of [3.26] in the presence of 
potassium carbonate ( 8  eq) and N-methyl-2-pyrrolidinone at 100 °C was performed (figure
3.38).58 The resulting precipitate of a brown material was analysed by 19F NMR 
spectroscopy, giving rise to three multiplets at -139.9 ppm (doublet), -155.2 ppm and -
164.1 ppm. A simplification of the fluoride spectrum is observed due to the displacement of 
the para and neighbouring fluoride atom. However, the low obtainable yields of both [3.24] 
and [3.27] and the elaborate nature of this synthesis restricted its use and further 
development.
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F
I V V ° H
[3.26]
F
■F
F
[3.24] [3.27]
Figure 3.38: Reagents and conditions: K2C 0 3 (8 eq.), NMP, 100°C.
3.15 Azo Containing Porphyrins
Many of the porphyrins that have been prepared have been metallated with either 
platinum or palladium. The conditions employed are harsh (temperatures greater than 200 
°C) and porphyrins that feature sensitive peripheral groups, namely phosphate do not 
withstand these conditions. 1 9  To overcome this problem, another metal source combined 
with milder conditions could be employed or alternatively another position of metallation 
incorporated. To date, the later has been explored by attempts to conjugate an azo group 
which incorporates a phosphate function. Compounds that contain an azo group are 
intensely coloured ranging from a deep red through to yellow. The incorporation of this 
functional group would enable markers to be visualised under a light microscope without 
the need for amplification with silver. An azo group attached to a phenyl ring can be 
metallated with palladium under mild conditions using palladium (II) bis(benzonitrile) 
dichloride, alleviating the need to metallate at the porphyrin centre.
A commercially available substrate of alkaline phosphatase, 4-nitrophenyl 
phosphate disodium salt was hydrogenated (H2 /Pd on carbon) to the water soluble amine 
[3.28]. Generation of the azo group was performed under aqueous conditions (figure
3.39) . 5 9
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o hHO,OHHO,
N a
[3.2]
+
OHHOOHHO
[3.28]
[3.29]
Figure 3.39: Attempted synthesis of [3.29]. Reagents and conditions: sodium carbonate, sodium nitrate.
Purification of the products was attempted using a cellulose dialysis membrane (see 
experimental section for details). The mass spectrum of the product contained a molecular 
ion at 782.2 Da/e and the *H NMR spectrum was identical to that of [3.2] thus indicating an 
unsuccessful reaction.
3.16 Laboratory Testing of Compounds
Previous studies1 9 have demonstrated that platinum and palladium porphyrin 
derivatives showed good redox activity in the catalytic reduction of aqueous silver ions. In 
contrast, metal-free derivatives showed no activity. A series of screen tests, as described in 
chapter 2  (section 2 .1 2 ), were carried out to establish whether the compounds synthesised 
are suitable for our application. Five complexes of 5,10,15,20-meso-tetraphenylporphyrin 
(TPP) were also included in the tests.
Results from the initial screen tests were in agreement with previous studies, with 
the metallated porphyrin derivatives catalysing the reduction of aqueous silver ions in times 
ranging from 5-30 minutes whilst the metal-free porphyrins showed no redox activity. The 
metallated porphyrin compounds were passed through a pad of Celite® and a short silica 
column to remove any traces of residual metal prior to a second screen testing. The results 
are presented in figure 3.40.
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Compound Solubility in
Physical
Developer
Redox Activity Compound Solubility in
Physical
Developer
Redox Activity
[3.1]H2 insoluble no activity [Pt(3.9)J insoluble no activity
[Pd(3.1>] insoluble no activity [3.13]H2 insoluble no activity
[3.2] H2 insoluble no activity [Pd(3.21>] insoluble no activity
[Pd(3.2>] insoluble no activity [TPP]H2 insoluble no activity
[Pt(3.2)l insoluble no activity [Pd(TPP)] insoluble no activity
[3.5]H2 insoluble no activity (Pt(TPP)] insoluble no activity
[Pt(3.5>] insoluble no activity [Ag(TPP)] insoluble no activity
[3.9]H2 insoluble no activity [Zn(TPP)] insoluble no activity
[Pd(3.9>] insoluble no activity IMn(TPP)] insoluble no activity
Figure 3.40: Summary of test results after trace metal removal. ‘No activity’ implies no notable change
during a 30 minute period.
Following further purification the metallated porphyrin derivatives were found to 
show no noticeable redox activity for the reduction of aqueous silver ions (i.e. no darkening 
of the physical developer over a 30 minute period). From this it can be deduced that 
previous positive results may be due to traces of free metal or metal carrier in the 
compounds.
3.17 Conclusion
The objective of this work was to prepare porphyrin systems featuring a phosphate 
group that are redox-active for the reduction of silver. The introduction of the phosphate 
groups was achieved via the benzaldehyde and also by the reaction between a phenol- 
porphyrin and chloro diethylphosphate.
We have found that the separation of 5,10,15-tri-(4-methoxyphenyl)-20-(4- 
tolyl)porphyrin [3.3] from 5,10,15,20-tetra-(4-tolyl)porphyrin on a large scale problematic. 
We introduced a benzyl ester to protect the phenol, which enabled the successful separation 
of 5,10,15-tri-(3,4,5-trimethoxybenzoic acid phenyl ester)-20-(4-tolyl)porphyrin [3.6] from
5.10.15.20-tetra-(4-tolyl)porphyrin. The difference in R f values of these two porphyrins is 
substantial enough to allow separation even on a large scale. The benzyl ester groups can be 
removed by treatment with hydrazine monohydrate to afford the corresponding phenol- 
porphyrin. Several symmetrical and unsymmetrical porphyrins bearing aryl phosphate 
esters have been prepared from the benzaldehydes [3.12] and [3.16] to afford the 
corresponding porphyrins in yields ranging between 0.5 and 8  %. The reaction of
5.10.15.20-tetra-(4-hydroxyphenyl)porphyrin, [3.2] and 5,10,15,20-tetra-(4-hydroxy-3-
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methoxyphenyl)porphyrin, [3.9] with chloro diethylphosphate in the presence of either 
sodium hydride or triethylamine failed to afford the tetra-phosphorylated products. The 
reaction of 5,10,15-tri-(4-teri-butylphenyl)-20-(4-hydroxy-3-methoxyphenyl)porphyrin,
[3.11] with chloro diethylphosphate afforded the product [3.20] along with unreacted
[3.11]. Attempts were made to phosphorylate the metal complex [Pd(3.2)]. When using 
sodium hydride, phosphorylation did not occur and the coordinated palladium was reduced 
to palladium metal. The reaction using triethylamine generated a mixture of phosphorylated 
products that were unable to be separated.
The metal complexes along with the corresponding free base analogues were tested 
to establish whether they were suitable catalysts for our application. Following purification 
the compounds were not found to show any activity for the reduction of silver in a Timm’s 
type reaction. This is not in agreement with earlier findings and we conclude that previous 
positive results were attributed to impurities in the tested samples.
Experimental 
General Procedure
Reagents were purchased from Aldrich, Avocado or Lancaster and were used as 
received. Solvents were purified by standard literature methods. 6 0  Tetra-arylporphyrins 
were synthesised using the Adler-Longo method11 unless otherwise stated and the pyrrole 
used was distilled prior to use. The porphyrins [TPPJFL, 11 [TPP]Pd, [TPP]Pt, 6 1 and 
[TPP]Ag, [TPP]Zn, [TPP]Mn6 2 ,6 3  were prepared by literature methods. Column 
chromatography was performed using silica gel (60 A). CAUTION: chloro
diethylphosphate is highly toxic and care must be taken when using this reagent. Due to the 
possibility of accidental acetylcholinesterase synthesis, reactions must be carried out in a 
fluoride free environment. The NMR spectra were recorded on a Briiker Avance AMX 400 
instrument at 400 MHz (!H) and 100 MHz (1 3 C), JEOL Lamda Eclipse 300 at 121.65 MHz 
(3 1 P) and 282.78 MHz ( 1 9F); !H and 13C chemical shifts are quoted in ppm relative to 
residual solvent peaks and P chemical shifts are quoted in ppm relative to external 85 % 
H3 PO4  (5 0). Coupling constants are quoted in Hertz. Mass spectra were obtained in APCI 
(atmospheric pressure chemical ionisation), El (electronic ionisation) or MALDI modes. IR 
spectra were obtained as KBr or NaCl discs using a Jasco FTIR 110 series spectrometer. 
UV/Vis spectra were recorded on a Jasco V-750 UV/Vis/NIR spectrophotometer.
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[3.1JH2 Meso-5,10,15,20-tetra (4-methoxyphenyl) porphyrin
,OMeMeO.
HN
MeO OMe
The general procedure is described for the preparation of meso-5,\0,15,20-tetra (4- 
methoxyphenyl) porphyrin [3.1]. Standard reactions were performed in a round bottomed 
flask fitted with a condenser open to the air. 4-Methoxybenzaldehyde (20 g,0.146 mol) and 
freshly distilled pyrrole (9.19 g, 0.137 mol) were added to refluxing propionic acid (250 
mL), reacted for 30 min, allowed to cool, filtered and washed with MeOH until the 
washings ran clear. The resulting purple solid was dissolved in chloroform and passed 
through with a short silica plug (approx lg  porphyrin to 20g silica gel). Eluting with 
chloroform and removal of solvents in vacuo affords the title compound [3.1] as a shiny 
purple solid (5.38 g, 20 %); 5H (400 MHz, CDC13) -2.60 (s, 2H, NH2), 4.0 (s, 12H, 
OCH3), 7.20 (d, 8 H, J  7.2, Ar H-3 and H-5), 8.1 (d, 8 H, J  8.3, Ar H-2 and H-6% 8 . 8  (s, 
8 H, tf-P-pyrrole); 5C (100 MHz, CDC13) 28.0, 56.2, 113.2, 119.6, 134.1, 136.8, 160.1; IR 
(KBr, cm'1) 3317 (NH stretch), 2930, 2840, 2365, 1745, 1609, 1510, 1470, 1438, 1351, 
1281, 1248, 1179, 1106, 1054, 965, 840, 800; UV/Vis (CHC13, nm, log s/dm3  mol' 1 cm'1) 
424 (5.10), 520,556, 594, 652; m/z (MALDI) 735.2 [M+l],
[Pd(3.1)] Meso-5,10,15,20-tetra (4-methoxyphenyl) porphyrin palladium 
Compound [3.1] (0.418 g, 0.56 mmol) and palladium (II) dichloride (100 mg, 5.6 x 10-4) 
were heated in benzonitrile (15 mL) for 6  h at 200°C. The reaction mixture was allowed to 
cool, filtered to remove any excess palladium salts and the benzonitrile removed in vacuo. 
The crude product was taken up in a small amount of MeOH and passed through a short 
silica column eluting with chloroform to afford the pure metallated product [Pd(3.1)J as a 
pink solid (0.112 g, 23 %) 5H (400 MHz, CDC13) 4.04 (s, 12H, OCH3), 7.20 (d, 8 H, J8.2, 
Ar H-3 and H-5), 8.0 (d, 8 H, J  8.4, Ar H-2 and H-6), 8.75 (s, 8 H, tf-P-pyrrole); 5C (100 
MHz, CDCh) 53.1, 109.4, 127.9, 132.1, 132.7, 139.2, 156.4; IR (KBr, cm'1) 1605, 1540, 
1457, 1352, 1286, 1247, 1173, 1008, 803; UV/Vis (CHC13, nm, log s/dm3 mol' 1 cm'1) 422 
(4.95), 526, 560; m/z (MALDI) 838. 249 [calculated 839.25],
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[3.2] Af£M>-5,10,15,20-tetra (4-hydroxyphenyl) porphyrin
OHHO.
HN
HO OH
Compound [3.1] (3.87 g, 5.27 mmol) was dissolved in degassed DCM (100 mL) and cooled 
to -80 C. To this, boron tribromide (2.26 mL) in DCM (10 mL) was added dropwise and 
stirred for 1 h at -80 °C. The solution was allowed to warm to room temperature and stirred 
overnight. Water was added to quench any unreacted boron tribromide and the solution was 
basified with triethylamine until a colour change from green to purple is observed. The 
precipitated solid was filtered, washed with water and was dried in a vacuum dessicator for 
48 h to afford [3.2] as a purple solid (1.78 g, 50 %); 5H (400 MHz, MeOD) 7.12 (d, 8 H, J  
8.3, Ar H-3 and H-5), 7.90 (d, 8 H, J  8.34, Ar H-2 and H-6), 8.80 (br s, 8 H, tf-P-pyrrole); 
IR (KBr disc, cm'1) 3311, 2954, 1610, 1524, 1401, 1286, 1260, 1177, 801, 769; UV/Vis 
(MeOH, nm, log s/dm3  mol" 1 cm '1) 422 (4.97), 518, 554,594,650; m/z (MALDI) 679.211 
[calculated 678.745].
[Pd(3.2)] Meso-5,10,15,20-Tetra (4-hydroxyphenyl) porphyrin palladium
This compound was prepared in an analogous manner to that of [Pd(3.1)J. The applied 
reagents were [3.2] (0.1 g, 0.147 mmol) and palladium dichloride (200 mg) to afford 
[Pd(3.2)J as a pink solid (0.0611 g, 53 %); 5H (400 MHz, MeOD) 7.05 (d, 8 H, J  8.2, Ar 
H-3 and H-5), 7.73 (d, 8 H, J  8.31, Ar H-2 and H-6), 8.65 (s, 8 H, tf-p-pyrrole); IR (KBr, 
cm’1) 3426, 2959, 1724, 1608, 1506, 1457, 1351, 1270, 1123, 1073, 1012, 798; UV/Vis 
(MeOH, nm, log e/dm3 mol*1 c m 1) 418 (5.00), 526; m/z (MALDI) 782.196 [calculated 
783.14].
[Pt(3.2)] Mes0-5,10,15,20-tetra (4-hydroxyphenyl) porphyrin platinum 
Compound [3.2] (0.2 g, 0.294 mmol) and platinum (II) dichloride (100 mg) were heated in 
benzonitrile (15 mL) for 6  h at 200°C. The reaction mixture was allowed to cool, filtered to 
remove any excess platinum salts and the solvent removed in vacuo. The crude product was 
passed through a short silica column eluting with THF to afford the pure product [Pt(3.2)J 
as an orange solid (0.15 g, 60%); 8 h (400 MHz, MeOD) 7.0 (d, 8 H, J  8.3, Ar H-3 and H- 
5), 7.6 (d, 8 H, J  8.27, Ar H-2 and H-6), 8.70 (s, 8 H, /7-P-pyrrole); UV/Vis (THF, nm, log 
s/dm3 mol' 1 cm'1) 408 (5.21), 512; m/z (MALDI) 872.142.
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[3.3]H2 Meso-5 j 10,15-T ri (4-tolyl)- 20-(4-methoxyphenyl) porphyrin
NH HN
OMe
The general procedure is described for the preparation of meso-5,10,15-tri (4-tolyl)- 20-(4- 
methoxyphenyl) porphyrin [3.3]. Standard reactions were performed in a round bottomed 
flask fitted with a condenser open to the air. 4-Tolylbenzaldehyde (20 g, 0.16 mol), 4- 
methoxybenzaldehyde (1.13 g, 0.008 mol) and pyrrole (10.89 g, 0.1624 mol) were added to 
refluxing propionic acid (250 mL) and reacted for 30 minutes, Upon cooling the reaction 
mixture was filtered and washed with MeOH. The crude product was taken up in 
chloroform and passed through a short silica plug eluting with chloroform to remove tar­
like impurities. The crude material was re-chromatographed on silica gel with hexane to 
elute meso-5,10,15,20-tetra(4-tolyl) porphyrin. The solvent system was changed gradually 
to a 3:5 ratio of hexaneichloroform to remove a second fraction (Rf 0.68) containing [3.3]. 
Removal of the solvents afforded [33] as a purple solid (0.62 g, 11 %); 5h (400 MHz, 
CDC13) -2.62 (s, 2H, NH2), 4.0 (s, 9H, OC//3), 7.22 (d, 2H, J  7.1, Ar H-3' and H-5’),
7.45 (d, 6 H, J  7.68, Ar H-3 and H-5), 8.05 (d, 6 H, J  7.74, Ar H-2 and H-6), 8.1 (d, 2H, J  
8.2, Ar H-2' and H-6'), 8.7 (s, 6 H, //-[i-pyrroie). 8 . 8  (s, 2H, //-fl-pyrrole'); IR (KBr, 
cm’1) 3329, 2968, 1571, 1510, 1473, 1408, 1384, 1347, 1208, 2000, 1156, 1072, 985; 
UV/Vis (CHCI3 , nm, log s/dm3  mol’ 1 cm"1) 422 (4.93), 520, 556, 594, 652 m/z (MALDI) 
687.325 [calculated 686.85].
[3.4] 3,4,5-Trimethoxy benzoic acid Phenyl Ester
OMe
OMe
Thionyl chloride (6.2 mL, 47 mmol) and DMF (1 drop) were added to a of suspension of 
3,4,5-trimethoxy benzoic acid (10 g, 47 mmol) in dry dichloromethane (200 mL) and 
stirred under an atmosphere of nitrogen for 1 h, until the solution had gone clear. The 
solvents were removed in vacuo to give 3,4,5-trimethoxyl benzyl chloride (11.28 g). 4- 
Hydroxybenzaldehyde (5.97 g, 48.9 mmol) was suspended in chloroform in a conical flask. 
To this, was added EtsN (1 molar equivalent) and DMAP (~ 100 mg), and the solution was 
cooled in ice. 3,4,5-Trimethoxybenzyl chloride (11.28 g, 48.9 mmol) in chloroform was
74
Chapter 3 - Porphyrins
cautiously added dropwise via a dropping funnel over a period of 1.5 h, after which the 
solution was allowed to stir for a further 1 h. The chloroform solution was washed with 
dilute HC1, aqueous NaHC03, water and dried over MgSC>4 . The solvents were removed in 
vacuo to give the desired product [3.4] as a cream solid (14.3 g, 81 %); 8 h (400 MHz, 
CDC13) 3.9 (s, 9H, OMe), 7.35 (d, 2H, J9 .0 , Ar H-3 and H-5), 7.4 (s, 2H, Ar H - 8  and H- 
12), 7.95 (d, 2H, J  8.58, Ar H-2 and H-6% 10.0 (s, 1H, CHO), 5C (100 MHz, CDC13) 
191.0, 164.2, 155.7, 153.1, 143.1, 134.0, 131.3, 123.6, 122.6, 107.4, 56.3; IR (KBr, 
cm •') 2948,2824, 2726, 1737 (ester 0=0), 1699 (aldehyde C=0), 1589, 1504,1406, 1417, 
1338,1233,1157, 1123,997,935,861,799,751,732,704; m/z (APCI) 317.0.
[3 .5 ]H2  A/es0-5,lO,15,2O-tetra-(3,4,5-trimethoxybenzoic acid phenyl ester) porphyrin
OMe
OMe
MeO,
OMe
MeO
OMe
MeO
MeO
The procedure described for [3.1] was followed, the applied reagents being [3.4] (1.63 g,
5.3 mmol), pyrrole (2.33 g, 5.0 mmol) and propionic acid (30 mL). Chromatographic 
purification on silica gel eluting with THF afforded [3.5] as a shiny purple solid. (0.487 g, 
26 %) 8 h (400 MHz, CDC13) -2.8 (s, 2H, NH) 3.95 (s, 36H, OMe), 7.55 (m,16H, Ar H-3, 
H-5, H - 8  and H-12), 8.24 (d, 8 H, J  8.35, Ar H-2 and H-6 ), 8.9 (s, 8 H, p-pyrrole); IR 
(KBr, cm'1) 3318 (NH), 2961, 1740 (ester 0=0), 1563, 1502, 1474, 1397, 1361, 1266, 
1222, 1194, 1106, 1023, 982, 968, 803; UV/Vis (CHC13, nm, log e/dm3 mol' 1 cm'1) 422 
(5.00), 516, 552, 592, 648; m/z (MALDI)1455.4594 (calc 1455.4662) HRMS (TOF ES) 
m/z calc for C8 4 H7 1N4 O2 0  1455.4594; found 1455.4662.
[Pt(3.5>]
This was prepared in the same manner [Pt(3.2)J, the applied reagents were [3.5] (0.1 g, 
0.068 mmol) and platinum (II) dichloride (100 mg) to afford [Pt(3.5)] as a pink solid 
(0.074 g, 6 6 %); 5H (400 MHz, CDC13) 3.95 (s, 36H, OCH3% 7.55 (m, 16H, Ar H-3, H-5,
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H- 8  and H-12), 8.20 (d, 8 H, J  8.35, Ar H-2 and H-6 ), 8.91 (s, 8 H, p-pyrrole); IR (KBr, 
cm ') 2880, 2654, 1745, 1672, 1642, 1208, 1284, 1119, 1039; UV/Vis (CHCU, nm, log 
e/dm3 mol' 1 cm'1) 402 (5.01), 510; m/z (MALDI) 1648.702 [calculated 1648.55],
[3 .6 JH2  10,15-tri-(4-tolyl)-20-mono-(3,4,5-trimethoxybenzoic acid phenyl ester)
porphyrin
OMe
The procedure described for [3.3] was followed, the applied reagents being 4- 
tolylbenzaldehyde (5 g, 41.6 mmol), [3.4] (0.63 g. 1.99 mmol), pyrrole (2.7 g, 40.24 mmol) 
and propionic acid (40 mL) (1.173 g). Chromatographic separation on silica gel eluting 
with chloroform removes tetra-(4-tolylphenyl) porphyrin and changing to 10 % MeOH (Rf 
0.053) affords [3.6] as a purple solid (O.Olg, 6  %); 5H (400 MHz, CDC13) -2.90 (s, 2H, 
NH), 2.65 (s, 9H, Me), 4.00 (3, 9H, OMe), 7.45 (d, 6 H ,J  7.68, A i H-3 and H-5), 7.55 (m, 
4H, Ar H-3’, H-5’, H-8 ’ and H A T ), 8.05 (m, 6 H, J  7.74, Ar H-2 and H-6), 8.25 (m, 2H, 
Ar H-2’ and H-6'), 9.80 (s, 6 H, P-pyrrole H), 9.85 (s, 2H, p pyrrole’ H ); IR (KBr, cm'1) 
3321, 2950, 1742, 1567, 1510, 1465, 1400, 1364, 1267, 1222, 1100, 958; HRMS (ES) m/z 
calc for C5 7 H4 7 N4 O5 867.3546; found 867.3503.
[3 .7 JH2  Mes0-5,lO,15-tri-(4-chlorophenyl)-2O-mono-(3,4,5-trimethoxybenzoic acid 
phenyl ester) porphyrin
OMe
The procedure described for [3.3] was followed, the applied reagents being 4- 
chlorobenzaldehyde (10 g, 70 mmol), [3.4] (1.08 g, 3.41 mmol), pyrrole (4.67 g, 69 mmol)
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and propionic acid (250 mL). Chromatographic separation as described above (Rf 0.09) 
afforded [3.7] as a purple solid (0.12 g, 4 %). SH (400 MHz, CDC13) 3.90 (s, 9H, OMe),
7.45 (d, 2H, J  8.35), 7.50 (m, 8 H), 7.95 (m, 8 H), 8.15 (d, 2H, J  8.30), 8.70 (s, 6 H, 13- 
pyrrole), 8.80 (s, 2H, p-pyrrole); IR (KBr, cm'1) 3323, 2945, 1743, 1577, 1521, 1453, 
1399, 1354, 1266, 1237, 1114, 958, 800; UV/Vis (CHC13, nm, log e/dm3 mol' 1 cm'1) 422 
(4.80), 516, 550, 590, 646; m/z (MALDI) 929.268 [calculated 928.268].
[3 .8 JH2  Meso-5,10,15,20-tetra (4-hydroxyphenyl) porphyrin
Compound [3.5] (0.4 g, 1.78 x 10-4  mol) and hydrazine monohydrate (0.043 mL [d = 
1.032]) were added to ethanol and refluxed for 48 h. Upon cooling the solution was filtered 
to remove unreacted started material and water was added to precipitate the phenol 
derivative and filtered. The crude material was recrystallised by dissolving in warm THF 
and then diluted with hot cyclohexane until crystallisation started to afford [3.8] as a purple 
solid (0.10 g, 53 %); The spectral data were analogous to that of [3.2]; m/z (MALDI) 
679.139 [calculated 678.745].
[3 .9 ]H2  3/£S0-5,lO,15,2O-tetra-(3-methoxy-4-hydroxyphenyl) porphyrin
OMe
OHHO.
OMe
MeO-
OHHO
MeO
The procedure described for [3.1] was followed, the applied reagents being vanillin (12 g,
78.8 mmol), pyrrole (4.93 g, 73.6 mmol) and propionic acid (250 mL). Chromatographic 
purification on silica gel eluting with acetone (Rf 0.89) afforded [3.9] as a purple solid 
(2.565 g, 16 %); 6 H (400 MHz, d-acetone) -2.90 (s, 2H, NH), 3.90 (s, 12H, OMe), 7.15 
(d,4H, J7.89), 7.55 (d, 4H, J  7.72), 7.70 (bs, 4H), 8 . 8  (s, 8 H, P-pyrrole); IR (KBr, cm'1) 
3495, 3432, 2945, 1700, 1597, 1559, 1515, 1458,1417, 1342, 1258, 1234,1207, 1122, 802; 
UV/Vis (acetone, nm, log e/dm3 mol' 1 cm'1) 424 (4.51), 518, 556, 594, 650; m/z (MALDI) 
799.317 [calculated 798.84].
[Pd(3.9)]
This compound was prepared in an analogous manner to that of [Pd(3.1)]. The applied 
reagents were [3.9] (0.5 g, 0.626 mmol) and palladium dichloride (200 mg) afforded
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[Pd(3.9)J as a pink solid (0.34 g, 61 %); 8 H (400MHz, CDC13) 3.85 (s, 4H, OCH3), 7.05 (d, 
4H, J  8.0), 7.50 (d, 4H, J  7.8), 7.75 (s, 4H), 8.65 (s, 8 H, //-p-pyrrole); UV/Vis (CHCI3 , nm, 
log s/dm3  mol' 1 cm'1) 422 (4.78), 526; m/z (MALDI) 904.82 [M + 1],
(Pt(3.9)J
This compound was prepared in an analogous manner to that of [Pt(3.2)]. The applied 
reagents were [3.2] (0.2 g, 0.250 mmol) and platinum dichloride (100 mg) afforded 
[Pt(3.9)J as an orange solid (0.121 g, 49 %); 8 H (400MHz, CDC13) 3.80 (s, 4H, OCH,% 7.0 
(d, 4H), 7.45 (d, 4H), 7.75 (s, 4H), 8.70 (s, 8 H, //-p-pyrrole); UV/Vis (CHC13, nm, log 
e/dm3 mol' 1 cm'1) 406 (4.81), 512; IR (KBr, cm'1) 3430, 2923, 1597, 1508, 1446, 1416, 
1353,1314,1262,1198,1165, 1118,1020,934,869, 799; m/z (MALDI) 993.0 [M + 1],
[3 .1 0 JH2  Afes0-5,lO,15-tri-(4-toIyl)-2O-mono-(3-methoxy-4-hydroxyphenyl) porphyrin
OH
MeO
The procedure described for [3.3] was followed, the applied reagents being 4- 
tolylbenzaldehyde (10.6 g, 8 8  mmol), vanillin (0.67 g, 4.4 mmol), pyrrole (5.53 g, 82 
mmol) and propionic acid (100 mL), (3.2 g). Chromatographic separation on silica gel 
eluting with chloroform afforded (Rf 0.18) [3.10] as a purple solid. (0.12 g, 4 %); 5h (400 
MHz, CDC13) -2.90 (s, 2H, NH), 2.6 (s, 9H, Me), 3.9 (s, 3H, OMe), 5.9 (bs, 1H, OH),
7.2 (d, 1H, J  8.50), 7.4 (m, 1H), 7.48 (d, 6 H, J7.70), 7.65 (s, 1H), 8.0 (d, 6 H, J7.79),
8.80 (s, 6 H, p-pyrrole), 8.85 (s, 2H, P-pyrrole); IR (KBr, cm'1) 3500, 1559, 1510, 1473, 
1346, 1262, 1220, 1181, 1118, 1037, 967; UV/Vis (CHC13, nm, log e/dm3  mol' 1 cm'1) 424 
(5.02), 518,554, 594,650; m/z (MALDI) 703.250 [calculated 702.85].
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[ 3 . 11 J H 2 Meso-5 , 1 0 , 1 5 - t r i  (4-teri-butylphenyl)-20-(4-hydroxy-3-methoxyphenyl)
porphyrin
OH
MeO
The procedure described for [3.3] was followed, the applied reagents being 4-tert- 
butylbenzaldehyde (20 g, 0.123 mol), vanillin (0.937 g, 0.0016 mol) pyrrole (8.08 g, 0.12 
mol) and propionic acid (200 mL). Chromatographic separation on silica gel eluting with 
chloroform (Rf 0.21) afforded [3.11] as a purple solid (0.080 g, 2 %); 5h (400 MHz, 
CDC13) -2.90 (s, 2H, NH), 1.52 (s, 27H, CH3), 3.92 (s, 3H, OCH3), 5.87 (br s, 1H, OH), 
7.21; UV/Vis (CHC13, nm, log s/dm3 mol' 1 cm"') 424 (5.15), 518, 554, 594, 650; m/z 
(MALDI) 829.54 [M + 1],
[3.12] Diethyl-4-formylphenyl Phosphate
H / = \  OEt
K > ° - r oo ----  OEt
NaH (60 % mineral oil dispersion (1.67g) was added to a Schlenk tube, degassed and 
washed with petroleum ether (2 x 30 mL), to this THF (120 mL) was added and stirred. 4- 
Hydroxybenzaldehyde (5.08 g) was added to this suspension and was left to stir for 1.5 h. 
Chloro diethylphosphate (7.18 g, 6  mL, 0.0416 mmol) was added dropwise and was stirred 
at room temperature for lh. The suspension was filtered and the solvent removed in vacuo 
to give the desired product [3.12] as a pale yellow oil (6.44 g, 60 %); 8 h (400 MHz, CDCI3 )
1.3 (m, 6 H, CH2 C//3 ), 4.2 (m, 4H, CH2CH3), 7.45 (d, 2H, J  8.22), 7.95 (d, 2H, J  8.26), 
10.0 (s, 1H, P-pyrrole); 8 C (100 MHz, CDC13) 190.5, 130.2, 133.4, 120.0, 115.8, 65.0, 20.3 
5p{H} (121.65 MHz, CDCI3 ) -6.48; IR (NaCl, cm*1) 3423, 2986, 2912, 2740, 1703 (C=0), 
1600, 1504, 1479, 1444, 1422, 1393, 1370, 1279 (P=0), 1225, 1160, 1099, 1038 (P-O-Et), 
965 (P-O-Ar), 840, 765, 710; m/z (APCI) 259 [M+H].
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[3.13JH2 Meso-5,\0,15,20-tetra (Diethyl 4-(diethyl phosphate)phenyl) porphyrin
O. OEt
O  OEtEtO Os
EtO, p
//*  \
O OEt
The procedure described for [3.1] was followed, the applied reagents being [3.12] (0.76 g, 
52 mmol), pyrrole (0.3 g, 44 mmol) and propionic acid (20 mL). The propionic acid was 
removed in vacuo, and the remaining residue was passed through a short silica plug ( 6 x 7  
cm) and eluting with MeOH. The MeOH was removed and the solution was absorbed onto 
silica. The silica was suspended in hot acetone, stirred and filtered, repeated twice. The 
resulting purple solution was reduced to half its original volume and hexane was added to 
precipitate any remaining polymeric material. The porphyrin was purified by column 
chromatography using ethyl acetate (98 %): MeOH (2 %) as the elutant, changing to MeOH 
(10%) to remove the desired purple band containing [3.13] (0.02 g, 3 %); 8 h (400 MHz, d6- 
acetone) -2.90 (s, 2H, NH), 1.35 (m, 24H, CH2 CH3), 4.30 (m, 16H, CH2CH3), 7.6 (d, 8 H, 
J  8.28, Ar H-3 and H-5), 8.15 (d, 8 H, J  8.27, Ar H-2 and H-6), 8.80 (s, 8 H, P-pyrrole H); 
8 p(H| (121.65 MHz, d6 -acetone) -4.60; IR (KBr, c m 1) 3456, 2950, 1654, 1599, 1499, 
1393, 1262 (P=0), 1213, 1157, 1096, 1056, 1029, 956, 801; m/z (MALDI) 1223.3695 
(calc 1223.3503); UV/Vis (CHCb, nm, log a/dm3  mol' 1 cm'1) 421 (5.10), 446, 516, 551, 
591,649; HRMS (ES) m/z calc for (M) 1223.3503; found 1223.3695.
[3.14]H2 Afes0-5,lO,15-tritolyl-2O-mono-(4(diethyl phosphate) porphyrin
O. .OEt
EtO O
The procedure described for [3.3] was followed, the applied reagents being 4- 
tolylbenzaldehyde (10 g, 80 mmol), [3.12] (0.617 g, 40 mmol), pyrrole (5.25 g, 78.4 mmol) 
and propionic acid (100 mL). Chromatographic separation on silica gel eluting with 
chloroform removed meso-5,10,15,20-tetratolylporphyrin. Eluting with chloroform/MeOH
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(98:2) removed the desired product ( R f  0.33). The material was re-chromatographed by 
preparative thin layer chromatography using the same solvent system as above to afford
[3.14] as a purple solid (0.07 g, 4 %); SH (400 MHz, CDC13) -2.90 (s, 2H, NH), 1.4 (m, 
6 H, CH2 CH3 ), 2.6 (s, 9H, CH3), 4.30 (m, 4H, C//2 CH3), 7.45 (d, 6 H, J7 .45, Ar H-3 and 
H-5), 7.55 (d,2H ,./7.70, A r//-3 ’ and 77-5’), 8.05 (d, 6 H, 77.05, Ar H-2 and H-6), 8.1 (d, 
2H, J1A 1, Ar H-2' and H-6'), 8.75 (s, 2H, [3-pyrrole’ H), 8.80 (s, 6 H, (3-pyrrole H); 8 p(hi 
(121.65 MHz, CDCI3 ) -5.61; IR (KBr, c m 1) 1699, 1603, 1501, 1471, 1398, 1348, 1272, 
1215, 1181, 1021, 965, 799, 733; UV/Vis (CHC13, nm, log e/dm3  mol' 1 cm'1) 422 (4.99), 
518, 552, 592, 648; m/z (MALDI) 809.322 [calc 809.357]; HRMS (ES) m/z calc for 
C5 1 H4 6 N4 O4 P 809.3257; found 809.3223.
[3.15]H2 Af£$0-5,lO,15-tri-(4-chlorophenyl)-2O-mono-(4(diethyl phosphate) porphyrin
EtO O
The procedure described for [3.3] was followed, the applied reagents being 4- 
chlorobenzaldehyde (5 g, 0.0355 mol), [3.12] (0.25 g, 0.0017 mol), pyrrole (2.31 g, 0.034 
mol) and propionic acid (50 mL) (0.77 g). Chromatographic separation as described above 
affords [3.15] as a purple solid (0.025g, 3
%) 8 h (400 MHz, CDC13) -3.00 (s, 2H, NH) 1.45 (m, 6 H, CH2CH3), 4.35 (m, 4H, 
C//2 CH3 ), 7.55 (d, 2H, J  8.45, Ar H-3’ and H-5’), 7.65 (d, 6 H, J  8.27, Ar H-3 and H-5),
8.1 (d, 6 H, J8 .3 , Ar H-2 and H-6), 8.13 (d, 2H, J8.35, Ar H-T  and //- 6 ’), 8.75 (s, 8 H, P- 
pyrrole); 6 P{H} (121.65 MHz, CDCI3 ) -5.92; m/z (MALDI) 871.245 [calculated 870.08].
[3.16] Diethyl 4-Formy 1-2-methoxyphenyl Phosphate
0 \  OEt
OMe
Method A: NaH (60 % mineral oil dispersion (2.6lg ) was added to a schlenk, degassed 
and washed with petroleum ether (x2), to this thf (150 mL) was added and stirred. Vanillin 
(10 g, 65.7 mmol) was added to this suspension and was left to stir for 1.5 h. Chloro 
diethylphosphate (11.3 g, 9.43 mL) was added dropwise and was stirred at room 
temperature for lh. The suspension was filtered and the solvent removed in vacuo to give
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the desired product [3.16] as a pale yellow oil (14.612 g, 77 %); 8 h (400 MHz, CDCI3 ) 
1.40 (m, 3H, C773), 4.30 (m, 2H, CH2), 7.45 (m, 3H, Ar 77-2, 77-3 and 77-6), 9.90 (s, 1H, 
C770), 8 C (100 MHz, CDC13) 190.92, 151.83 (JCp 10 Hz), 144.93 (JCP 11 Hz), 133.95, 
125.01, 121.55 (JCp 4 Hz), 110.84, 64.93, 58.93, 15.97; 8 P{H} (121.65 MHz, CDC13) -6.09; 
IR (NaCl, cm'1) 3483, 2984, 2940, 2839, 2736, 1701 (C=0), 1595, 1506, 1466, 1423, 1392, 
1278 (P=0), 1216, 1151, 1124, 1032 (P-O-Et), 959 (P-O-Ar), 824, 780, 733; m/z (APCI) 
289 [calc 288.43].
Method B: DMAP (0.079 g) and triethylamine (0.65 g) in dry THF (20 mL) were added to 
a 100 mL round bottomed flask and sealed with a rubber septum. To this was added 
chlorodiethyl phosphate (1.13 g, 0.94 mL) and vanillin (1 g, 6.5 mmol) and was left to stir 
for 2 h. The solvents were removed in vacuo to give the product [3.16] as a colourless oil 
(60 %) which has identical spectral properties as above.
[3.17]H2 Mes0-5,10,15,20-tetra ((4-diethyl phosphate) -  3 -  methoxyphenyl) porphyrin
Q , .OEt
OMe
O  OEtEtO O,
OMe
MeO
EtO. p
MeO//* \
O OEt
The procedure described for [3.1] was followed, the applied reagents being [3.16] (4 g, 13.8 
mmol), pyrrole (0.86 g, 12.9 mmol) and propionic acid (15 mL). Chromatographic 
purification on silica gel eluting with chloroform/MeOH (90:10) affords [3.17] as a purple 
solid (0.37 g, 8  %); 8 H (400 MHz, CDC13) -2.82 (s, 2H, NT/), 1.40 (m, 24H, CH2 CTT3),
3.80 (s, 12H, OCTT3 ), 4.40 (m, 16H, CT/2 CH3), 7.10 (d, 4H, J  8.0), 7.58 (d, 4H, J  7.8), 
7.75 (s, 4H), 8.9 (s, 8 H, p-pyrrole), 5 p !H ) (121.65 MHz, CDC13) -5.48; IR (KBr, cm'1) 
3300 (NH w), 2976, 1646, 1591, 1522, 1488, 1394, 1260 (P=0, strong), 1167, 1038 (P-O, 
strong), 797,612,509; m/z (MALDI) 1343.742 [calc 1343.18],
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[3.18JH2 Meso-5,10,15-tri-(4-toly l)-20-((4-diethy 1 phosphate) — 3 — methoxyphenyl)
porphyrin
MeO
The procedure described for [3.3] was followed, the applied reagents being 4- 
tolylbenzaldehyde (4 g, 41.6 mmol), [3.16] (0.6 g, 2.08 mmol), pyrrole (2.73 g, 40.7 mmol) 
and propionic acid (40 mL), reacted for 30 min and allowed to cool and filtered. The 
resulting purple solid was dissolved in chloroform and absorbed onto silica. The crude 
mixture was separated on a silica column, eluting with chloroform removed the tetra 
chlorophenylporphyrin, changing the solvent system to chloroform: MeOH (99:1) to 
remove the desired porphyrin (Rf 0.51). The product was further purified using preparative 
thin-layer chromatography using CHCl3:MeOH (99:1) to afford [3.18] as a purple solid 
(0.0086 g, 0.5 %); SH (400 MHz, CDC13) -2.7 (s, 2 H, NH2), 1.45 (m, 6 H, CH2 C773), 2.62 (s, 
9H, CH3), 3.90 (s, 3H, OCH3), 4.38 (m, 4H, CH2CH3), 7.50 (d, 6 H, J7 .4 , Ar H-3 and H-5), 
7.60 (d, 1H, J  8.03, Ar H), 7.72 (d, 1H, J  8.06, Ar H), 7.76 (s, 1H, Ar H-6’), 8.05 (d, 6 H, 
J  7.01, Ar H-2 and H-6), 8.80 (s, 8 H, P pyrrole); 6 P{H} (121.65 MHz, CDC13) -4.99; IR 
(KBr, cm 1) 3437, 2962, 1506, 1473, 1261, 1218, 1096, 1023, 969, 917 , 800 UV/Vis 
(CHCI3 , nm, log s/dm3  mol' 1 cm '1) 422 (5.06), 518/522, 552, 592, 648; m/z (MALDI) 
839.336 [calculated 838.94],
[3.19] Attempted Synthesis of /wes0-5,lO,15,2O-tetra((4-diethyl phosphate) -  3 -  
methoxyphenyl) porphyrin
Method A: NaH (60 % mineral oil dispersion (0.076 g) was added to a schlenk, degassed 
and washed with petroleum ether (2 x 30 mL), to this THF (10 mL) was added and stirred. 
[3.9] (0.37 g, 4.81 x 10"4  mol) was added to this suspension and was left to stir for 1.5 h. 
Diethyl chlorophosphate (0.32 g, 0.26 mL, 1 mmol) was added dropwise and was stirred at 
room temperature for 2h. The suspension was filtered and the solvent removed in vacuo to 
give the desired product [3.19] as a mixture of products; 5P{h} (121.65 MHz, CDC13) -5.04; 
IR (KBr, cm'1) 3437, 2978, 1593, 1510, 1486, 1407, 1265, 1220, 1166, 1128, 1031, 961, 
916, 800, 709; m/z (MALDI) calculated 1343.167 contains 799.208 and 935.258.
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Method B: DMAP (0.0299 g) and triethylamine (0.248 g) in dry THF (20 mL) were added 
to a 100 mL round bottomed flask and sealed with a rubber septum. To this was added 
chlorodiethyl phosphate (0.423 g, 0.35 mL) and 5, 10, 15, 20 Tetra 4-hydroxy-3 -  
methoxyphenyl) porphyrin [3.9] (0.49 g) and was left to stir overnight. The solvents were 
removed in vacuo to give the product [3.19] as a mixture of products.
[3.20] M£S0-5,lO,15-tri-(4-/e/,/-butylphenyl)-2O-((4-diethyl phosphate) — 3 -
methoxyphenyl) porphyrin
MeO
DMAP (0.002 g) and triethylamine (0.01 g) in dry THF (10 mL) were added to a 50 mL 
round bottomed flask and sealed with a rubber septum. To this was added chloro 
diethylphosphate (0.0166 g, 0.0139 mL) and [3.11] (0.08 g, 9.65 x 10 5 mol) and was left 
to stir for 2 hours. The solvents were removed in vacuo to give the product [3.20] as a 
purple solid; 8 P{H> (121.65 MHz, CDCI3 ) -5.8; IR (KBr, cm'1) 3406, 1648, 1564, 1445, 
1400, 1261 (P=0, strong), 1217, 1055 (P-O, strong), 950, 800; m/z (MALDI) 965.537 
[calculated 965.1751].
[Pd(3.21)] Attempted Synthesis of meso-5,10,15,20-tetra(4-(diethyl phosphate)phenyl) 
porphyrin palladium
EtO, JOO n  P E t
O  OEt
N — Pd— N
EtO, p
V \
O OEt
DMAP (-100 mg, catalytic amount) and triethylamine (0.02g) in dry THF (20 mL) were 
added to a 50 mL round bottomed flask and sealed with a rubber septum. To this was added 
chlorodiethyl phosphate (0.75 mL) and [Pd(3.2)J (0.11 g, 1.43 x 1 O' 4  mol) and was left to
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stir for 2 h. The solvents were removed in vacuo to give the product. The crude product was 
passed through a short silica column eluting with THF. The solvent was removed and taken 
up in chloroform, washed with water, dried over MgSC>4 and the solvent removed in vacuo 
to give the title compound [Pd(3.21)] as a mixture of products; 5p{hj (121.65 MHz, CDCI3 ) 
-5.45; IR (KBr, cm'1) 2985,2925, 1659, 1503, 1478, 1443,1393, 1353, 1257, 1222,1162, 
1036,976,815; UV/Vis (CHCI3 , nm, log c/dm3  mol' 1 cm'1) 418 (5.02), 421,520, 525.
[3 .2 2 ]]H2  M£S0-5,lO,15,2O-tetra(4-fluorophenyl)porphyrin
This was prepared in an analogous method to that of [3.1]. The applied reagents were 4- 
fluorobenzaldehyde (2g, 16.11 mmol) and pyrrole (lg, 15.04 mmol) to afford [3.22] as a 
purple solid (0.3 8 g, 14 %). The spectroscopic data was consistent with the literature. 6 4
[3.23] H2  A/£S0 -tetra(4 -fluoro-3 nitrophenyl) porphyrin
n o 2
n o 2
Pyrrole (0.08 g, 1.15 mmol) and 4-fluoro-3-nitrobenzaldehyde (0.209 g, 1.23 mmol) were 
added to refluxing propionic acid (20 ml). After 30 min the solution was left to cool 
overnight and filtered. The resulting black crystalline material was washed with methanol 
until the filtrate ran clear, and allowed to air dry to afford [3.23] as a black solid (0.056g, 21 
%). Due to the insolubility of this product only characterisation by IR spectroscopy was 
possible. (IR KBr, cm'1) 3418 (NH stretch), 1537, 1338 (N=0) and 1266 (C-F).
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[3.24] ]H2 Af£50-tetra(pentafluorophenyl)porphyrm
A 3-neck round bottomed flask was fitted a septum port, a reflux condenser and a gas inlet 
port. The flask was charged with distilled CH2 CI2  (122 mL), pentafluorobenzaldehyde (0.1 
g, 0.5 mmol) and pyrrole ( 0.06 mL). The resulting solution was stirred at room temperature 
and purged with N2  for 15 min. BF3 etherate (4 ml of a 2.5 M solution in CH2 CI2 .) was 
added via a syringe and stirred for 2 h under nitrogen. After addition of 2,3-dichloro-5,6- 
dicyano-l,4-benzoquinone (0.28 g) the solution was stirred overnight, then passed through 
a short alumina column to remove the tar. The reaction mixture was separated by column 
chromatography on silica gel with CH2 CI2 : «-hexane (1:4) to afford [3.24] as a dark red 
solid (0.024g, 20 %); 5H (400 MHz, CDC13) -3.0 (s, 2H, N//), 8.9 (s, 4H, pyrrole-//); § f  
(282.78 MHz, CDC13) -161.1 (m), -151.1 (m), 136.3 (m); UV/Vis (CHCI3 , nm, log s/dm3 
mol' 1 cm"1) 412 (4.99), 510, 580; m/z (MALDI) 975.64 [M+ 1],
[3.25] Iodo-3,4-dimethoxybenzene
Veratrole (0.5 g, 3.6 mmol) and iodine monochloride (0.58 g, 3.6 mmol) were added to 
acetic acid (10 mL) and was left to stir overnight, shielded from the light. The acetic acid 
was removed in vacuo. The residue was extracted with DCM (10 mL) and washed with 
sodium metabisulfate ( 2 x 1 0  mL), water ( 3 x 1 0  mL) and dried over MgSC>4 . The solvents 
were removed in vacuo to afford [3.25] as a brown solid (0.6g, 62 %); 5h (400 MHz, 
CDC13) 3.80 (s, 6 H, OC//3 ), 6.50 (d, 1H, Ar-//), 7.00 (d, 1H, Ar-//), 7.15 (dd, 1H, Ar-//); 
m/z (APCI) 265 [M + 1].
[3.26] I odo-3,4-dihydroxybenzene
Compound [3.25] (0.15 g, 0.56 mmol) was dissolved in degassed DCM (25 mL) and cooled 
to -80 C. To this boron tribromide (0.48 g, 0.18 mL, 1.1 mmol) in DCM (2 mL) was added
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dropwise and stirred for 1 h at -80 °C. The solution was allowed to cool to room 
temperature and stirred overnight. Water was added to quench any unreacted boron 
tribromide and the product was extracted with diethyl ether (25 mL) and dried over MgSC>4 . 
The solvent were removed in vacuo and recrystalistion from hot afforded [3.26] as a fawn 
solid (0.12g, 74 %) 5H (400 MHz, CDC13) 5.7 (br s, 1H, OH), 6.6 (d, 1H, Ai-H), 7.0 (dd, 
1H, Ar-H), 7.10 (d, 1H, Ar-H); m/z (APCI) 237 [M + 1].
[3.27]
co
This was prepared using the method described by McKeown et al. [3.24] (0.06g, 0.67 
mmol), [3.26] (0.016g, 0.27 mmol) and potassium carbonate (0.009 g, 0.52 mmol) were 
added to Ar-methyl-2-pyrrolidinone (5 mL) and heated to reflux overnight. Upon cooling a 
small quantity of a brown precipitate formed which was collected by filtration; 8f (282.78 
MHz, D20 ) -139.9 (d), -155.2 (m), -164.1 (m); m/z (MALDI) 1758.7 [M+l].
[3.28] 4-Aminophenylphosphate disodium salt
H2NHC ^ opo2Na2
To a solution of 4-nitrophenylphosphate disodium salt (5.00 g, 19 mmol ) in a mixture of 
water (100 mL) and ethanol (4 mL) was added 10 % palladium on charcoal (~50 mg). The 
resulting black suspension was stirred at room temperature, under an atmosphere of 
hydrogen, for 72 hours. The suspension was then filtered through Celite® and the clear 
solution was evaporated to dryness under reduced pressure to yield [3.28] as a cream solid. 
The product was used without further purification (3.9g, 88 %); 8h (400 MHz, D20 ) 6.60 
(d, 2H, J 8.00), 7.05 (d, 2H, J7.95); 5P{H} (121.65 MHz, D20 ) -5.01; IR (KBr, cm'1) 3441, 
2615, 1512,m 1284, 1241, 1206, 1169, 1099, 969, 831.
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Attempted synthesis of [3.29]
0 P 0 2Na2
0NsN
Na20 2P0
n=n
Na2OzPO
This was prepared using methodology described in the literature.59 To a solution of sodium 
carbonate (0.11 g) and [3.28] (0.5 g) in water (10 mL) at 0 °C was added a solution of 
sodium nitrite (0.15 g) in water (5 mL) at 0 °C. The resulting solution was then added to a 
mixture of crushed ice and concentrated HC1 (2 mL) with rapid stirring. The resulting ice 
cold solution was then added to a solution of 5,10,15,20-tetetra (4-hydroxyphenyl) 
porphyrin [3.2] (0.6 g) in 10 % NaOH (2 mL) at 0 °C for 1 h. The pH of the solution was 
adjusted to 7. A 50 cm strip of dialysis membrane was immersed in boiling water until soft. 
A knot was tied into one end and 25 mL of the porphyrin mixture was poured in, and the 
other end was tied. The bag was suspended by a piece of string into 1 L of distilled water; 
the water was changed after one week (orange colour) and was continued until the water 
remained colourless. The solid that had precipitated out inside the dialysis bag was 
analysed and was found to be 5,10,15,20-tetra (4-hydroxyphenyl) porphyrin.
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Introduction
This chapter presents preliminary work concerned with the attachment of a redox 
active compound directly to an antibody molecule.
4.1 Terpyridine background
Polypyridine compounds are an important class of nitrogen donor multidentate 
ligands, with examples including 2,2’-bipyridine, 2,2’:6,2”-terpyridine and 1,10- 
phenanthroline. 2,2’:6,2”-Terpyridine is constructed from three pyridine units bound by a 
single bond (figure 4.1) and was first discovered in 1932 by Morgan and Burstall1 by the 
heating of pyridine and anhydrous iron (III) chloride at 340 °C and 50 atms for 36 hours.
4’
4
5
6”6
Figure 4.1: Unsubstituted 2,2’:6,2”-terpyridine
In solution and the solid phase the terpyridine ligand adopts a planar configuration 
with the nitrogen atoms in adjacent rings aligning trans to each other, which minimises the 
repulsion between the nitrogen lone pairs and the aromatic protons (//-3, H-3’ and H -5\ H- 
3”) (figure 4.2). This trans configuration in the solid state has been confirmed by 
crystallography e.g. for 2,2, :6,2”-terpyridine2 and 4-phenyl-2,2’:6,2”-terpyridine.3
trans, trans conformation cis, cis conformation of
of free ligand chelated ligand
Figure 4.2: Trans, trans conformation o f a free 2 ,2’:6,2”-terpyridine ligand and cis, cis conformation of a
chelated terpyridine
2,2, :6,2”-Terpyridines can be functionalised at the central and terminal pyridine 
rings generating a wide variety of derivatives. The substituents can be incorporated into 
either the starting materials or introduced via a coupling procedure. The most common 
substitution is at the 4’ position.
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4.2 Coordination Chemistry and Metal Complexes
The coordination chemistry of 2,2’:6,2”-terpyridine and the substituted analogues 
has been extensively studied and a wide variety of transition metal complexes are known. It 
coordinates as a planar tridentate ligand with a metal to form two five-membered chelate 
rings. Upon coordination the terpyridine ligand adopts a cis-cis conformation (figure 4.2) 
with changes to the dihedral angle between the terminal and central pyridyl rings (figure 
4.3).
distortion in bond angles upon 
complexation
Figure 4.3: Changes in the dihedral angle upon coordination.
Terpyridine metal complexes display characteristic optical and electrochemical 
properties i.e. metal to ligand charge transfer (MLCT) in the visible light region, reversible 
reduction and oxidation processes and luminescence. The extent of these properties can be 
controlled or altered by the functional groups incorporated into the terpyridine ligand.
The majority of the resulting metal complexes exhibit either a 1:1 or 1:2 
metal :ligand ratios. Many transition metal ions in low oxidation states form bis-complexes 
with two terpyridine ligands, including Cr(III), Cr(II), Fe(III), Fe(II), Ru(II), Ni(II), Cu(II) 
and Zn(II). The terpyridine ligands coordinate to the metal centre in a meridinal (mer) 
fashion. Complexes of this type are stabilised by the strong metal-ligand (d-7t*) back 
donation and a distorted octahedral geometry at the metal centre is displayed, as confirmed 
by crystal structural analysis.4 Square planar geometries are also observed e.g. Pt(II) and 
Pd(II). In both cases the bond to the central pyridyl ring is shorter than the bonds to the 
terminal rings for instance, the central bond lengths in the Zn(II) octahedral complex5 and 
Pt(II) square planar complex6 are on average 0.1 and 0.15 A respectively, shorter.
4.3 Applications
Terpyridine derivatives and their complexes have found use in a wide area of 
applications. The incorporation of electron withdrawing or releasing substituents can be 
used to fine tune the redox and photophysical properties of the terpyridine complexes, for 
example an electron withdrawing substituent in [Ru(Xtpy)2 ]2+ renders the complex 
luminescent at room temperature.7 This electronic influence has led to the use of terpyridine
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8complexes in areas of photochemistry e.g. in the design of luminescent devices and as 
sensitizers for light-to-electricity conversion.9,10 The addition of iron (II) ions to a solution 
of a terpyridine compound gives rise to a purple colour indicating the formation of a metal 
complex, hence terpyridine compounds have been used as reagents for the colorimetric 
determination of metals.1113 Terpyridine derivatives have also found other potential uses in 
clinical and biochemical applications including DNA binding agents14' 16 and in anti-tumour 
research.17' 19 Chloro (terpyridine) platinum(II) (figure 4.4) has been used to non-invasively 
label amino acids, peptides and Cytochromes c via the displacement of the chloride by 
histidine ’ and guanidine ’ residues. Lanthanide complexes i.e. Eu (III) and Tb (III) of
2,2, :6,2”-terpyridine ligands with pendent carboxylate groups (figure 4.4) are attracting 
interest as luminescent agents for protein labelling.24,25
R
//  V I / /  N -P t-C l
Cl
,N=<
Where R = NCS or (\ ,N '  //N 
C^l
N
Ln3+
N
[Pt(tpy)Cl]+ O O O O  O O O O
Figure 4.4: Examples of terpyridine systems used in biological applications.
4.4 Routes of Synthesis
4.4.1 The Krohnke Method 13
This is regarded as a useful method to synthesise 2,2’:6’,2” aryl-substituted 
terpyridine ligands. It involves the reaction of a pyridinium salt 2 with an unsaturated 
ketone (chalcone) 3 via a Michael addition to form 1,5-diketone 4. Treatment with 
ammonium acetate results in ring closure to generate the 4’-aryl substituted terpyridine 813 
(figure 4.5, route A). The pyridinium salt is obtained by the reaction of 2-halo-l-pyridin-2- 
ylethanone with the pyridine, and the chalcone from the reaction of a benzaldehyde with 
acetylpyridine. Despite the common use of this synthesis, the protocol is time consuming, 
products require purification and yields are generally moderate to low.26'28
4.4.2 Cave and Raston Method
Cave and Raston reported a modified Krohnke method where the solventless aldol 
condensation of benzaldehyde 5 with one equivalent of acetylpyridine 1 in the presence of
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solid NaOH generates the unsaturated ketone product 6. The reaction of a second 
equivalent of acetylpyridine results in 6 undergoing a Michael addition to generate the 
diketone 7. This is followed by treatment with ammonium acetate to generate the 
terpyridine 8 in yields typically greater than 75% (figure 4.5, route B). This versatile 
method allows access to a range of compounds that were previously unobtainable using 
conventional methods. The mild conditions utilised result in clean products.
4.4.3 Other Methods
Over the last decade interest in microwave-assisted synthesis has increased 
dramatically, with numerous reports that support the advantages and use of microwave
• • Tft 11irradiation to carry out organic synthesis. ’ As a result of using microwave irradiation, an 
increase in rates, yields and in the purities of the products have been observed.
More recently the preparation of 4’-aryl-2,2, :6,,2” -terpyridines by a one-pot 
reaction of 2-acetylpyridine with benzaldehyde in the presence of ammonium acetate under
T9microwave irradiation has been reported. This method provides a shorter, higher yielding 
route to terpyridines with an easier work-up, shorter reaction times and using more 
environmentally friendly conditions than conventional methods.
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X
iodine, pyridine
O
R
NaOH, grind
6
B
NaOH
grind
O
[NH4][OAc]
8
[NH4][OAc]
Figure 4.5: Scheme illustrating the Krohnke synthesis (A) and Raston method (B) preparation of terpyridine
8.
4.5 Bioconjugation Methods
The ability to chemically attach one biological molecule to another has generated a 
billion dollar industry which serves areas of research, diagnostics and the therapeutic 
markets. Modified or conjugated molecules have been used for the purification, detection or 
localisation of specific cellular components and in the treatment of disease. The reactive 
groups present in cross-linking reagents, tags and probes provide the means to specifically 
label certain target groups on proteins, peptides, carbohydrates, lipids, nucleic acids, 
oligonucleotides and synthetic polymers.
4.6 Reactive Groups
The conjugation process involves the reaction of a functional group on one 
molecule (e.g. a label) with a functional group on the desired target (i.e. an antibody),
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resulting in the formation of a covalent bond. There are many reagent systems that are 
commercially available or that are described in the literature for coupling reactions and can 
be categorised into the following chemical reactions:
• Amine reactive
• Thiol reactive
• Carboxylate reactive
• Hydroxyl reactive
• Aldehyde and ketone reactive
• Active hydrogen reactive
• Photoreactive
Functional groups that are able to couple with amine-containing molecules are the most 
commonly used in bioconjugation. The wide use is since amine-coupling reactions can be 
used to conjugate with nearly all protein and peptide molecules. The reaction of the reactive 
group and an amine results in the formation of stable amide or secondary amine bonds. The 
thiol-reactive class are the second most commonly used whilst the others are more limited.
4.7 Examples of Reactive Groups
4.7.1 A-Hydroxysuccinimide (NHS) Ester
Many of the commercially available cross-linking or modification agents utilise 
NHS-esters. The NHS-esters can react with primary and secondary amines to form stable 
amide or imide bonds with the loss of a NHS leaving group (figure 4.6-(l)). Therefore they 
are most commonly used to couple proteins principally with the a-amines at the N- 
terminals and the e-amines of lysine side chains. NHS-esters can also react with a 
sulfhydryl or hydroxyl groups to form thioester or ester bonds, however these bonds are not 
stable since they can be hydrolysed in an aqueous environment.
4.7.2 Isothiocyanates and Isocyanates
Isothiocyanates differ from isocyanates by the replacement of oxygen atom by 
sulfur. Isothiocyanates can react with amines, sulfhydryls and the phenolate ion of tyrosine 
side chains.33 Only stable bonds are formed with primary amines to give an isothiourea 
bond (figure 4.6-(2)) so isothiocyanates are selective for coupling to s- and A-terminal 
amines in proteins. Isocyanates also couple to amines to give isourea bonds (figure 4.6-(3)) 
and additionally to hydroxyl-containing molecules. However, the reactivity of isocyanates
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is greater than that of isothiocyantes which results in problems associated with their 
stability. In fact many commercial suppliers do not offer them since they are readily 
decomposed by moisture.
4.7.3 Arylating Agents
Aryl halides can react with amines resulting in a stable arylamine covalent bond. 
They can also react with thiols, imidazolyls and the phenolate groups of amino acid side 
chains.34 Fluorobenzene derivatives, such as l,5-difluoro-2,4-dinitrobenzene (DFDNB) are 
utilised as homobifunctional cross-linker molecules (figure 4.6-(4)). Homobifunctional 
cross linkers are like a “molecular rope” that can ‘tie’ one protein to another by reaction of 
two common groups. The main disadvantage of using homobifunctional reagents is the 
potential for generating poorly defined conjugates, despite this these types of reagents are 
prevalent choices in conjugation applications. Difluorobenzene reagents have been used for 
a number of purposes including the cross-linking of phospholipids in human erythrocyte
T S TAmembranes and conjugation of small peptides to the carrier protein albumin.
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,R + N-O H
Amide bond NHS leaving group
R’- N - C - N - R
Isothiourea bond
R -N H 2 -
Amine
compound R '-N -C -N -R
Isourea bond
HN NH
ii
O O
(1)
(2)
(3)
(4)
Figure 4.6: Bioconjugation methods. The reaction of an amine compound , RNH2 with (1) NHS-ester, (2)
isothiocyante, (3) isocyanate and (4) DFDNB.
4.8 Aims and Objectives
Our group has previously demonstrated the ability of systems based on 2,2’:6,2”- 
terpyridine and 2,2’-bipyridyl ligands as positive catalysts for the reduction of silver in a
- i n
Timm’s type reaction (figure 4.7).
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R
Compound tested Solubility in the 
physical developer
Redox activity (time in minutes)
Where R = complex Noticeable change End point
OH - Insoluble 3 10
OH PtCl Insoluble 20 40
OH PtI Insoluble 2 4
OH PdCl Insoluble 3 6.5
OP(0)(OEt)2 - Sparingly soluble 3 8
0P (0)(0H )2 - Soluble 3 6
0P(0)(0H )2 PtI Soluble 2 4
Figure 4.7: Summary of previous results based on 4 ,-phenyl-2,2’:6’,2” -terpyridine.
It was shown that the phosphate derivatives of the above systems were suitable 
substrates for the enzyme alkaline phosphatase. Following enzymatic phosphate hydrolysis 
the corresponding phenol derivatives were found to deposit at the site of action. Despite 
displaying redox activity in a Timm’s style reaction, the deposited compounds did not 
adhere to tissue sections and were washed away. This could lead to a potential mis- 
diagonosis.
Building on from these encouraging results we opted to incorporate a means of 
attaching a similar system directly to an antibody (figure 4.8-(a)). The direct attachment of 
a marker to a secondary antibody would eradicate the need to incorporate an enzyme 
substrate and would not rely on the marker adhering to the cell surface. The marker system 
would be required to be water soluble, redox active for the reduction of silver and to 
contain a reactive group suitable for conjugation to an antibody.
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marker
system
2° antibody
Conjugation Qpi X
N =<
Linker group to Reactive 
impart water conjugation gp for 
solubility
wash with aqueous 
solution o f  silver ions1° antibody
linkage to amine 
groups on antibody
Redox
activeantigenv A A /‘
(a)
Figure 4.8: (a) Schematic diagram of proposed system and (b) Proposed marker compound.
This chapter outlines the work undertook in the design and synthesis of redox active 
systems suitable for antibody labelling based on 4,-phenyl-2,2’:6,2”-terpyridine. This 
preliminary work has centred on systems that feature a short polyethylene glycol (PEG) 
chain to act as a linker to decouple the marker from an antibody and also to aid water 
solubility (figure 4.8-(b)).
Results and Discussion
4.9 Reactions Involving 4’-(4-Fluorophenyl)-2,2’:6 \2” -terpyridine
Our first approach was to synthesise a terpyridine derivative that was susceptible to 
nucleophilic attack, in order to incorporate a linker chain. An amine terminated short PEG 
chain was selected as the linker (figure 4.9), which could undergo further modification for 
bioconjugation purposes.
Figure 4.9: Polyethylene glycol chain.
4,-(4-Fluorophenyl)-2,2’:6’,2” -terpyridine [4.1] was synthesised using the method 
developed by Raston,29 whereby the diketone intermediate is formed in the absence of a 
solvent. Subsequent cyclisation with ammonium acetate and ethanol afforded [4.1) as a 
cream solid. The spectroscopic data was consistent with that described elsewhere.
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F Nuc
Where Nuc
H2N ~ A  b —  O P(0)(O N a)2 K2CO;
base =
KF
I4.1J
Figure 4.10: Attempts to functionalise 4 ,-(4-fluorophenyl)-2,2, :6 \2 ” -terpyridine [4.11 with a nucleophile
The feasibility of replacing the fluoride with a nucleophile was investigated by the 
reaction of both ethylene diamine and 4-aminophenylphosphate disodium salt with [4.1] 
and base in anhydrous DMF for 24 hours (figure 4.10). Reaction with ethylene diamine in 
the presence of potassium fluoride afforded a yellow oil. Spectroscopic data confirmed this 
to be a mixture. Thin-layer chromatography revealed the mixture to be of unreacted 
terpyridine [4.1] and amine substituted product. Attempts to separate the mixture have 
proved unfruitful. The analogous reaction of 4-aminophenylphosphate disodium salt with 
potassium carbonate failed to yield any desired product. The limited success of these 
reactions prompted us to reconsider our synthetic strategy.
4.10 Reactions Involving Phenol Derivatives
Alternatively, the reaction of an electrophilic alkyl halide and 4’-(4- 
hydroxyphenyl)-2,2’:6,,2” -terpyridine was utilised to access the target ligand illustrated in 
figure 4.11.
4’-(4-Methoxyphenyl)-2,2’:6,,2” -terpyridine [4.2] (figure 4.12) was prepared by 
grinding 4-methoxybenzaldehyde and 2-acetylpyridine in a pestle and mortar with sodium 
hydroxide to yield the corresponding diketone. Subsequent cyclisation with ammonium 
hydroxide in ethanol afforded [4.2] as a cream solid (67 %). Of the methods commonly 
used for demethylation, molten pyridinium hydrochloride was chosen since high yields are 
obtained and its use is economical for large scale preparations.38-40 To this end, [4.2] was
Figure 4.11: Alternative target ligand, where n = 3.
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converted to 4,-(4-hydroxyphenyl)-2,2, :6,,2” -terpyridine [4.3] in 87 % yield with the 
spectroscopic data for both compounds being consistent with the literature.
OMe
O
N
H
67%
OH OMe
[4.3J
87%
[4.21
Figure 4.12: Preparation of [4.2J and [4.3] . Reagents and conditions', (a) NaOH, grind; (b) ammonium 
hydroxide, EtOH, reflux; (c) pyridinium hydrochloride, 210 °C.
The Gabriel synthesis can be used to prepare primary amines by the reaction of 
potassium phthalimide and an alkyl halide to give an A-alkylphthalimide, followed by 
hydrolysis to generate the amine. A short PEG chain terminating with a halide and a 
phthalimide [4.4] was therefore prepared by reacting an excess amount of l,2-bis(2- 
chloroethoxy)ethane with potassium phthalimide (figure 4.13-(l)).43 The excess dichloride 
was removed by distillation and the resultant residue purified via a soxhlet extraction to 
give [4.4] as an oil in 27 % yield. The spectroscopic data was comparable to that previously 
reported.43
Initial attempts to react [4.3] and [4.4] via the sodium salt in presence of tetra-butyl 
ammonium iodide proved unsatisfactory (figure 4.13-(2)). Although the desired product 
appeared to have been formed, it was contaminated with many impurities.
The reaction between 4,-(tetrafluoro-4-hydroxyphenyl)-2,2, :6,,2”-terpyridine and 
chloroethanol using cesium carbonate to give 4’-(tetrafluoro-4-(2-hydroxyethoxy) phenyl)- 
2,2’:6,,2”-terpyridine has been reported 44 An adaptation of this synthesis was used for our 
purposes, with the addition of sodium iodide (in situ Finkelstein reaction- figure 4.13-(2)).
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i) NaH or Cs2C 0 3, 
DMF
N=<
I4.3| [4.41
Figure 4.13: (1) Synthesis of (4.4] of a protected amine via the Gabriel synthesis and (2) reaction of [4.3] and 
[4.41 with either i) NaH or ii) Cs2C 0 3 in DMF and 2-{2-[2-(2-chloroethoxy)ethoxy]ethyl} isoindole-1,3-dione.
During the reaction work-up, a significant amount of material was precipitated, 
confirmed by 'H NMR spectroscopy to be unreacted [4.3]. The *H NMR spectrum showed 
other contamination, but the formation of the desired product was verified by a parent ion at
587.3 Da/e in the ESI mass spectrum. This indicates that our synthetic strategy may be 
successful. However, the low obtainable yields of [4.4] limit this reaction to small scales 
and the unclean products are undesirable.
The scheme below (figure 4.14) illustrates the successful routes undertaken for the 
preparation of amine ligand [4.9]. Addition of the short chain PEG was undertaken both 
prior to and following terpyridine assembly.
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!K>ks;Cl (a)81 %
[4.6] cr h
(c) 6 5 %
B
[4.7]
(b) 2 9 %
OH
[4.3]
66%
A
[4.5]
O
hydrolysis
6 0 % (c)
Cl
Figure 4.14: Reagents and conditions: (a) l,2-bis(2-chloroethoxy)ethane, caesium carbonate, Nal, DMF, 
65°C, 24 h; (b) i. 2-acetyl pyridine, NaOH, ii. Ammonium acetate, EtOH; (c) potassium phthalimide, Nal,
DMF, 100°C, 24 h;
4.10.1 From 4’-(4-Hydroxyphenyl)-2,2’:6’,2’’-Terpyridine (Method A, figure 4.14)
The reaction of [4.3] with cesium carbonate and a ten-fold excess of l,2-bis(2- 
chloroethoxyethane) in DMF, cleanly afforded [4.5] as a pale brown solid (66 %). An 
excess of the dichloride was used to minimise the substitution at both ends of the chain. 
Removal of the excess dichloride was achieved via a Kugelrohr distillation and residual 
cesium salts were removed by treatment with water. A parent ion at 476.17 Da/e in the ESI- 
MS can be assigned to [4.5] and a minor ion at 340.14 Da/e corresponds to unreacted [4.3]. 
The aromatic resonances in the proton spectrum attributed to the three pyridyl and phenyl 
rings show little deviance from phenol derivative [4.3]. 1,2-Bis(2-chloroethoxyethane) is a
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f n
symmetrical compound as is seen in the H / C NMR spectra; the successful addition of 
the PEG chain is observed by the loss of this symmetry giving rise to four proton multiplets 
and six carbon resonances in the regions of 3.55-4.10 ppm and 71.4 - 42.8 ppm 
respectively. The IR spectrum shows the loss of the OH stretch and the appearance of an 
intense absorption at 1132 cm' 1 in the region for the C-0 of ethers.
Conversion of the alkyl chloride to a primary amine was achieved via a Gabriel 
procedure. The reaction of [4.5] with potassium phthalimide and trace amounts of sodium 
iodide in anhydrous DMF afforded [4.8] as a low melting solid (60 %). An excess of 
potassium phthalimide was used to ensure the complete conversion of chloride to 
phthalimide, unreacted material can be removed upon cooling by filtration. The 'H NMR 
spectrum revealed the crude product to be of reasonable purity, chromatography on neutral 
alumina (ethyl acetate) removed any minor impurities. The ESMS confirmed the product
[4.8] with the parent molecular ion at 587.1 Da/e. A strong IR stretching absorption at 1717 
cm' 1 (C=0 amide) and a multiplet between 7.7-7.8 ppm in the proton spectrum are 
consistent with the presence of the phthalimide.
4.10.2 From 4-Hydroxy benzaldehyde (Method B, figure 4.14)
As illustrated in figure 4.14, terpyridine [4.8] was also synthesised from the 
benzaldehyde. Compound [4.6] was prepared in the same manner as [4.5], where 4- 
hydroxybenzaldehyde replaces [4.3] to cleanly afford [4.6] as a brown oil (81 %). The 
parent ion was identified at 273.1 Da/e in the mass spectrum. Peaks assigned to the ether
i i
chain are comparative to those observed in both the H and C NMR spectrum of [4.5]. 
Reaction of [4.6] with potassium phthalimide in DMF afforded the phthalimide 
fimctionalised benzaldehyde [4.7] as a yellow solid (65 %).
Compound [4.7] was reacted with 2-acetylpyridine and NaOH using the method 
developed by Raston to afford the corresponding diketone as an orange, hygroscopic solid 
(figure 4.15). The NMR data for the diketone was more complicated than expected and 
recrystalisation attempts (from hot toluene and ethanol) were not wholly successful. 
Regardless, cyclisation was carried out using ammonium acetate in ethanol. Due to the 
nature of the diketone the proton NMR spectrum of the product was contaminated with 
some impurities. The cyclisation to the terpyridine [4.8] was confirmed by a molecular ion 
at 587.2 Da/e. The impurities can be removed by column chromatography on neutral 
alumina eluting with ethyl acetate to give the pure product (29 %) with identical spectral 
properties as previous.
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hygroscopic 
diketone intermediate
29 %  (a + b)
N =<
[4-9]
NH 9
Figure 4.15: Reagents and conditions: (a) NaOH, grind; (b) ammonium acetate, ethanol, reflux; (c) i) HC1,
H2 0 , ii) NaOH, H2 0.
The ligand [4.8] has been prepared by the two routes A and B illustrated in figure 
4.14, in overall yields of 23 and 15 % respectively. Introduction of the functionalised PEG 
chain to an aryl-terpyridine (route A) provides a four step synthesis of [4.8]. All four 
synthetic steps, including the preparation of [4.2] and [4.3], were obtained in good yields 
(65-87 %) with few impurities present in the products. All of the synthetic steps are suitable 
for large scale preparations. The preparation of [4.8] from 4-hydroxybenzaldehyde (route 
B) is advantageous as it involves one less step, with the functionalised benzaldehydes [4.6] 
and [4.7] being prepared in 81 and 65 % yields respectively. However, the final terpyridine 
assembly using the Raston methodology was low yielding (29 %) attributed to the 
hygroscopic nature of the diketone intermediate. This problem may be overcome by the use
of an alternative methodology that does not isolate the diketone intermediate. Examples of
• 1 ^this are via the classical Krohnke method whereby the chalcone intermediate is isolated or
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via a one-pot method4 2 ,4 5  in which a benzaldehyde is reacted 2 -acetylpyridine and 
potassium /-butoxide in THF followed by cyclisation with ammonium acetate.
4.11 Conversion to the Amine
De-protection of the amine was achieved by refluxing [4.8] in hydrochloric acid 
overnight (figure 4.15). The precipitated phthalic acid was filtered off upon cooling and the 
acid removed to give the salt as a yellow solid. The amine was generated by subsequent 
base treatment. The conversion of the phthalimide [4.8] to the amine [4.9] was confirmed 
by the observation of the parent ion at 457.2 Da/e in the ESI MS, however this conversion 
was not complete as an ion corresponding to [4.8] (587.1 Da/e) is also seen. The amine 
compound [4.9] was treated as hygroscopic and was kept refrigerated as a toluene solution. 
This compound is not readily water soluble.
4.12 Introduction of a Reactive Group for Bioconjugation
In order to be suitable for conjugation to a biomolecule, the compound must feature 
a reactive group. The primary amine in [4.9] can be modified for this purpose. We initially 
chose to react [4.9] with 1,5-difluoro-2,4-dinitrobenzene (DFDNB) giving rise to a 
compound which contains a reactive fluoride (figure 4.16).
NO
14.9]
76%
N02
[4.10]
Figure 4.16: Introduction o f reactive group. Reagents and conditions: K2 C 0 3 (1 eq), MeCN, -15°C.
One molar equivalent of potassium carbonate was added to a cooled (-15 °C) 
solution of 1,5-difluoro-2,4-dinitrobenzene in acetonitrile. To this was added a solution of 
[4.9] in acetonitrile and an instant change of colour to yellow was observed. Removal of the 
solvent afforded [4.10] as a yellow oily substance. These reaction conditions were tested 
out prior with decylamine and l,5-difluoro-2,4-dinitrobenzene. Selected NMR data is
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presented in figure 4.17. A downfield shift of 4.2 ppm in the 1 9F{lH} NMR spectra is 
observed upon the displacement of one of the fluoride atoms. A disappearance of some of 
the fluorine coupling and a significant upfield shift of the aryl He resonance is observed due 
to the displacement of a fluoride with a less electronegative substituent. This compound 
does not possess the required water solubility; hence attempts were made to resolve this.
8 p 8 h
h 3 h 6
DFDNB -104.6 8.9 (m, J H-h 7.56, J<h-f) 15.1) 7.3 (J(H.h) 9.75, J (H.f)19.5)
Decylamine + DFDNB -100.4 9.05 (d, 7(h-h) 8.02) 6.55 (d, ./(h-f) 13.5)
|4.10| -100.4 9.00 (d, J(h-h> 8.0) 6.55 (d, J(h-f) 13.4)
Figure 4.17: Selected NMR data
4.13 Modification to Impart Water Solubility
It has been shown that the addition of a morpholinomethyl group to salen ligands 
imparts water solubility . 4 6 - 4 9  The morpholinomethyl group can be introduced via a Mannich 
reaction5 0  under non-aqueous aprotic conditions. We therefore decided to adopt this as an 
initial means of imparting water solubility to our ligands.
The Mannich base ethoxy-A-morpholinomethane [4.11] was prepared from 
morpholine and paraformaldehyde in ethanol with potassium carbonate. 5 0  Distillation using 
a Kugelrohr apparatus afforded the product as a colourless oil (44 %), the spectroscopic 
data was in agreement with the literature . 5 0
The pendant morpholino groups were introduced using an adapted method of 
Fenton and co-workers5 0  for the preparation of 4-bromo-2-formyl-6-(morpholin-4- 
ylmethyl)phenol. We chose to incorporate two pendent morpholino group to our system, 
the reaction conditions were tested using 4-ter/-butylphenol with 2.2 equivalents of ethoxy- 
vV-morpholinomethane [4.11] under an inert atmosphere in dry acetonitrile using potassium 
carbonate as the base (figure 4.18-(l)). The successful introduction of two pendent groups 
ortho to the phenol prompted an analogous reaction using (4 -hydroxyphenyl)-2 ,2 ’:6 ,2 ”- 
terpyridine [4.3] to be carried out (figure 4.18-(2)).
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EtOH2CN O
EtOH2CN O
Figure 4.18: Reagents and conditions: (1) [4.11] (2.2 eq), MeCN, K2 C 03, 3 days; (2) [4.11] (2.2 eq),
DMF, K2 C 0 3, 3 days.
It was observed that under these conditions poor yields of [4.12] were obtained, 
despite the reaction time being increased to 96 hours. Although the desired product was 
formed, identified by a molecular ion at 524.2 Da/e, it was contaminated with partially 
mono functionalised material (425.2 Da/e) and unwanted by-products. The low yield may 
be attributed to the poor solubility of [4.3] in refluxing acetonitrile. Alternatively, the 
reaction was repeated employing anhydrous DMF as the solvent and potassium carbonate 
as the base over a period of 72 hours. Removal of the DMF and purification by 
chromatography (alumina, ethyl acetate) gave the desired product as a brown solid (61 %). 
Mass spectral data (ESI) showed the expected molecular ion at 524 Da/e. Notable changes 
are observed in the 'H NMR spectrum of [4.12], The pair of doublets ( 8  7.80 and 6.95 ppm) 
assigned to the four aromatic phenol protons are no longer seen as a result of the 
introduction of the morpholino pendent groups. Due to this substitution, a single signal ( 8  
7.60 ppm) corresponding to the two protons at the 2 and 6  positions is observed.
An amine terminated PEG chain was introduced at the 4 position, in an analogous 
method to that already described (figure 4.19). Each ligand [4.13], [4.14], and |4.15] has 
been characterised by *14 NMR spectroscopy and ES mass spectrometry.
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OH
N=<
|4.12| O-
(a)
61 %
N = -
Cl
5 9 % (b)
N
N=<
[4.14]
NO-
N
[4.16J where n = 3
(d)
7 8 %
6 9 %
N=<
[4.15]
NH,
Figure 4.19: Reagents and conditions: (a) 1,2-bis(2-chloroethoxy)ethane, caesium carbonate, Nal, DMF, 
65°C, 24 h; (b) potassium phthalimide, Nal, DMF, 100°C, 24 h; (c) i) HC1, H2 0 , ii) NaOH, H2 0 ; (d) 1,5- 
difluoro-2,4-dinitrobenzene, K2 C 03, MeCN, -15°C.
1,5-Difluoro-2,4-dinitrobenzene was used to modify the ligand [4.15] suitable for 
bioconjugation (figure 4.19). Hence [4.15] was added to a cooled solution of 1,5-difluoro-
2 ,4-dinitrobenzene and potassium carbonate in acetonitrile51 and a colour change of orange 
was observed. Removal of the solvents in vacuo afforded [4.16] as a light orange solid. The 
l9F NMR spectrum shows a single resonance at -100.9 ppm and due to the displacement of 
one of the fluoride atoms, a loss of fluorine coupling is also seen in the NMR spectrum, 
both of which are comparable with that of [4.10].
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Despite the introduction of two morpholine pendent groups the ligands [4.15] and 
|4.16] remain water insoluble. The water solubility of these compounds may be increased 
by either the use of a longer polyethyleneglycol chain (e.g. where n = 1 0 ) or the use of an 
alternative amine pendent group such as diethanoldiamine or diglycine.
4.14 Testing of Metal Complexes
A number of octahedral transition metal complexes along with platinum (II) 
complexes were prepared on a small scale, (figure 4.20, details in experimental section) in 
order to test for redox activity and solubility. The complexes were characterised by ESI 
mass spectrometry.
n
N  P t N
N  M  N
►=N N =<
I
where R =
where M =  Fe, Zn, Co, Cu
Cl
2+OH
M  N OHHO
N  P t N
N =<►=N
where M =  Fe, Zn, Co, Cu
Figure 4.20: Metal complexes.
Testing of compounds was carried out in an analogous manner to that described in 
chapter 2  (section 2 . 1 2 ), compounds which demonstrated redox activity (i.e. initial 
darkening of the developer solution within 30 minutes) were filtered through celite®. The
'X 7results obtained (figure 4.21) were in agreement with earlier studies with the first row 
transition metal octahedral complexes showing no activity whereas the square planar 
complexes of platinum are able to catalytically reduce silver ions to silver metal via a 
Timm’s type reaction. The complexes [Pt(4.5)Cl]+ and [Pt(4.12)CI]+ show good redox 
activity (5 minutes in both the solid state and in a DMSO solution). After filtration through 
celite®, both complexes exhibited less redox activity (20 and 24 minutes) and a more 
gradual darkening of the physical developer. This indicates that traces of free metal may be
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responsible for the rapid darkening of the solution. The complexes showed either no or little 
solubility in the physical developer solution.
Compound Solubility in physical developer Redox activity
14.31 Insoluble No activity
14.51 Insoluble No activity
|Pt(4.5)Cl|* insoluble 20 minutes
|Fe,l(4.S)2||C I0 4|2 Insoluble No activity
|Zn"(4.5)2||C I0 4| 2 Insoluble No activity
|Co"(4.5)2||C 104| 2 Insoluble No activity
[Cu"(4.5)2||C I0 4| 2 Insoluble No activity
(4.121 Insoluble No activity
|Pt(4.12)CI|* Insoluble 24 minutes
|Fe"(4.12)2||C I0 4| 2 Sparingly soluble No activity
|Zn"(4.12)2||C I0 4| 2 Sparingly soluble No activity
[Co"(4.!2)2||C I0 4| 2 Insoluble No activity
|C u“(4.I2)2||C I0 4| 2 Sparingly soluble No activity
Figure 4.21: Summary o f test results after trace metal removal. ‘No activity’ implies no notable change
during a 30 minute period.
4.15 Conclusion
A series of functionalised 4’-aryl-2,2’:6’,2”-terpyridine ligands have been prepared. 
A short PEG chain was incorporated to impart water solubility and act as a spacer group 
between the terpyridine sub-unit and a reactive group suitable for bioconjugation. These 
ligands were found not to be water soluble. Unfortunately the addition of two 
morpholinomethyl pendant groups into our ligands did not dramatically increase the 
solubility of these ligands in water. Previous work had shown that metal terpyridine 
complexes and in particular complexes of platinum were able to catalyse the reduction the 
silver ions in a Timm’s type reaction . 3 7  We have found that the time taken to darken the 
physical developer solution decreases following further purification of the complexes. It 
was also shown that 4 ,-(4-hydroxyphenyl)-2,2’:6’,2” -terpyridine was found to rapidly 
darkened the physical developer solution (3 minutes) . 3 7  During the course of this work 
several batches of 4’-(4-hydroxyphenyl)-2,2’:6’,2” -terpyridine were prepared. Following 
recrystallisation from ethanol several times, each batch was tested by adding a small sample 
to the physical developer solutions. None of the samples exhibited any redox activity for 
the reduction of silver in a Timm’s type reaction. From this we can conclude that earlier 
samples may have contained trace (unknown) impurities that were able to rapidly reduce 
silver ions to silver metal.
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Experimental 
General Procedure
Non-synthesised reagents were purchased from Aldrich, Avocado or Lancaster and 
were used as received. Solvents were purified by standard literature methods. The NMR 
spectra were recorded on a Briiker Avance 400 instrument at 400 MHz (*H) and 100 MHz 
( l3 C), Jeol Lamda Eclipse 300 at 282.78 MHz ( 1 9F); !H and 13C chemical shifts are quoted 
in ppm relative to residual solvent peaks and. Coupling constants are quoted in Hertz. Mass 
spectra were obtained in either APCI (atmospheric pressure chemical ionisation), El 
(electronic ionisation). IR spectra were obtained as KBr or NaCl discs using a Jasco FTIR 
1 1 0  series spectrometer.
[4.1] 4’-(4-Fluorophenyl)-2,2’:6’,2 ’’-terpyridine
F
This was prepared in an analogous method to that of Raston et al.29 4-Fluorobenzaldehyde 
(7.068 g, 0.056 mol), 2-acetyl pyridine (13.79g, 0.110 mol) and sodium hydroxide (4.5 g, 
0.112 mol) were ground in a pestle and mortar until a yellow powder was formed. This 
powder was then added to a solution of ammonium acetate (21.7 g, 0.281 mol) in ethanol 
(450 mL) and refluxed for 24 h. the volume of the reaction mixture was reduced in vacuo 
by one third, cooled and the crude product was collected by filtration. The product was 
recrystallised from hot EtOH to give the pure product [4.1] as a yellow solid (7.64 g, 41 %) 
8 h (400 MHz, CDC13) 8 . 8  ( d ,2 H ,J 3.89), 8.7 (m, 4H), 7.85 (m, 4H), 7.30 (m, 2H), 7.15 
(t, 2H, J8.59, Ar H-m); 5F (282.78 MHz, CDC13) -112.7025; m/z (APCI) 328 [M + 1 ].
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OMe
N=<
This was prepared in an analogous method to that of [4.1], the applied reagents were 4- 
methoxybenzaldehyde (17.0 g, 0.125 mol), 2-acetyl pyridine (30.2 g, 0.250 mol) and 
sodium hydroxide (10 g, 0.250 mol) to afford [4.2] as a cream solid (28.3 g, 67 %); 8 h (400 
MHz, CDCI3 ) 8.65 (d, 2H, J  4.4, Ar H-6 ), 8.60 (s, 2H, Ar H-3’), 8.55 (d, 2H, J  7.95, Ar 
H-3), 7.80 (m, 4H, Ar H-4 and H-o), 7.25 (t, 2H, J , Ar H-5 ), 6.95 (d, 2H, J  8.62, Ar H- 
m), 3.8 (s, 3H, C //3); 5C (100 MHz, CDC13) 161.2, 157.4, 156.0, 150.3, 149.7, 137.6, 
131.6, 129.0, 124.4, 122.8, 119.2, 115.0 and 55.5; IR (KBr disc, cm'1) 3084,3006,2835, 
1600, 1584, 1468, 1388, 1284, 1260, 1187, 1100, 1042, 8 8 8 , 830 and 730; m/z (APCI)
340.1 (339.1).
[4.3] 4 ’ -(4-Hyd roxyphenyl)-2,2 ’: 6 ’ ,2 ” -terpyridine
OH
N=<
This was carried out in a similar manner to a standard preparative manner. 3 8  4’-(4- 
Methoxyphenyl)-2,2, :6,,2” -terpyridine [4.2] (6.0 g, 17.69 mmol) was added was added to 
molten pyridinium hydrochloride (40 mL) at 210 °C and allowed to stir for 4 h. The 
reaction mixture was allowed to cool and warm water (50 mL) was added. The pH was 
adjusted to 7-8 with sodium hydrogen carbonate and the precipitate was removed by 
filtration. The crude product was then washed with water (3 x 1 5  mL), dichloromethane (3 
x 15 mL) and dried in vacuo. Recrystalisation from hot ethanol afforded the pure product
[4.3] as a fawn solid (5.061 g, 87 %); 8 h (400 MHz, </-dmso) 9.95 (br s, 1H, OH), 8.80 
(d, 2H, J4.12, Ar H-6), 8.65 (m, 4H, Ar H-3 and H-V), 8.05 (t, 2H, J  7.67, Ar H-5), 7.80 
(d, 2H, J  8.62, Ar H-o (2,6)), 7.50 (t, 2H, J  6.7, Ar HA), 6.95 (d, 2H, J  8.57, Ar H- 
m(3,5)); 8C(100 MHz, </®-dmso) 159.0, 156.4, 155.2, 150.1, 138.0, 129.7, 128.5, 125.5,
121.3, 118.0, 117.0 and 116.1; IR (KBr disc, cm '1) 3690,3387,3030, 1594, 1532, 1418, 
1354, 1297, 1035, 832, 776 and 738; m/z (APCI) 326.
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[4.4] 2-{2-[2-(2-Chloroethoxy)ethoxy]ethyl}isoindoIe-l,3-dioiie43
o
A mixture of 1,2-bis(2-chloroethoxy)ethane (59 g, 0.315 mol) and potassium phthalimide 
(5.8 g 0.031 mol) was stirred at 130 °C for 24 h. After concentration in vacuo, the residue 
was treated with toluene (30 mL) and the solid material was removed by filtration. The 
toluene was removed in vacuo yielding a brown oily residue. The residue was combined 
with sand and extracted with petroleum ether using a soxhlet extractor for 3 days. The 
solution was evaporated to give [4.4] as a yellow oil (2.559 g, 27 %); Sh (400 MHz, 
CDCls) 7.90 (m, 2H), 7.65 (m, 2H), 3.85(m, 2H), 3.5-3.7 (m, 8  H), 3.45 (m, 2H); 5C 
(100 MHz, CDC13) 168.2, 133.9, 132.1, 123.2, 71.4, 70.6, 70.1, 68.0, 42.7, 37.2; IR 
(NaCl, cm'1) 3477, 2872, 1774, 1716, 1394, 1290, 1115, 956, 797 and 720; m/z (APCI) 
298.
[4.5]
N =<
Cesium carbonate (14g, 42.9 mmol, 1.5 equiv) which had been ground in a hot pestle and 
mortar was added to a Schlenk tube containing dry, degassed DMF (50 mL). [4.3] (10 g, 
30.67 mmol), l,2-bis(2-chlorothoxy)ethane (57.49 g, 307 mmol) and a few crystals of 
sodium iodide in DMF (20 mL) were added to a pressure equalising dropping funnel which 
was attached to the Schlenk tube. The DMF-CS2 CO3 suspension was heated to 65 °C and 
the terpyridine-dichloride mixture was added slowly drop wise. After the addition stirring 
and heating was continued for 24 h. Upon cooling the reaction mixture was filtered and the 
DMF was removed in vacuo. The residue was treated with water to dissolve solid cesium 
salts and was extracted with chloroform (3 x 40 mL), dried over MgSC>4 and solvent 
removed in vacuo to give [4.5] as a pale brown solid (9.601 g, 6 6  %); 8 h (400 MHz, 
CDCI3 ) 8 . 6 8  (m ,4H ,A r//-6  and H-V), 8.55 (d, 2H, J7.91, A r//-3), 7.80 (m, 4H, Ar H- 
4 and H-o), 7.25 (m, 2H, Ar H-5), 6.95 (d, 2H, J  8.7, Ar H-m), 4.10 (m, 2H, C //2), 3.82 
(m, 2H, CH2) 3.65 -3.70 (m, 6 H, C//2), 3.55 (m, 2 H,C H 2); 5C (100 MHz, CDC13) 159.7,
156.3, 155.8, 149.7, 136.9, 130.9, 128.5, 123.8, 121.4, 118.2, 115.0, 114.3, 71.4,
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70.9, 70.6, 69.8, 67.5, 42.8; IR (KBr, cm '1) 3051,2964,2893,1609,1585, 1543,1491, 
1468, 1457, 1389, 1260, 1185, 1132, 1094, 1022, 825 and 790; m/z (ES Q-TOF) 476.17
[Pt"(4.5)Cir
To a solution of [4.5] (0.04 g, 0.08 mmol), in ethanol (10 mL) was added a solution of 
[Pt(COD)Cl2 ] (0.034 g, 0.08 mmol) in ethanol (5 mL). The resulting yellow solution was 
refluxed for 12 hours. The solid product was removed by filtration, washed with ice cold 
ethanol and dried in vacuo to give [Pt(4.5)CI]+ as a yellow solid (0.048 g, 82 %); 5h (400 
MHz,7-dmso) 8.82 (m, 4 H ,), 8.65 (d, 2H, 75.13), 8.40 (t, 2H, 77.87), 8.25 (d, 2H, 8.75, 
Ar H-o) 7.80 (t, 2H, 7  6.67), 7.25 (d, 2H, 7  8.77, Ar-//-m), 4.30 (m, 2H, C //2), 4.0 (m, 
2H, CH2), 3.75-3.85 (m, 6 H, C //2), 3.70 (m, 2H, CH2); m/z (APCI) 706.
[Fe"(4 .5 )2 | |C 1 0 4 ] 2
To an ethanolic solution of [4.5] (0.01 g, 0.021 mmol) was added a solution of iron(II) 
perchlorate hexahydrate (0.002 g, 0.011 mmol) in ethanol and stirred for 12 hours. Upon 
the addition of the iron(II) perchlorate the solution turned dark purple and a precipitate was 
formed. Diethyl ether was added and the purple solid filtered and dried in vacuo to afford 
IFen(4 .5 )2 |[C 1 0 4] 2  (0.011 mg, 90 %); 5H (400 MHz, CD3 CN) 9.05 (m, 8 H ), 8.50 (d, 4H, 
J  7.45), 8.25 (d, 4H, J  8.23), 7.82 (m, 4H ), 7.25 (d, 4H, J  8.48), 7.1 (m, 4H ), 4.0 (m, 
4H), 3.8 (m, 4H), 3.6 (m, 4H), 3.3 (m, 4H; m/z (ES) calc. 1206.7 for C5 4 Hs2 N6 0 | 4 Cl4Fe 
found 1107.8 (- C104‘).
[Zn"(4 .5 )2 ][C1 0 4 ] 2
This was prepared in a similar manner to [Fen(4 .5 )2 l[C 1 0 4 ]2 , replacing zinc(ll) perchlorate 
hexahydrate to afford |Z n n(4 .5 )2 lICI0 4 ) 2  as a yellow solid (0.016 g, 89 %); 5h (400 MHz, 
CD3 CN) 9.20 (s,4H), 9 . 0  (d, 4H, . / 8 .1 ), 8.4-8.5 (m, 8 H), 8.10 (d, 4H, J  4.87), 7.70 (m, 
4H), 7.60 (d, 4H, J  8.83), 4.60 (m, 4H, CH2), 4.10 (m, 4H, CH2), 3.99-4.05 (m, 16H, 
CHi), m/z (ES) calc. 1216.2 for C5 4 H 5 2N6 0 |4 Cl4Zn found 1017.9 (-2C1CV).
[Cu"(4 .5 )2 ]|CI0 4 ] 2
This was prepared in a similar manner to |FeM(4 .5 )2 )[CI0 4 ]2 , replacing copper(II) 
perchlorate hexahydrate to afford (Cu,l(4 .5 )2 l(C 1 0 4 ] 2  as a pale green solid (0 . 0 1 1  g, 81 
%); m/z (ES) calc. 1214.4 for Cs4 H5 2 N6 0 i4 Cl4Cu found 1016.2 (-2CKV).
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|Com(4.5)21[CI04]2
This was prepared in a similar manner to [Fell(4 .5 )2 l[CI0 4 ]2 , replacing cobalt(II) 
perchlorate hexahydrate to afford |Con(4.5)2) [0 0 4 ) 2  as a brick-red solid (0.009 g, 87 %); 
m/z (ES) calc. 1209.7 for C 5 4 H5 2 N6 OMCI4 C0  found 1011.3 (-2CKV).
[4.6)
A mixture of cesium carbonate (11.9 g, 36.52 mmol, excess) and 4-hydroxybenzaldehyde 
(3 g, 24.5 mmol) was stirred in dry DMF (20 mL) for 45 min at 80°C, after which l,2-bis(2- 
chlorothoxy)ethane (38.4 mL, 45.95 g, 240 mmol ) and a trace of Nal were added and the 
heating continued overnight. After cooling the solution was filtered and the DMF removed 
in vacuo, followed by removal of the excess dichloride via a Kugelrohr distillation. The 
resulting residue was treated with water and extracted with chloroform (3 x 30 mL). The 
chloroform solution was dried over MgSC>4 and the solvent removed in vacuo to give [4.6] 
as a brown oil (5.41 g, 81 %); 6 H (400 MHz, CDC13) 9.80 (s, 1H, CM)), 7.75 (d, 2H, J  
9.46, A rM 2andM 6), 6.90 (d, 2 H ,J 9.48, A rM 3 and M5), 4.15 (m, 2H, C //2), 3.85 (m, 
2 H, CM), 3.65 (m, 6 H, CM), 3.55 (m, 2H, CM); 5c ( 1 0 0  MHz, CDC13) 190.7, 163.8,
131.9, 130.0, 114.9, 71.4, 70.8, 70.6, 69.5, 67.8, 42.8; IR (NaCl, cm'1) 3011,2872, 
2741, 1684, 1600, 1577, 1509, 1453, 1427, 1393, 1311, 1258, 1219, 1161,1114, 1055, 925, 
835 and 755; m/z (APCI) 273.1 [calc 272.1).
[4.7]
To a suspension of potassium phthalimide (27.16 g, 146.6 mmol, 10 fold excess) in dry 
DMF (20 mL) heated to 100 °C under nitrogen, was added [4.6] (4.0 g, 14.66 mmol) and 
the heating was continued overnight. The reaction mixture was cooled, poured onto crushed 
ice and allowed to stand for 1 h. The mixture was filtered; the residue was taken up in 
chloroform. The organic phase was washed with NaOH (aq) (0.5 M), water, dried over 
MgSC>4 and the solvent removed in vacuo to give [4.7] as a yellow soild (3.66 g, 65 %); 5h 
(400 MHz, CDC13) 9.82 (s, 1H, CM)), 7.75 (m, 4H, Ar M2, M 6  and Mphthalimide), 
7.65 (m, 2H, Ar Mphthalimide), 6.95 (d, 2H, J6 .84, Ar M3 and M5), 4.08 (t, 2H, J4 .7 , 
CM2  ), 3.80 (t, 2 H, J5 .7 , CM), 3.75 (m, 2 H, CM), 3.70 (m, 2 H, CM), 3.62 (s, 4H, CM); 
5C (100 MHz, CDC13) 190.8, 168.3, 163.8, 134.0, 132.1, 131.9, 130.0, 123.2, 114.9,
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70.8, 70.2, 69.5, 68.0, 67.7, 37.3; IR (KBr, c m 1) 2873,1771,1715,1600,1576,1509, 
1467, 1394, 1312, 1257, 1161, 1111, 1027, 835 and 721; m /z(k?C \) 384.1 [calc 383.4]
[4.8]
Method A: This was prepared in an analogous manner to [4.7], the applied reagents were 
potassium phthalimide (15 g, 80.98 mmol 10 fold excess), [4.5] (7.914 g, 16.6 mmol) and 
DMF (20 mL). The crude product was taken up in the minimum amount of chloroform and 
passed through a short alumina (neutral) column, eluting with ethyl acetate to give [4.8] as 
a brown solid (5.85 g, 60 %);. 6 H (400 MHz, CDC13) 8.62-8.65 (m, 4H, Ar H - 6  and H-3’), 
8.58 (d, 2H, J  8.12, Ar H-3), 7.7-7.8 (m, 6 H, Ar H-o and //-phthalimide), 7.6 (m, 2H, Ar 
//-4), 7.3 (m, 2H, Ar H-5), 6.9 (d, 2H, J  7.09, Ar //-m), 4.05 (m, 2H, C //2), 3.85 (m, 2H, 
C//2), 3.75 (m, 2H, C //2), 3.68 (m, 2H, C //2), 3.60 (s, 4H, C//2); 6 C (100 MHz, CDC13)
168.2, 159.7, 156.3, 155.7, 149.6, 149.0, 136.8, 133.9, 132.0, 128.4, 123.8, 123.2, 121.3,
118.2, 114.9, 70.7, 70.2, 69.7, 68.0, 67.4, 40.6; IR (KBr, c m 1) 3821, 2962, 1717, 1654, 
1583, 1560, 1541, 1508, 1466, 1388, 1261, 1091, 1024 and 799; m/z (APCI) 587.1 
Method B: Compound [4.7] (2 g, 5.21 mmol), 2-acetyl pyridine (1.26 g, 10.43 mmol) and 
sodium hydroxide (0.41 g, 10.43 mmol) were ground in a pestle and mortar until a orange 
powder was formed. This powder was then added to a solution of ammonium acetate (2 g) 
in ethanol (200 mL) and was heated under reflux for 24 h. Upon cooling the reaction 
mixture was concentrated by approximately one third and the dark brown precipitate was 
collected by suction filtration. The crude product was purified by column chromatography 
on alumina (neutral) and eluting with ethyl acetate gave the title compound [4.8] as a brown 
solid (0.88 g, 29 %) with identical spectral properties as above.
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[ 4 . 9 ]
N H ,
Compound [4.8] (0.6 g, 1 . 0 2  mmol) was taken up in hydrochloric acid and heated to reflux 
for 24 h at 110 C. The solution was allowed to cool in ice and the precipitated solid was 
collected by suction filtration and washed with water. The filtrate was reduced in vacuo 
affording the hydrochloride salt as a pale yellow solid. The solid was taken up in the 
minimum amount of water; to this sodium hydroxide was added (pH 14) and 10 mL of 
toluene. A Dean-Stark apparatus was attached and the collection arm was filled with 
toluene. The mixture was heated to 120 °C overnight to remove the water and to afford the 
amine [4.9] as a toluene solution. Removal of the solvents in vacuo afforded [4.9] as a 
cream, moisture sensitive solid (0.38 g, 82 %); §H (400 MHz, CDCI3 ) 8.62 (m, 4H, Ar H-6 
and //-3 ’), 8.58 (d, 2H, J  7.98, Ar H-3), 7.75 (m, 4H, Ar H A  and H-o), 7.25 (m, 2H, Ar 
H-5), 6.95 (d, 2H, J  8.83, Ar H-m), 4.1 (t, 2H, J4 .94 , CH2 ), 3.8 (m, 2H, CH2), 3.7 (m, 
2H, C //2), 3.6 (m, 2H, CH2), 3.45 (t, 2H, J 5.18, CH2), 2.78 (t, 2H, J 9.16, C //2); 6C(100 
MHz, CDCI3 ) 159.78, 156.32, 155.84, 149.11, 137.83, 136.81, 128.49, 125.38, 123.79, 
121.33, 118.22, 115.01, [73.6, 70.85, 70.35,69.72,67.50,21.51; m/z (ES Q-TOF) 457.2
[4.10]
n o 2
1,5-Difluoro-2,4-dinitrobenzene (0.13g, 0.66 mmol), freshly ground potassium carbonate 
(O.lg, 0.66 mmol) and dry acetonitrile (10 mL) were added to pressure tube and cooled to -  
15 C. To this stirred solution, was added [4.9] (0.3g, 0.66 mmol) in acetonitrile (10 mL) 
and an instant colour change of colourless to intense yellow was observed. The solution 
was warmed to room temperature and stirred for a further 2 h. The reaction mixture was 
diluted with DCM, filtered and the solvent was removed in vacuo to give the product [4.10] 
as a yellow oil (0.32 g, 76 %), which solidified upon cooling. 5h (400 MHz, CDCI3 ) 9.05 
(d, 1H, J  8.5, Ar H), 8.55 (m, 6 H, Ar H-3, H-6 and H-3’), 7.8 (m, 4H Ar H-4 and H-o),
7.3 (m, 2H, Ar H-5), 6.98 (d, 2H, J8 .78, A ri/-m ), 6.5 (d, 1H, JCF 13.39, Ar H), 4.15 (m,
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2H), 3.85 (m,2H), 3.65-3.75 (m, 6H), 3.40 (m, 2H); 5F (282.78 MHz, CDC13) -100.402; 
IR (KBr, cm '1) 3838, 3751, 3625, 3447, 3102, 2962, 1624, 1596, 1559, 1521, 1423, 1326, 
1297,1261,1189, 1097, 1054, 917, 800 and 740; m/z (ES) 641.2
|4.111 Ethoxy-N-morpholinylmethane5"
Morpholine (20 g, 0.23 mol) was added dropwise to suspension of paraformaldehyde (8.61 
g, 0.29 mol) and anhydrous potassium carbonate (63 g, 0.45 mol) in ethanol (125 mL) with 
external cooling in ice. The mixture was vigourously stirred for 48 h allowing the 
temperation to reach ambient gradually. The solid was then filtered off and washed with 
diethyl ether. The filtrate was concentrated in vacuo to give a yellow oil which was distilled 
on a Kugelrohr apparatus to give [4.11] as a colourless oil (14.633 g, 44 %); 8 h (400 MHz, 
CDC13) 3.95 (s, 2H, N C//2 O), 3.55-3.65 (m, 4H, C //2 - 3  and C//2 -5), 3.40 (q, 2 H, J 6.87, 
OC//2 CH3 ), 2.5-2 . 6  (m, 4H, CH2-2 and CH2-6 ), 1.10 (t, 3H, J6 .94 , C //3); 5C (100 MHz, 
CDCI3 ) 15.2, 50.1, 65.2, 66.4, 88.7; m/z (APCI) 146.2.
[4.12]
OH
N =<
A mixture of [4.3] (1.5 g, 4.61 mmol) and [4.11] (1.48 g, 140.14 mmol) in dry DMF (40 
mL) were heated under reflux in a nitrogen atmosphere for 3 days . After cooling to room 
temperature the solvent was removed in vacuo to give the product [4.12] as a brown glassy 
solid (1.47 g, 61%); 5H (400 MHz, CDCI3 ) 8.65 (d, 2H, J  4.21, Ar H-6), 8.60 (m, 4H, Ar 
H-3 and H-3’), 7.80 (m, 2H, Ar H-5), 7.6 (s, 2H, Ar H-o (2,6)), 7.3 (m, 2H, Ar H-4), 
3.65-3.75 (m, 12H), 2.55 (m, 8 H); IR (KBr, cm '1) 3425 (br, OH), 2811, 1671, 1598, 1581 
(strong), 1562, 1485, 1437, 1392, 1347, 1298, 1262, 1178, 1115 (strong, C-O-C), 1070, 
861,794; m/z (ES) 523.3.
[Pt(4.12)|CI+
This was prepared in an analogous method to [Ptn(4.5)Cl]+, to afford [Pt(4.12)Cl]+ as a 
yellow solid (0.008g, 74 %); m/z (ES) calc 754.16 for 0 6 2 H3 3 N5 O3 PtCl found 755.2.
122
Chapter 4 - Terpyridines
[Fe"(4.12)2||C104h
This was prepared in a similar manner to [Fell(4.5)2][C104]2 to afford [Fe“(4.12)2][C104[2 
as a purple solid (O.OlOg, 87 %); 5H (400 MHz, CD3 CN) 9.20 (s, 4H), 8.70 (d, 4H,./7.47), 
8.25 (s, 4H), 8.0 (t, 4H, J  7.24), 7.30 (m, 4H), 7.10 (m, 4H), 3.9 (m, 24H), 2.8 (m, 16H); 
m/z (ES) calc. 1302.0 for C6 2 H6 6 NioOi4 Cl2Fe found 1202.6 (- C104).
|ZnN(4.12)2|ICI04]2
This was prepared in an analogous method to [Znn(4.5)2j[C104]2 to afford
|Zn"(4.12)2|[CI04|2 as a yellow solid (0.015g, 81%); 5H (400MHz, CD3 CN) 8.85 (s, 4H),
8 . 6  (d, 4H, J  7.96), 8.0 (m, 4H), 7.95 (s, 4H), 7.6 (m, 4H), 7.2 (m,4H), 3.6 (m, 24H), 2.5 
(m, 16H); m/z (ES) calc. 1311.54 for C^H^NioOMChZn found 1112.8 ( - 2C104).
|Cun(4.12)2| |C104)2
This was prepared in an analogous method to [Cu (4.5)2] {C104)2 to afford
[Cun(4.12)2l[C104]2 as a pale green solid (0.008g, 79 %); m/z (ES) calc. 1309.7 for
CmH ^ . oO mCIjCu found 1110.9 (- 2C104).
[Co"(4.12)][C104)2
This was prepared in an analogous method to that of [Co (4 .5 )2 ] [CI04]2 to afford 
[Coh(4.12)2][2C104] as a dark orange solid (0.01 g, 8 6  %); m/z (ES) calc. 1305.1 for 
C6 2 H6 6 NioO|4 C 12 Co found 1122.6 (- 2C104).
[4.131
N=r<
This was prepared in an analogous method to that of [4.5] substituting [4.12] (0.25 g, 0.477 
mmol) to afford [4.13] as a pale brown solid (0.19 g, 61 %); 8 h (400 MHz, CDCI3 ) 8.7 (d, 
2H, J4 .15 , Ar H-6), 8.65 (m, 4H, Ar-//-3 an d //-3 ’), 7.80 (m, 2H, Ar-H-5), 7.75 (s, 2H, 
Ar H-o (2,6)), 7.30 (m, 2H, Ar H-4), 4.15 (m, 2H, C //2), 3.8 (m, 2H, CH2), 3.55-3.75 (m, 
20H), 2.4 (s, 8 H, N C//2 O); m/z (ES) 674.2 [M + 1].
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14.14]
N =<
This was prepared in an analogous method to [4.8] via method A, substituting [4.13] (0.18 
g, 0.34 mmol) to afford [4.14] as a brown solid (0.121 g, 59 %); 5h (400 MHz, CDCI3 ) 
8.70 (d, 2H, J  4.17, Ar H-6), 8.63 (m, 4H, Ar H-3 and H-3’), 7.80 (m, 4H, Ar H- 
phthalimide), 7.70 (s, 2H, Ar H-o), 7.65 (m, 2H, Ar H A) 7.25 (m, 2H, Ar H-5), 4.1 (m, 
2 H,CHi), 3.90 (m ,2 H, C //2), 3.80 (m, 2 H, CH2), 3.6-3.7 (m, 14H), 3.5 (s, 4H, C //2), 2.4 
(s, 8 H, NC//2 O); IR (KBr, cm '1) 2856, 1772, 1712, 1583, 1567, 1467, 1393, 1350, 1295, 
1115, 1027, 884; m/z (ES) 785.8 [M + 1],
[4.15]
N —
This was prepared in an analogous method to [4.9] the applied reagents were [4.14] (O.lg, 
0.127 mmol) to afford [4.15] as an off-white solid (0.06g, 69%); 5h (400 MHz, CDCI3 ) 
8 . 6 8  (d, 2H, J  3.35, Ar H-6), 8.60 (m, 4H, Ar H-3 and H A'), 7.85 (m, 2H, Ar HA), 7.75 
(s. 2H, Ar H-o), 7.30 (m, 2H, Ar H-5), 4.20 (m, 2H, CHi), 3.80 (m, 2H, CH2), 3.70 (m, 
2H, CHi), 3.55-3.65 (m, 14H), 3.50 (m, 2H, CHi), 2.80 (m, 2H, CH2), 2.45 (s, 8 H, 
NC//2 O); m/z (ES) 655.9 [M + 1].
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14.16]
N =<
'O'
0 , N
F
n o 2
This was prepared in analogous method to [4.10] the applied reagents were [4.15] (0.05g, 
0.076 mmol) and 1,5-difluoro-2,4-dinitrobenzene (0.02g, 0.076mmol) to afford [4.16] as a 
dark yellow solid (0.03g, 78 %); 5H (400 MHz, CDC13) 8.85 (d, 1H, J  7.94, Ar H), 8 . 6  
(m, 6 H, Ar H-3, H-3’ and H-6), 7.78 (m, 4H, Ar H-4 and H-o), 7.3 (m, 2H, Ar H-5), 6.70 
(d, 1H, J C f  11.95, Ar H), 4.20 (m, 2H, CH2), 3.80 (m, 2H, CH2), 3.55-3.70 (m, 18H), 
3.20 (m,2H , CH2), 2.50 (m, 8 H, N C //2 0); 8F (282.78 MHz, CDC13) -101.0; m/z (ES) 
839.9 [M + 1 ].
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Introduction
This chapter investigates the potential of markers based on jV-functionalised 1,4,7- 
triazacyclononane.
5.1 Azamacrocycles
The azamacrocycles are a class of ligands which contain varying numbers of 
nitrogen donor atoms within rings of various sizes. In 1972, a non-templated, low dilution 
method for the preparation of azamacrocycles was reported. 1 Modifications in 19742 
provided an effective method of synthesis for ring sizes of 9-24 atoms containing 3-8 
nitrogen atoms. These cyclic, multidentate ligands form more stable metal complexes than 
their corresponding open chain analogues. This is due to the macrocyclic effect which 
arises due to both entropic and enthalpic effects (figure 5.1).
H J  I ,HN N
N 1SL
H I I H
^NH HN^
N
H 2
N  
H 2
1.4,8,11 -Tetraazatetracyclodecane 
(Cyclam )
N 1 r/V3-bis(2-am inoethyl)propane-1,3- 
diamine
2
Low Spin High spin
AH  (kJ m ol'1) TAS (kJ m of1) AH  (kJ mol"1) TAS (kJ mol'1)
1 -78.2 49.3 - 1 0 0 . 8 24.3
2 -6 6 . 1 21.7 -80.3 10.9
Figure 5.1: Thermodynamic data for the formation o f Ni(II) complexes with macrocyclic ligand 1 and open
chain analogue 2 at 298 K . 3
The most common and most studied azamacrocycles contain four nitrogen donor 
atoms known as tetraazamacrocycles. Examples include 1,4,8 ,11-tetraazatetracyclodecane 
(cyclam, figure 5.1) and 1,4,7,10-tetraazacyclododecane (cyclen, figure 5.2). Rings 
containing greater or smaller number of donor atoms are generally of less importance with 
the exception of 1,4,7-triazacyclononane (tacn, figure 5.2) which exhibits interesting 
coordination chemistry.
h r~\ h
N—
N N  
H' \___ /  H
1,4 ,7 ,10-Tetraazacyclododecane 
(Cyclen)
H . I  \  „H 
N N
1,4,7-Triazacyclononane 
(Tacn)
Figure 5.2: The tetra- and tri-azamacrocycles cyclen and tacn.
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5.2 1,4,7-Triazacyclononane
The coordination chemistry of 1,4,7-triazacyclononane (tacn) has been extensively 
studied and complexes with most of the transition metals have been reported . 4  When 
coordinated as a tridentate ligand, it exhibits a strong ligand-field i.e. forms low spin 
complexes. Owing to the small ring size and consequently relatively small hole size, 1,4,7- 
triazacyclononane is unable to form equatorial complexes with transition metal ions, 
instead coordinating to the metal centre in facially capping manner. In the presence of six 
donors the resulting complexes exhibit either octahedral or distorted octahedral geometries. 
Vacant coordination sites can be occupied by anions such as Cl", Br' or OH'. Occupation by 
neutral donors such as CO e.g. in [Mo(tacn)(CO)3 ]+ exhibit a piano-stool geometry5 whilst 
coordination to a second 1,4,7-triazacyclononane molecule affords a sandwich type
9-1- f\structure e.g. [Ni(tacn)2 ] .
5.3 A-Functionalisation of 1,4,7-Triazacyclononane
The introduction of one, two or three pendent arm donors at the nitrogen positions 
allows the formation of tetra, penta or hexadentate complexes. The first derivative to be
y #
extensively studied was 1,4,7-trisacetate-1,4,7-triazacyclononane (TCTA, figure 5.3). This 
is an example of a potential hexadentate ligand with a N 3 O3 donor set. It forms 
mononuclear complexes with all of the first row transition metal in a pseudo octahedral 
environment8 with the exception of titanium. In addition it also forms stable complexes 
with alkaline earth metals and some lanthanide metals. 9
o
(TCTA)
Figure 5.3: l,4,7-Trisacetate-l,4,7-triazacyclononae (TCTA).
The tridentate 1,4,7-triazacyclonone is a strong-field ligand, whereas the 
hexadentate TCTA ligand imposes a much weaker ligand field. For example, the Fe11 and 
Fe111 bis(tacn) complexes are low spin, 1 0 whereas the Fe11 and Fe111 complexes of TCTA 
complexes are high spin . 8 Therefore by altering the nature of the pendant arms the ligand 
environment around the metal centre can be controlled. Various pendant arms have since 
been investigated including hard donors such as alcohols, 1 1 ' 14 amines, 15 and phosphonates1 6
17 18 19and softer donors such as alkenes and sulfides. ’
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Much work has been carried out on the introduction of three pendant arms. 
However, less investigation on the selective iV-functionalisation with either one or two arms 
has been carried out partly due to the associated synthetic difficulties. Protecting groups 
and high dilution methods are commonly employed in order to selectively functionalise
1,4,7-triazacyclononane.
5.3.1 Use of Protecting groups
Mono-substituted 1,4,7-triazacyclononane derivatives can be prepared from the 
orthoamine l,4,7-triazatricyclo[5.2.1.04  ,0 ]decane. This method has been used to prepare 
several mono-substituted derivatives e.g. 7V-(2-hydroxybenzyl)- 1,4,7-triazacyclononane. 2 0  
Further functionalisation at the remaining two positions can be carried out if desired whilst 
treatment with either acid or base removes the formyl group (figure 5.4).
H „ /  \  , H /  \  + H . I \  ,H
N N  C H (O C 2H5)3 N ^ N  H+/ H 20  N  N
N ^ y  v - n
» H ^ O
Figure 5.4 : The synthesis o f  mono-jV-formyl Tacn via l,4,7-triazatricyclo[5.2.1.04 1 0 ]decane.
Mono-protection can also be achieved by the treatment of 1,4,7-triazacyclononane 
(10 equivalents) with tosyl chloride (1 equivalent) or from l,4,7-tris-tosyl-l,4,7- 
triazacyclononane (figure 5.5).
H„ /  \  .H
N  N
NI
H 
10 eq.
T osy l Chloride 
1 eq.
Phenol
HBr /  AcOH
T s. / \ /Ts
N  N.
Figure 5.5: Synthesis of 7V-tosyl-l,4,7-triazacyclononne.
The tosyl group can also be used to protect two of the nitrogen positions in 1,4,7- 
triazacyclononane by either the addition of one equivalent of tosyl chloride to 7V-tosyl-
1 ,4 ,7 -triazacyclononane2 1 o f by the careful addition of two equivalents of tosyl chloride to 
the hydrobromide salt of 1,4,7-triazacyclononane2 2  (figure 5.6).
Tosyl C hloride  
1 eq.
N N NaOH
TsCl (2 eq)
r i
1TN N H 2
w
H2
3Br"
Figure 5.6: Synthesis of bis-protected tacn.
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5.3.2 jV-Nitroarylation of 1,4,7-Triazacyclononane
The straightforward synthesis of the ligand 1,4,7-tris-(2-aminophenyl)-1,4,7- 
triazacyclononane (L3 3 R) via the intermediate l,4,7-tris-(2-nitrophenyl)-l,4,7- 
triazazcyclononane (L 3 3 )  has been previously reported2 3  (figure 5.7). This ligand is a rigid 
pendant-arm macrocycle and forms complexes with the formula [M ^I^jO JfC lO ^ (where 
M = Fe11, Nin, Cu11, or Zn11) upon the reaction with divalent first row transition metal 
perchlorate salts. Crystallographic data shows that the complexes of Fe11 and Ni11 possess a 
distorted pseudo-octahedral geometry at the metal centre, coordinating with the three 
macrocyclic W-donors and the three anilino donors.
h„ r~\ „ h
N N
NH
//
0 2N  
3 equiv.
Figure 5.7: Synthesis of 1,4,7-tris-(2-aminophenyl)- 1,4,7-triazacyclononane. Reagents and 
conditions: (a) K2 C 0 3, MeCN, reflux overnight; (b) 10% Pd/C, H2, THF-EtOH (20:1), 20 h.
It was shown, by electrochemical analysis that the nickel(II) and copper(II) 
perchlorate complexes exhibit irreversible oxidation and reduction processes. The iron(II) 
complex displayed two reversible oxidation process at +0.181 and +0.475 V and a weaker 
reversible process at +0.695 V (figure 5.8). In addition three irreversible oxidation 
processes at -1.03, -1.585 and -1.900 V were also observed. The oxidation process at + 
0.181 V can be assigned to the metal based Fen/Fem process whilst the oxidation process at 
+ 0.475 V can be tentatively assigned to either a ligand centred process or a second metal 
based process (Feni/FeIV).
/
0
F J\
Figure 5.8: Cyclic voltammogram of [Fen(L3 3 R)][C1 0 4 ] 2  in 0.1 M [n-Bu4 N]PF6  in acetonitrile vs. Fc-
Fc+ . 2 3
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5.3.2.1 Selective TV-Nitroarylation of 1,4,7-Triazacyclononane
Our group has previously demonstrated that the addition of either one or two mole 
equivalents of 2-chloronitrobenzene to 1,4,7-triazacyclononane in the presence of 
potassium carbonate, affords almost exclusively the mono and di-substituted derivatives in 
6 8  and 73 % yields respectively . 2 4  This straightforward route for the preparation of mono 
and di-nitroaryl substituted derivatives allows for subsequent introduction of another, 
different pendant arm to afford the “mixed” ligand l,4-(2-nitrophenyl)-7-(4-nitrophenyl)-
1,4,7-triazacyclononane, L m jX25 as illustrated in figure 5 . 9 .
Figure 5.9: Preparation of the “mixed” ligand, Lmix. Reagents and conditions: (i) 4-chloronitrobenzene (1 eq), 
K2 C 0 3, MeCN, reflux 8  h; (ii) 2-fluoronitrobenzene (2 eq), K2 C 0 3, MeCN, reflux 12 h; (iii) 2- 
chloronitrobenzene (2 eq), K2 C 0 3, MeCN, reflux 18 h; (iv) 4-chloronitrobenzene, K2 C 0 3, MeCN, reflux 4 h.
5.4 Aims and Objectives
To date, metal complexes of 1,4,7-triazacyclononane have not been investigated as 
catalysts for the reduction of aqueous silver ions in a Timm’s type reaction. The ability to 
selectively Wfunctionalise 1,4,7-triazacyclononane and depending on the nature of the 
pendant arms, controlling the ligand environment around the metal centre may afford 
compounds that exhibit the desired redox activity. Encouraged by the interesting redox 
properties of the compound [Fen(L3 3 R)][C1 0 4 ] 2  we set out to synthesise similar 
ligands/complexes for our own purposes.
Here we outline the preparation of 1,4,7-triazacyclononane derivatives containing 
nitrophenyl pendant arms. We have developed a one-pot methodology suitable for the 
synthesis of 1 ,4 ,7 -triazacyclononane ligands that contain a mixture of pendant donor
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groups. Attempts to attach porphyrins and terpyridines to the azamacrocycle ring are also 
presented.
Results and Discussion
5.5 Nitro-Benzaldehyde 1,4,7-Triazacyclononane Derivatives
We felt it would be interesting to introduce aniline pendent groups which 
incorporate a benzaldehyde. This would allow the attachment to other multidentate ligands 
such as porphyrins and terpyridines, but could also provide a means of conjugation to a 
biomolecule.
5.5.1 Synthesis of 4-Fluoro-3-nitrobenzaldehyde [5.1]
4-Fluoro-3-nitrobenzaldehyde [5.1] was prepared using an adapted procedure for 
the synthesis of l,5-dichloro-2,4-dinitrobenzene by the nitration m-dichlorobenzene using a 
mixture of potassium nitrate and sulfuric acid (figure 5.10) . 2 6  To this end, 4- 
fluorobenzaldeyde was cautiously added to a solution of potassium nitrate ( 1  mole 
equivalent) and concentrated sulfuric acid. The reagents were added at room temperature 
and the temperature gradually increased to 130 °C over a period of 1.5 hours. Pouring the 
reaction mixture onto crushed ice, results in the precipitation of the crude product. 
Extraction with dichloromethane and recrystallisation from diethyl ether afforded [5.1] as a 
cream solid (72 %). The spectroscopic data is consistent with that reported elsewhere in the
97 •literature. Under these conditions only the mono-nitrated product is formed and any 
unreacted 4-fluorobenzaldehyde can be removed via a Kugelrohr distillation. This 
procedure has been extended to the synthesis of 4-fluoro-3-nitrobenzoic acid [5.5].
F F
7 2%
Figure 5.10: Preparation of |5.1].
5.5.2 Preparation of l,4,7-tris-(2-nitro-4-benzaldehyde) 1,4,7-triazacyclononane [5.2],
(L 3 3 A )
3 Mole equivalents of 4-fluoro-3-nitrobenzaldehyde [5.1] and 1,4,7- 
triazacyclononane were reacted in refluxing acetonitrile in the presence of anhydrous 
potassium carbonate (3 mole equivalents) to afford a bright yellow solid (figure 5.11). A 
complicated ’H NMR spectrum was obtained for the product, indicative of a mixture of
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substituted derivatives. Repetition of the reaction using DMF as a solvent produced similar 
results. However, the reaction in acetonitrile employing potassium fluoride as the base 
afforded only a single product. The generation of the HF2 ' anion during the course o f  the 
reaction may thermodynamically drive this reaction to completion. Recrystallisation from 
hot toluene afforded [5.2] in 42 % yield. This compound in its pure form is sparingly 
soluble in solvents such as chloroform, but is soluble in DMSO. The NMR spectrum is 
comparable to that of the ligand L3 3  with a single resonance at 5 3.70 ppm attributed to the 
six equivalent methine groups of the macrocycle. The HRMS was consistent with the 
formation of the tris-substituted product.
FL /  \  ,H
N N
O H
/= \ .O
fH \ // H
o 9n
KF, MeCN  
4 2 %
NO
NO
[5.21
Figure 5.11: Preparation of the ligand L33A, (5.2|.
5.6 Selective N-Nitroarylation
1,4,7-Triazacyclononane can be selectively jV-nitroarylated by altering the 
stoichiometry of the reagents used. The ability to do this allows for “mixed” ligands, 
involving one or more different pendent groups to be prepared. 1,4-Bis-(2-nitrophenyl)-
1.4.7-triazacyclononane, [L3 2 ] was synthesised as previously. 2 5  Whereby two mole 
equivalents of 2 -fluoronitrobenzene and potassium carbonate were added to a so lu tion  of
1.4.7-triazacyclononane in acetonitrile and heated to reflux overnight (figure 5.12). 
Recrystallisation from hot ethanol afforded [5.3] as an orange crystalline material (31 %). 
Under these conditions, the tris-nitroaryl substituted product is also produced contributing 
to the low isolated yield of [5.3]; the desired substituted derivative can be removed as the 
hydrochloride salt following an acidic workup.
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— n -— y  ^ C n^  + C n ^  N°2
2 C 0 3 0 2N
-N-I
H
[5.3]
L 3 2  
31 %
plus traces o f  L 33
Figure 5.12: Preparation of |5.3] (L 3 2 ).
5.7 A-Nitroarylation using 4-Fluoro-3-NitrobenzaIdehyde [5.1J
Reaction of [5.3] (L3 2 ) with 1 mole equivalent of 4-fluoro-3-nitrobenzaldehyde [5.1] 
and 1 . 1  mole equivalent of anhydrous potassium carbonate in refluxing acetonitrile 
overnight yielded the crude product as an oily residue (method A, figure 5.13). 
Recrystallisation from hot acetonitrile afforded the novel mixed ligand [5.4] (L3 2 A) in 53 % 
yield. The introduction of a third, different pendent group was substantiated by the splitting 
of the macrocyclic methine protons in the NMR spectrum. The ES mass spectrum 
showed two molecular ions at 521.2 and 559.1 Da/e corresponding to [M + 1] and [M + K+] 
respectively.
O2 N [5.1]
5 3%
15.3] L 3 2
Figure 5.13: Synthesis o f [5.4] (L32A) by the two-step method A and the one step method B.
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5.7.1 One-Pot Synthesis of L3 2 A
The ligand [5.4] (L3 2 A) was also prepared in a two-step, one-pot reaction directly 
from 1,4,7-triazacyclononane (figure 5.13, method B). The first step involved the in situ 
preparation of L3 2  by the reaction of 1 mole equivalent of 1,4,7-triazacyclononane with 2 
mole equivalents of 2-fluoronitrobenzene and potassium carbonate. During the previous 
preparation of L3 2 , the tris-substituted nitroaryl product (L3 3 ) was also formed. Therefore, in 
order to limit the production of L3 3  we decided to perform the reaction for 2 hours at room 
temperature and then increase the temperature to 80 °C for a further 2 hours. Upon cooling
1.1 equivalents of 4-fluoro-3-nitrobenzaldehyde [5.1] and a further portion of potassium 
carbonate (1.1 equivalents) were added and the heating at 80 °C was continued overnight. 
Removal of the solvent and recrystallisation from hot acetonitrile afforded [5.4] as a yellow 
solid (59 %). This compound has identical spectral properties to that produced by method 
A. Proton NMR spectral analysis of the crude material showed a small resonance at 8 3.45 
ppm verified to be L3 3  in the ratio of 20:1 (L3 2 A-L3 3 )-
The two-step method A affords [5.4] (L3 2 A) in an overall yield of 16 % compared to 
the 59 % obtained by method B. The isolated yield of L3 2  is lower than previously reported 
(31 % c f  73 % ) . 2 4  Taking this into account a hypothetical overall yield of 38 % was 
calculated, which is still considerably lower than the one-pot synthesis. Therefore, this one- 
pot method presents a novel and efficient method for the preparation of “mixed” 1,4,7- 
triazacyclononane ligand systems.
5.7.2 Reduction of the Benzaldehyde
In order to render the ligands [5.2] (L3 3 A) and [5.4] (L3 2 A) suitable for metal 
complexation with divalent first row transition metal salts, the nitro group must be reduced 
to the amine. This can be achieved by hydrogenation (10% Pd/C or Pt/C, THF-EtOH) as 
reported for L3 3 R. 2 5  Work-up of the reduced ligand must be carried out anaerobically since 
solutions of L3 3 R were found to darken rapidly upon exposure to air. Since our new ligand 
possesses an aldehyde function which can be subject to reduction under these types of 
conditions, investigations were performed to test their stability. To this end, hydrogenation 
of 4-fluoro-3-nitrobenzaldehyde [5.1] was carried out (10% Pt/C, THF-EtOH). Under these 
conditions the aldehyde appears to be partially reduced. In the IR spectrum of the product, a 
strong absorption at 3410 cm ' 1 (NH) and a weaker absorption at 1697 cm" 1 (C=0) are 
observed. The !H NMR spectrum is complicated suggesting a mixture of products.
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5.8 Benzoic Acid 1,4,7-Triazacyclononane Derivatives
Due to the possible difficulties of reducing the nitro groups by hydrogenation in the 
presence of a benzaldehyde, attempts were made to prepare 1,4,7-triazacyclononane 
compounds that incorporate benzoic acid pendent groups. 4-Fluoro-3-nitrobenzoic acid
[5.5] (figure 5.14) was synthesised in the same manner as 4-fluoro-3-nitrobenzaldehyde
[5.1] (54%).
F F
54%
HO
Figure 5.14: Reagents and conditions: potassium nitrate, concentrated sulphuric acid, 130 °C
The reaction between 1,4,7-triazacyclononane and 4-fluoro-3-nitrobenzoic acid
[5.5] (3.3 mole equivalents) with potassium carbonate in acetonitrile (figure 5.15) resulted 
in the precipitation of a yellow solid which was insoluble in both acetonitrile and 
dichloromethane. Proton NMR analysis of this material showed it to be a mixture of 
unreacted 4-fluoro-3-nitrobenzoic acid [5.5] and the trisubstituted product [5.6] in the ratio 
of 4:1. Hydrochloric acid was added to protonate the product and thus enable separation 
from the potassium carbonate. The *H NMR spectrum of the precipitated hydrochloride salt 
contained several peaks centred around 3.5 ppm possibly due to the presence of varying 
degrees of protonation. The IR spectrum supports this, with two strong absorbencies 
appearing at 1705 cm’1 (C=0 stretch) and 1612 cm’1 (antisymmetric stretch of CO2 ’).
H .  /  \  , H
N N
l
H
Figure 5.15: Preparation of |5.6| from 1,4,7-triazacyclononane and 3.3 equivalents o f 4-fluoro-3-nitrobenzoic
acid
NO
OH
NO
K2C 0 3, M eCN 0 ?N
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Using our one-pot method, [5.7] was prepared from 1,4,7-triazacyclonone, 2- 
fluoronitrobenzene and 4-fluoro-3-nitrobenzoic acid [5.5] in the presence of potassium 
carbonate (figure 5.16). Upon cooling the reaction mixture was filtered to remove a large 
quantity of solid material, removal of the solvent in vacuo afforded an orange oil. The *H 
NMR spectrum identified this substance to be solely L3 2 . The solid material was washed 
with water to remove the potassium carbonate. The *H NMR spectrum of the material was 
found to consist of the product [5.7] and unreacted 4-fluoro-3-nitrobenzoic acid.
OH
FL r A , H 
N N
NO
/ \
NO
OH
15.7]
n o 2
, H
N N
N
O .N
J32
Figure 5.16: Preparation of (5.7] using the one-pot method gave a mixture of [5.7] and L32. Reagents and 
conditions: (1) 2-fluoronitrobenzene (2 eq), K2 C 0 3 (2 eq), MeCN, 2 h (25 °C), 2h (90 °C); (2) 4-fIuoro-3-
nitrobenzoic acid (1.1 eq), K2 C 0 3, 90 °C overnight.
5.9 Benzyl Ester 1,4,7-Triazacyclononane Derivatives
The problems encountered in the reactions involving 4-fluoro-3-nitrobenzoic acid, 
prompted the protection of the benzoic acid as the benzyl ester. We envisaged that the ester 
could be removed by hydrogenation to generate the corresponding acid. Benzyl-4-fluoro-3- 
nitrobenzoate [5.8] was prepared as illustrated in figure 5.17.
n o 2
HO'
[5.8]
HO'
Figure 5.17: Reagents and conditions', (a) SOCl2, DMF, reflux 4 h; (b) DMAP (catalytic amount), Et3N,
DCM
The reaction of (5.81 with 1,4,7-triazacyclononane in the presence of potassium 
fluoride and acetonitrile afforded [5.9] (L3 3 Benzyi) as a dark yellow solid (56 %) (figure 
5.18). The mass spectrum (APCI) showed ions corresponding to both the two-on (640.2
140
Chapter 5 -  1,4,7-Triazacyclonone
Da/e) and three-on (895.3 Da/e) additions. Separation of these two products was achieved 
chromatographically on silica gel eluting with dichloromethane. The mono-benzyl 
derivative (5.10] (figure 5.18) was also prepared (L3 2 Benzyi) using the one pot synthesis. 
However this reaction does not proceed cleanly and the product is contaminated with both 
L3 3  and L3 2  amongst other unidentifiable trace impurities.
n o 2
[5.9J
NO
NO
Figure 5.18: The ligands [5.9| and [5.10|.
Attempts were made to reduce the nitro group and cleave the benzyl ester 
simultaneously using palladium on carbon under an atmosphere of hydrogen (figure 5.19). 
The reaction mixture was left to stir under a hydrogen atmosphere for 2 days, during which 
the yellow solution turned colourless indicating the successful reduction of the nitro 
moieties. However, we have encountered difficulties regarding this hydrogenation step. The 
product obtained is highly contaminated and further investigation is required to optimise 
and improve the reaction conditions.
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OH
NO NH
HO"
H2, Pd/C(10 %)
NO NH
THF-MeOH
(2 0 :1)
OH
Figure 5.19: Attempts to simultaneously reduce the nitro groups and cleave the benzyl ester groups proved
problematic.
5.10 O ther Ligands
The use of the one-pot synthesis was further exemplified by the successful 
preparation of the ligands L3 2 T, L3 2 AI0  L3 2 Q as illustrated in figure 5.20.
H . / ~ \  .H
N N FA \
(2 eq)
49%
n o 2 O
N NN N
15.111
(^ 32t)
[5.12J
(L32AIc)
15.13J
( L 3 2 Q )
Figure 5.20: One-pot synthesis of L32T, L32A|C and L32Q. Reagents and conditions: (i) 2-fluoronitrobenzene (2 
eq), K2C 0 3 (2 eq), MeCN, 2h at 25°C, 2h at 90°C; (ii) 4-fluoro-3-nitrotolune (1.1 eq), K2C 0 3 (1.1 eq), 90°C 
overnight; (iii) racemic propylene oxide (excess), THF/EtOH, 5 days at 25°C; (iv) 2,3-dichloro-l,4- 
napthoquinone (1.1 eq), K2C 0 3 (1.1 eq), 90°C overnight.
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5.10.1 Ligand [5.11] - L 32t
This was prepared in the same manner as [5.4] (L3 2 A) to afford the crude product as 
an orange oil (figure 5.20). Recrystallisation from hot ethanol gave [5.11] (L3 2 T) as an 
orange crystalline solid (64 %). Hydrogenation in toluene-MeOH (20:1) in the presence of 
Pt/C afforded [5.11R] (L3 2 TR) as an off-white solid (68 %) (figure 5.21). Solutions of this 
compound were found to rapidly decompose in the presence of air. An ethanolic solution of 
nickel (II) perchlorate hexahydrate was added to [5.11R] (L3 2 TR) instantly producing a pink 
solution. Removal of the supernatant and subsequent drying in vacuo afforded 
[Nin(5.11R)][0 0 4 ) 2  as an air stable pale pink solid (84 %) (figure 5.21). Unfortunately 
recrystallisation by vapour diffusion did not produce crystals suitable for X-ray analysis. 
The obtained complex was washed several times with ethanol and diethyl ether to remove 
any traces of metal perchlorate. The compound was tested using the procedure described in 
chapter 2 (section 2.12). It was found that after a period of 3 minutes, solid particles of the 
complex darken in colour (brown-black) followed by a gradual darkening of the developer 
solution (10 minutes).
Pt/C, h2
NO
NO
I5.11J
toluene-MeOH
6 8 %
NH
[5.11R]
Nin(C104)2.6H20 84%
[Nin (5.11R>] [C104]2 
Figure 5.21: Preparation of the complex lNiu(5.11R)l[C104]2.
5.10.2 Ligand [5.12] - L 32a ic
The hexadentate ligand l,4,7-tris-[(2S)-2-hydroxypropyl]-l,4,7-triazacyclonone has 
been previously prepared by the regioselective ring opening of (S)(-) propylene oxide with
1,4,7-triazacylcononane, at the epoxide centre11,14,28 (figure 5.22). This ligand has the 
potential to coordinate in less than a hexadentate fashion. But also has the potential to 
demonstrate protonation-deprotonation equilibria at the alcoholic OH groups.
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H O ^
UH. I \ ,H  L. / \  OHN N O  _  N N
OH
Figure 5.22: Synthesis of 1,4,7-tris-[(2S)-2-hydroxypropyl]-1,4,7-triazacyclononane as reported by Peacock
et al.
We have prepared a mixed pendant arm ligand which incorporates two nitro/anilino- 
phenyl groups alongside the harder donor group (2 S)-CH2 CH(Me)OH. Hence, compound 
[5.12J (L3 2 aic) was prepared using both the one-pot method (figure 5.20) and also by the 
addition of propylene oxide to L3 2  (figure 5.23) to afford [5.12] in 40 % and 50 % yields 
respectively. The latter reaction provided a cleaner route of synthesis whilst the one-pot 
method generated a mixture of products.
OH
N N N N
(racemic)
[5.12]
Figure 5.23: Preparation o f L32aic from L32. Reagents and conditions', racemic propylene oxide (excess), THF-
EtOH (1:1), 25°C, 5 days.
The in situ preparation of the di-substituted L3 2  may also generate traces of the 
mono-substituted product (mono-(2-nitrophenyl)-1,4,7-triazacyclononane, L3 j) which will 
also react with propylene oxide. Since the racemic mixture was used, there is no control 
over the stereoselectivity and hence a number of possible products can be formed, 
contaminating the desired product (figure 5.24).
-n o 2 ^ ^ n o 2
/ \ ,H A  - o hN N N N
-31
OH
mixture o f  enantiomers 
contaminates the 
desired product L32aic.
Figure 5.24 : Traces of mono-substituted L31 generated during the in situ preparation of L32 can react with 
propylene oxide (racemic) to give a mixture of enantiomers.
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The nitro groups in L3 2 AIC were reduced using Pd/C as the hydrogenation catalyst in 
toluene-MeOH (30:1). The hydrogenation step is very much dependent on the purity of the 
aryl-nitro ligand. An unsuccessful hydrogenation can be attributed to trace impurities 
present in the sample which may poison the catalyst. The reduced ligand, L3 2 AICR was found 
to be very air sensitive, with solutions readily discolouring in the presence of air, attempts 
to obtain a well resolved proton NMR spectrum failed. Several efforts were made to reduce 
the nitro groups but none were successful. Consequently attempts to prepare metal 
complexes (Ni(II) and Fe(II)) were also unsuccessful.
5.10.3 Ligand [5.13] -L3 2 Q
Quinones can act as single-electron carriers to assist oxidation-reduction reactions. 
Addition of one proton and one electron to a quinone affords a stable radical called a 
semiquinone, and addition of a second electron plus proton affords a hydroquinone (figure 
5.25). The quinone/hydroquinone redox couple can interconvert reversibly in protic media. 
This redox couple is involved in various biological electron transfer systems e.g. the 
substituted p-benzoquinone, plastoquinone is known to be involved in electron transfer 
from photosystem II to photosystem I in green plants. Quinones have been shown to be 
good electron acceptors whilst in contrast hydroquinones are good electron donors. 
Hydroquinone (the reduced form of quinone) and its derivatives are water soluble and are 
used as developing agents in black and white photography, lithography and x-ray films. In 
the presence of the compound Metol (A-methyl-p-aminophenolsulfate), hydroquinone 
reduces silver halides to silver metal to give a visible silver image. This process is similar to 
the Timm’s reaction therefore quinone/hydroquinone compounds were worth investigating.
0 0 0
/?-quinone semiquinone p-hydroquinone
(free radical)
Figure 5.25: The quinone/hydroquinone redox equilibrium between/?-quinone and/^-hydroquinone.
The introduction of a napthoquinone moiety to 1,4,7-triazacyclononane was 
achieved using our one-pot methodology (figure 5.20). To the best of our knowledge, this is 
the first example of 1,4,7-triazacyclononane directly functionalised with a napthoquinone. 
Following the in situ generation of L 32 , 1.1 mole equivalents of 2,3-dichloro-l,4- 
napthoquinone and potassium carbonate were added accompanied by a change of colour to
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bright red. Following work-up, the crude product was purified by flash chromatography to 
remove unreacted 2,3-dichloro-l,4-napthoquinone. Removal of the solvent in vacuo 
afforded [5.13] as a red solid (49 %). It was found that solutions of this compound were 
light sensitive and darkened in colour on prolonged exposure to light. In the IR spectrum 
two typical strong quinonic absorptions are observed at 1676 and 1640 cm '1. In the mass 
spectrum the parent ion is observed at 562.1 Da/e.
l  A
Previous work has shown that when sodium borohydride is added to a solution of 
a napthoquinone compound A (as illustrated in figure 5.26) a colour change of red to 
colourless is observed due to the spontaneous reduction of the quinone to hydroquinone. 
This process is reversible unless kept under nitrogen.
NaBH 4,
MeOH, RT
Me
Me
N - S -
quinone compound, A  - red
OH
Me
Me
N - S -
OH
[O]
hydroquinone compound, B - colourless 
Figure 5.26: Reversible oxidation/reduction of quinone A to hydroquinone B as reported by Bittner et al.30
A solution of [5.13] (L3 2 Q) in THF-MeOH was hydrogenated in the presence of Pt/C 
(figure 5.27). After 24 hours the solution became colourless, consistent with the reduction 
of both nitro and quinone functions. On exposure to air, the solution undergoes a colour 
change of colourless to red upon the oxidation of the hydroquinone to quinone. The 
solution quickly became dark in colour due to the instability of the aryl amines in air. A 
small sample of the colourless solution was added to the silver developer/reducer solutions. 
As anticipated the hydroquinone was rapidly oxidised to the quinone accompanied by the 
reduction of Ag+ to Ag(m). Unfortunately attempts to characterise the reduced ligand and 
prepared metal complexes have been unsuccessful due to the rapid decomposition.
|5.13] L32Q [5.13R]
(red) (colourless)
Figure 5.27: Hydrogenation of [5.13] to [5.13RJ.
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5.11 Attachment of a porphyrin and terpyridine to 1,4,7-triazacyclononane
The ligands [5.2] and [5.4] both contain a benzaldehyde function. This would allow 
other systems i.e porphyrin or terpyridine to be incorporated. This section presents the early 
attempts to achieve this.
5.11.1 Attachment of Porphyrin
There are few reports of 1,4,7-triazazcyclononane-porphyrin conjugates in the 
literature. Collman et al ’ have reported 1,4,7-triazacyclononane-capped porphyrins, 
designed as an active site analogue of myoglobin. Such systems have been prepared by the 
addition of 1,4,7-triazacyclononane to a Michael acceptor porphyrin (figure 5.28)
We have attempted to build a porphyrin framework directly onto 1,4,7- 
triazacyclonone. To this end, a statistical mixture of [5.4] (L3 2 A), 4-ter/-butylbenzaldehyde
Figure 5.29: Attempted synthesis of porphyrin-tacn system using Adler methodology. Reagents and
conditions', propionic acid, 30 min, reflux.
Figure 5.28: Example of a Tacn-capped porphyrin as reported by Collman et al.
and pyrrole were added refluxing propionic acid (figure 5.29). Upon cooling the resultant 
precipitate was filtered and washed with MeOH.
147
Chapter 5 -  1,4,7-Triazacyclonone
The MALDI mass spectrum of the crude product mixture did not contain the 
expected molecular ion at 1197 Da/e, only a strong peak corresponding to 5,10,15,20- 
tetra(4-/-butylphenyl) porphyrin was observed. Attempts to react [5.2] with 4-t- 
butylbenzaldehyde and pyrrole in a similar reaction also appeared to be unsuccessful. The 
Adler methodology is not suitable for the preparation of all substituted porphyrins therefore 
an alterative methodology may be more successful e.g. Lindsey or MacDonald 2+2 
condensation (described in chapter 3, section 3.5).
5.11.2 Attachment of a Terpyridine.
There has been a report of 1,4,7-triazacyclononane containing a phenyl-terpyridyl 
pendant arm, whereby the terpyridylbenzyl pendant arm is introduced into the macrocycle 
by reaction with the tricyclic orthoamide l,4,7-triazatricyclo[5.2.1.0410]decane (figure 
5.30). This ligand contains both a meridionally coordinating sub-unit (terpy) and a facially 
coordinating triazamacrocycle (tacn).
Figure 5.30 : Synthesis of a terpyridyl pendant-arm macrocycle, 4’-(p-1,4,7-triazacyclonon-1 - 
ylmethylphenyl)-2,2’:6’,2”-terpyridine (L) as reported by Moore et a lP  Reagents and conditions: (i) THF, 
r.t. 24 h; (ii) water, 100 °C, 3.5 h; (iii) KOH, EtOH:water (3:1), 100 °C, 48 h.
We set about to attach three terpyridyl sub-unit to our tris-nitrobenzaldehyde-1,4,7- 
triazacyclononane derivative [5.2]. Initial attempts to assemble the terpyridyl units using 
the Raston methodology were unsuccessful. Alternatively, a one pot synthetic method in 
which the benzaldehyde is reacted with 2 mole equivalents of 2-acetylpyridine and
n
o
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potassium /-butoxide in THF followed by cyclisation with ammonium acetate was 
employed (figure 5.31).
n o 2
Figure 5.31: Reagents and conditions: (i) N2, potassium /-butoxide, THF; (ii) anhydrous ammonium acetate,
glacial acetic acid-ethanol (1:1).
Using this method, a yellow-brown solid was obtained; initial attempts to 
recrystallise this product have not been successful and hence the ’H NMR spectrum was not 
well resolved. Upon the addition of an ethanolic solution of ammonium ferrous sulfate an 
instant colour change of purple was observed. Octahedral iron(II) complexes of terpyridine 
with a metakligand ratio of 1:2 are purple in colour. The observed colour change may be 
attributed to the presence of a terpyridine sub-unit. The low resolution MS of the product 
does not show the expected molecular ion at 1187 Da/e. The spectrum contains a lot of 
background noise, but a substantial peak is observed at 780.5 Da/e, a possible assignment is 
illustrated in figure 5.312.
H
Mass = 779.76
Figure 5.32: Possible structural for the peak observed at 780.5 Da/e.
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5.12 Conclusion
We have developed a novel one-pot synthesis for the preparation of “mixed” nitro- 
aryl containing 1,4,7-triazacyclononane ligands in reasonable yields. This synthesis has 
been extended to the preparation of 1,4,7-triazacyclononane derivatives containing alcohol 
and naphthoquinone pendant groups. The coordination chemistry and subsequent 
electrochemistry of the prepared ligands has not been fully explored owing to difficulties 
encountered during the hydrogenation steps. The complex Ni[5 .1 1 R][C1 0 4 ] 2  catalyses the 
reduction of silver ions in a Timm’s type reaction in 3 minutes. This encouraging result 
shows the potential of hexadentate metal complexes of functionalised 1,4,7- 
triazacyclononane ligands as catalysts of silver ions to silver metal in Timm’s type reaction. 
The ability to selectively A-functionalise 1,4,7-triazacyclononane would allow the 
introduction of groups suitable for bioconjugation.
Experimental 
General Procedure
Non-synthesised reagents were purchased from Aldrich, Avocado or Lancaster and 
were used as received. Where appropriate solvents were dried and degassed by reflux over 
standard drying agents34 under a nitrogen atmosphere. The NMR spectra were recorded on 
a Brtiker Avance 400 instrument at 400 MHz (!H) and 100 MHz (13C), Jeol Lamda Eclipse 
at 282.78 MHz (19F); *H and ,3C chemical shifts are quoted in ppm relative to residual 
solvent peaks and. Coupling constants are quoted in Hertz. Mass spectra were obtained in 
either APCI (atmospheric pressure chemical ionisation), El (electronic ionisation). IR 
spectra were obtained as KBr or NaCl discs using a Jasco FTIR 110 series spectrometer.
[5.1] 4-Fluoro-3-nitrobenzaldehyde
n o 2
Sulfuric acid (75 mL) and potassium nitrate (19.69g, 0.194 mol) were added to an unsealed 
pressure tube and stirred well until dissolved. 4-Fluorobenzaldehyde (24g, 0.193 mol) was 
slowly added with stirring and the temperature was gradually raised to 130 °C over a period 
of 45 minutes, and stirred for an additional 1 h. The yellow mixture was allowed to cool 
slightly and poured over crushed ice and was vigorously stirred for 1 h. This aqueous 
mixture was extracted with dichloromethane, dried over MgSC>4 and the solvent remove in 
vacuo to give the crude product as an orange oil. Further purification on a Kugelrohr
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apparatus and recrystallisation from diethyl ether yielded the product as a yellow solid 
(23.54g, 72 %); 5H (400 MHz, CDC13) 9.98 (1H, s, CM)), 8.55 (1H, m, Ar H), 8.15 (1H, 
m, Ar H), 7.45 (1H, m, A r //), IR (KBr, cm '1) 3360,2867,1716,1698,1614,1531,1493, 
1422, 1355, 1257, 1203, 1135, 1078, 974, 927, 903 and 844; m/z (APCI) 170.0 [M + 1].
[5.2] L33a
n o 2
To a solution of 1,4,7-triazacyclononane (0.147 g, 1.13 mmol) in dry acetonitrile (10 mL) 
in a pressure tube, were added 4-fluoro-3-nitrobenzaldehyde [5.1] (0.638 g, 3.77 mmol) and 
anhydrous potassium fluoride (0.219 g, 3.3 equiv). The reaction mixture was heated to 80 
°C overnight. Upon cooling the reaction mixture was diluted with dichloromethane (20 
mL), filtered and the solvent removed in vacuo to give the crude product as a yellow solid. 
Recrystallisation from hot toluene gave the title compound as a yellow solid (0.275g, 42 
%); 5h (400 MHz, d-DMSO) 9.85 (3H, s), 8.25 (3H, d, J  1.98), 7.95 (3H, dd, J  8.87, 
1.91), 7.40 (3H, d, J  8.92), 3.70 (12 H, s); 5C (100 MHz, </-DMSO) 188.6, 145.9, 137.3,
131.3, 128.4, 125.4, 118.3, 51.3; IR (KBr disc, cm'1) 1689.6 (strong, C=0 stretch),
1602.8, 1524.9 (strong, N =0 antisymmetric stretch), 1423.6, 1359.4, 1196.3, 1166.3,
1097.9, 990.2 and 813.8; m/z (ES) 575.4242 [M + 1]; HRMS (ES Q-TOF) m/z calc for 
C27H24N609Na 599.1502, found 599.1497.
[5.3] L32
To a solution of 1,4,7-triazacyclononane (0.5 g, 3.86 mmol) in dry acetonitrile (20 mL) in a 
pressure tube, were added 2-fluoronitrobenzene (1.09 g, 7.7 mmol) and finely ground 
potassium carbonate (1.06g, 7.66 mmol). The reaction mixture was heated to 90°C and 
stirred overnight. Upon cooling, the mixture was diluted with DCM (20 mL), filtered and 
the solvents were removed in vacuo. The residue was dissolved in CHC13 (50 mL) and
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extracted with HC1 (4 M, 2 x 50 mL). The aqueous layer was basified with aqueous NaOH 
to PH 12 and then extracted with CHCI3 (100 mL). The organic phase was dried over 
MgS( > 4  and the solvents removed in vacuo. Recrystallisation from hot ethanol afforded the 
title compound as an orange crystalline material (0.444 g, 31 %) 8 h (400 MHz, CDCI3 ) 
7.54 (dd, 2H, J  8.06, 1.44, Ar H), 7.32 (t of d, 2H, J  7.43, 1.56, Ar //)), 7.00 (d, 2H, J  
8.47, A r//) , 6.80 (t, 2H, 7  8.13, Ar H), 3.60 (s, 4H, CH2 macrocycle), 3.35 (m, 4H, C H2 
macrocycle), 2.88 (m, 4H, CH2 macrocycle); 8C(100 MHz, CDC13) 143.9, 141.8, 132.9,
126.0, 120.1, 119.1, 56.0, 54.1, 48.9; m/z (ES) 372.5 [M + 1].
[5.4] L 32a
N N
Method 1: To a solution of 1,4,7-triazacyclononane (0.2 g, 15.4 mmol) in dry acetonitrile 
(10 mL) in a pressure tube, was added 2-fluoronitrobenzene (0.437g, 30.9 mmol) and finely 
ground potassium carbonate (0.6017 g, 2.2 equiv). The reaction mixture was stirred at room 
temperature for 2 h, the temperature was raised to 80 0  C and stirred for a further 2 h. Upon 
cooling 4-fluoro-3-nitrobenzaldehyde (0.288g, 17.0 mmol) was added and was stirred at 80 
°C overnight. The reaction mixture was diluted with dichloromethane (30 mL), filtered and 
the solvent removed in vacuo to give the crude product as an orange oily solid. 
Recrystallisation from hot acetonitrile gave the title compound as a bright yellow solid 
(0.47 g, 59 %). Yield: 5H (400 MHz, CDC13) 9.75 (s, 1H, CHO), 8.08 (d, 1H, J2 .04 , Ar 
H), 7.80 (dd, 1H, J  8.95, 2.0, Ar IT), 7.55 (dd, 2H, J  8.05, 1.55, Ar H), 7.40 (t, 2H, J  8 .6 , 
A r//), 7.15 (d, 2H, J8 .4 , A r//) , 6.98 (m, 3H, Ar //an d  Ar / f ) ,  3.65 (d, 4H, J  4.54, CH2 
macrocycle), 3.60 (d, 4H, J4 .3 9 , CH2 macrocycle), 3.30 (s, 4H, CH2 macrocycle); 6 c 
(100 MHz, CDCI3 ) 188.7, 147.7, 145.1, 144.3, 139.0, 133.7, 133.3, 130.5, 126.5, 
126.1, 123.4, 122.6, 118.0, 56.4, 54.6, 54.1; IR (KBr disc, cm'1) 1683.9 (strong, C=0 
stretch), 1601.6 (strong), 1511.8 (strong, N=0 stretch), 1391.0, 1346.0, 1299.4, 1263.6, 
1201.2, 1174.2 and 993.4; m/z (ES) 521.2 [M + 1], 559.1 [M + K]
Method 2: To a solution of 1,4-di(2-nitrophenyl)- 1,4,7-triazacyclononane, L3 2  (0.444 g, 
1.19 mmol) in dry acetonitrile (20 mL) in a pressure tube, was added 4-fluoro-3- 
nitrobenzaldehyde (0.2 g, 1.19 mmol) and finely ground potassium carbonate (0.18 g, 1.30 
mmol) and was heated to 90 °C overnight. Upon cooling the reaction mixture diluted with
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dichloromethane, filtered and dried in vacuo to give the crude product as an orange oily 
solid. Recrystallisation from hot acetonitrile gave the title compound as a bright yellow 
solid (0.319 g, 52 %) with identical spectral properties as above.
[5.5] 4-fluoro-3-nitrobenzoic acid
F
n o 2
This was prepared in an analogous method to that of [5.1], the applied reagents were 4- 
fluorobenzoic acid (15g, 107.1 mmol) and potassium nitrate (10.8g, 106.82 mmol). 
Recrystallisation from hot toluene afforded [5.5] as a cream needles (10.62g, 54 %); 8 h 
(400 MHz, CDCI3 ) 12.60 (br s, 1H, OH), 8.90 (m, 1H, Ar H), 8.50 (m, 1H, Ar H), 7.45 
(m, 1H, Ar H); 5C (100 MHz, CDC13) 169.1, 159.7, 157.6, 137.5, 137.1 (JcF 8  Hz), 128.6,
126.3, 119.1 ( J cf  17 Hz); IR (KBr, cm'1) 3078 (OH stretch), 2830, 2674, 2559, 1710 
(C=0 stretch), 1618, 1539 (N=0 antisymmetric vibration), 1427, 1351 (N=0 symmetric 
stretch), 1286, 1267, 1159, 1124, 1077, 918, 849, 820, 770; m/z (APCI) 186.2 [M + 1].
[5.6] L 3 3 BA
OH
HO'
n o 2
OH
To a solution of 1,4,7-triazacyclononane (0.147 g, 1.13 mmol) in dry acetonitrile (10 mL) 
in a pressure tube, was added 4-fluoro-3-nitrobenzoic acid (0.638 g, 3.77 mmol) and dry 
potassium carbonate (0.219 g, 3.3 equiv). The reaction mixture was heated to 80 °C 
overnight. Upon cooling the reaction mixture was diluted with dichloromethane (20 mL) 
and filtered to remove the precipitated yellow solid. The solid was dissolved in water to 
remove the potassium carbonate and hydrochloric acid was added to precipitate the product 
as the hydrochloric salt. Attempts to isolate the desired product from unreacted starting 
materials were unsuccessful. 8 h (400 MHz, D2 O) 7.98 (d, 3H, J  2.15), 7.65 (dd, 3H, J  
8 .8 8 , 2.15), 6.95 (d, 3H, J  8.91), 3.30 (s, 12H, CH2) IR (KBr, cm’1) 3427, 2963, 1705 (s, 
C=0 stretch), 1612 (antisymmetric CO2 ' stretch), 1530 (N=0 antisymmetric stretch), 1457, 
1414, 1354 (N=0 symmetric stretch), 1302, 1259, 1215 , 1171, 1152, 1125, 1073, 989, 917, 
846; m/z (APCI) 625.6 [M + 1].
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[5.7] L32BA
OH
n o 2
This was prepared in an analogous method to that of [5.4] method 1. the applied reagents 
were 1,4,7-triazacyclononane (0.634g, 4.90 mmol), 2-fluoronitrobenzene (1.38g, 9.78 
mmol), potassium carbonate (1.35g, 9.76 mmol) and 4-fluoro-3-nitrobenzoic acid (lg, 5.40 
mmol) and potassium carbonate (0.96 g, excess). Upon cooling the reaction mixture was 
filtered and the solvents removed in vacuo to afford an orange oil verified to be L3 2  by 
proton NMR spectroscopy. The filtered solid was washed with water to afford the crude 
product. Recrystallisation from hot ethanol yielded [5.7] as a yellow solid (1.02g, 39 %); 
5h (400 MHz, </-DMSO) 8.0 (d, 1H, J  1.86), 7.95 (dd, 1H, .7 8.67, 1.89), 7.62 (dd, 2H, J  
8.06,1.47), 7.45 (m,2H), 7.25 (d, 2H, J  8.64), 7.1 (d, 1H, J  8.64), 6.95 (t, 2H, J  7.4), 
3.45 (m, 4H, C //2), 3.35 (m, 4H, CH2), 3.15 (s, 4H, C//2); m/z (APCI) 537.6 [M + l].
[5.8] Benzyl 4-fluoro-3-nitrobenzoate
n o 2
4-Fluoro-3-nitrobenzoic acid (5.00 g, 27 mmol), DMF (3 drops) and thionyl chloride (20 
mL, excess) were refluxed for 4 h under a nitrogen atmosphere. The solvents were removed 
in vacuo to give the corresponding acid chloride (4.2 g). 4-Fluoro-3-nitro acid chloride (4.2 
g) was dissolved in dry DCM (20 mL) and was cautiously added dropwise to a solution of 
benzyl alcohol (2.4 g, 22 mmol), triethylamine (2.29 g, 1.1 molar equiv), DMAP (~ 100 
mg) in DCM. The combined solution was stirred for 2 h. The DCM solution was washed 
with dilute HC1, NaHC0 3 (aq) and water, dried over MgSC>4 . The solvents were removed in 
vacuo to give the title compound as an oil which solidified upon cooling (4.76g, 64 %); §h 
(400 MHz, CDCI3 ) 8.75 (dd, 1H, J  7.14, 2.06, Ar-//), 8.30 (m, 1H, Ar-//), 12-1A  (m, 6 H, 
Ar-//), 5.30 (s, 2H, CH2); IR (KBr, cm'1) 3034, 2929, 2851, 1731 (strong, C=0 stretch), 
1619, 1538 (N=0 antisymmetric stretch), 1497, 1443, 1410, 1352 (N=0 symmetric 
stretch), 1316, 1281, 1227, 1151, 1126, 1077, 993, 917, 843, 817; m/z (APCI) 276 [M + 
!]•
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[5.9] L33Benzyl
O
n o 2
To a solution of 1,4,7-triazacyclononane (0.2g, 1.54 mmol) in dry acetonitrile (20 mL) in a 
pressure tube, was added benzyl 4-fluoro-3-nitrobenzoate (1.40g, 5.08 mmol) and dry 
potassium fluoride (0.269 g, 5.1 mmol). The reaction mixture was heated to 80 °C 
overnight. Upon cooling the reaction mixture was diluted with dichloromethane (20 mL), 
filtered and the solvents were removed in vacuo. The crude product was purified by flash 
chromatography on silica gel eluting with dichloromethane and subsequent recrystallisation 
from acetonitrile afforded [5.9] as a dark yellow solid (0.77g, 56 %); 8 h (400 MHz, 
CDCI3 ) 8.25 (d, 3H, J  1.87, Ar-//), 7.95 (dd, 3H, J8.81, 1.80, Ar-//), 7.3-7.4 (m, 15H, 
Ar-//), 6.95 (d, 2H, J  8.85), 5.30 (s, 6 H, C//2), 3.5 (s, 12H, CH2 macrocycle); 5C (100 
MHz, CDCI3 ) 164.7, 146.9, 140.7, 135.9, 134.6, 129.0-128.7, 121.8, 119.2, 67.4, 54.0; IR 
(KBr, cm '1) 3465, 2961, 1717 (s), 1609 (s), 1526 (s), 1455 (w), 1361 (m), 1279, 1242 (s), 
1171,1119 (m), 753 (m); m/z (APCI) 895.3 [M + 1],
[5.10] L<32Beiizyl
n o 2
This was prepared in the same manner as [5.4] using method 1. The applied reagents were
1,4,7-triazacyclononane (0.469g, 3.36 mmol), 2-fluoronitrobenzene (1.02g, 7.26 mmol), 
potassium carbonate (1.1 Og, 7.9 mmol) and benzyl 4-fluoro-3-nitrobenzoate (l.Olg, 3.7 
mmol) and potassium carbonate (0.5lg, 3.7 mmol). Recrystallisation attempts from various 
hot solvents were unable to separate the desired product from impurities. 8 h (400 MHz, 
CDC13) 8.30 (d, 1H, 72.14), 7.95 (dd, 1H, J 8.93 ,2.19), 7.55 (dd, 2H, J 8.08, 1.68), 7.25-
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7.40 (m,7H), 7.10 (d, 2H, J  8.38), 6.95 (m, 2H), 5.30 (s, 2H, CH2), 3.6 (d, 4H, J  5.33), 
3.55 (d, 4H, J4.37), 3.30 (s, 4H); m/z (APCI) 628.
(5.11] L32T
n o 2
This was prepared in an analogous manner to that of [5.4] (method 1). The applied reagents 
were 1,4,7-triazacyclononane (0.833g, 6.45 mmol), 2-fluoronitrobenzene (1.81 g, 12.8 
mmol) potassium carbonate (1.95g, 14.1 mmol) and 4-fluoronitrotoluene (lg, 6.4 mmol) 
and potassium carbonate (0.88g, 6.4 mmol). Recrystallisation from hot ethanol afforded 
[5.11] as an orange crystalline material (2.09g, 64 %); 5h (400 MHz, CDCI3 ) 7.53 (dd, 
2H, J 8.04, 1.34, A r//), 7.32 (m, 3H, A rH and A r /f ) ,  7.14 (dd, 1H, J8 .44, 1.75, A r IT), 
7.05 (m, 3H, , Ar H  and Ar IT), 6.85 (m, 2H, Ar H), 3.52 (s, 4H, C/ / 2  macrocycle), 3.41 
(d, 4H, J3.34, CH2 macrocycle), 3.37 (d, 4H, J3.30, CH2 macrocycle), 2.20 (s, 3H, C //3), 
6 C (100 MHz, CDCI3 ) 144.7, 144.5, 143.8, 143.0, 142.3, 134.0, 133.2, 132.1, 126.0, 123.6,
121.3, 120.2, 55.3, 54.9, 54.5, 20.5; IR (KBr disc, cm'1) 2890 (CH stretch), 1603, 1561, 
1519 (strong, N =0 antisymmetric, stretch), 1437, 1340 (strong, symmetric N =0 stretch), 
1294, 1256, 1204, 1169, 1071, 1049,989,907,801; m/z (ES) 507.2 [M + 1]
NiI5.ll] [Ni"(L32TR)][CI04]2
To a solution of [5.11] (200 mg, 0.394 mmol) in toluene-methanol (20:1, 20 mL) was 
added platinum on carbon (10 %, 50 mg). Hydrogen was bubbled through the reaction 
mixture for 20 hours. Under an inert atmosphere, the reaction mixture was filtered through 
glass fibre filter paper and the solvent removed in vacuo to give the reduced ligand [5.1 IR] 
as an off-white solid (110 mg, 6 8  %). An excess of Ni(ClC>4 )2 .6 H2 0  was added to a 
suspension of [5.HR] (110 mg) in degassed ethanol and the reaction mixture was left to stir 
overnight. Removal of the supernatant by cannula and subsequent drying in vacuo afforded 
the desired complex as a pale pink crystalline powder (270 mg, 84 %); IR (KBr, cm'1) 3414 
(strong), 2360, 2341, 1653, 1616, 1497, 1457, 1364, 1279, 1261, 1143, 1109, 1089 (strong), 
809.
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[5.12] L32AIC
Method 1: To a solution of 1,4,7-triazacyclononane (0.2 g, 15.4 mmol) in dry acetonitrile 
(10 mL) in a pressure tube, was added 2-fluoronitrobenzene (0.437 g, 30.9 mmol) and 
finely ground potassium carbonate (0.6017 g, 2.2 equiv). The reaction mixture was stirred 
at room temperature for 2 h, the temperature was raised to 80 0  C and stirred for a further 2 
h. Upon cooling, racemic propylene oxide (excess) in a mixture of THF (1 mL) and EtOH 
(1 mL) was added and the pressure tube was tightly sealed. The reaction mixture was 
stirred for 5 days at ambient temperature. The reaction mixture was filtered and the solvents 
removed in vacuo to give the product as an oily orange residue. The minimum amount of 
hot toluene was added and hexane was added until precipitation occurred to yield the title 
compound as a bright orange solid (0.265g, 40 %); 5h (400 MHz, CDCI3 ) 7.55 (dd, 2H, J  
8.06, 1.47, Ar H ), 7.35 (m, 2H, Ar H ), 7.0 (d, 2H, J  8.24, Ar //), 6.80 (t, 2H, J  7.93, Ar 
//), 3.55 (s, 4H, C/ / 2  macrocycle), 3.50 (m, 1H, CH), 3.45 (m, 4H, C/ / 2  macrocycle), 
2.75 (m, 4H, CH2 macrocycle), 2.50 (dd, 1H, J  12.68, 2.37, CH o i  CH2), 2.2 (m, 1H, CH 
of CH2), 0.8 (d, 3H, C //3); 5c(100 MHz, CDC13) 144.1,141.7,133.1,126.3,119.3,119.1,
68.0,64.5,56.1,55.2,55.0,19.93; m/z (APCI) 430.2 [calc 429.4]; IR (KBr, cm'1) 3568 
(sharp, OH stretch), 2964, 1602, 1563, 1516 (strong, antisymmetric N =0 stretch), 1444, 
1398, 1354 (strong, symmetric N =0 stretch) (medium, C-N stretch, 1301, 1261, 1227, 
1167, 1131, 1093, 1046, 998, 870, 771 and 741.
Method 2: 1,4-Di(2-nitrophenyl)- 1,4,7-triazacyclononane, L3 2  (200 mg), propylene oxide ( 
~ 400 mg, excess), ethanol (5 mL) and THF (5 mL) were placed in a tightly sealed pressure 
tube and stirred for 5 days at ambient temperature. The solvents were removed in vacuo to 
give the product as an oily orange residue. The minimum amount of hot toluene was added 
and hexane was added until precipitation occurred to yield the title compound as a bright 
orange solid (0.115g, 50 %) with identical spectral properties as above
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[5.13] L320
This was prepared in the same maimer as [5.4] (method 1). The reagents applied were
1,4,7-triazacyclononane (lg, 7.73 mmol), 2-fluoronitrobenzene (2.18 g, 15.4 mmol), 
potassium carbonate (2.12g, 15.4 mmol) and 2,3-dichloro-l,4-dinapthoquinone (1.74g, 
7.66 mmol) and potassium carbonate (1.05g, 7.66 mmol). The crude product was purified 
by flash chromatography on silica eluting with chloroform. Removal of the solvent in 
vacuo afforded [5.13] as a red solid (2.12g, 49 %); 8 h (400 MHz, CDCI3 ) 8.05 (d, 1H, J  
7.41, Ar / /q u in o n e ) ,  8.00 (d, 1H, J7.24, Ar / /q u in o n e ) ,  7.62 (m, 2H, Ar / /q u in o n e ) ,  7.48 (dd, 2H, 
J  8.04, 1.48, Ar //), 7.35, (m, 2H, Ar //), 7.08 (d, 2H, J  8.19, Ar //), 6.90 (t, 2H, J  7.62, 
Ar //), 3.98 (m, 4H, C/ / 2  macrocycle), 3.60 (m, 4H, C/ / 2  macrocycle), 3.42 (s, 4H, CHj 
macrocycle); IR (KBr, cm '1) 3467,2962,1676 (m), 1640,1609 (strong), 1560,1545 (N=0 
antisymmetric stretch, strong), 1515, 1487, 1456, 1435, 1354, 1342 (medium, N=0 
symmetric stretch) 1303, 1283, 1251, 1205, 1173, 1122, 1078, 1043, 993, 840, 803, 771 
and 742; m/z (ES Q-TOF) 562.1 [M+l], 584.1 [M+Na] and 600.1 [M+K]; HRMS (ES Q- 
TOF) m/z calc for C2 8 H2 4 N 5 O6 CI 561.973, found 562.1493.
Attempted synthesis of terpyridine-l,4,7-triazacyclononane system
n o 2
2-Acetylpyridine (0.151g, 1.248 mmol) was added to a solution of potassium ^-butoxide 
(0.307g, 2.74 mmol) in freshly distilled THF (20 mL) and was stirred for 10 min. The 
resultant yellow suspension was treated with a solution of [5.2] (0.12g, 0.208 mmol) in 
THF (5 mL) and the mixture was stirred overnight at room temperature under an
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atmosphere of N2 . After this period, a solution of dry ammonium acetate (excess) in 
ethanol rglacial acetic acid (1:1) was added and was heated to reflux overnight. The reaction 
mixture was cooled and was treated with ice and water. The resultant yellow-brown solid 
was collected by filtration. IR (KBr, cm'1) 1602, 1564, 1516, 1437, 1388, 1354, 1295, 1261, 
1221,1172, 1090, 1048, 997, 830, 744; m/z (ESI) 780.5.
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Conclusions
The objective of this research was to design and prepare compounds that possess 
properties that render them suitable immunohistochemical marker/marker substrates. The 
marker substrate compound must incorporate a phosphomonoester, a substrate of alkaline 
phosphatase. It must be water soluble to allow administration to the tissue sample. 
Following enzymatic cleavage of the phosphomonoester the marker must become insoluble 
in histological preparations e.g. water at pH 6-9.5, ethanol and xylene. The marker must be 
designed such that it is able to form interactions and thus adhere to the target site. Most 
importantly the marker must support redox catalysis to enable amplification with a physical 
developer. Since the silver ions present in the physical developer are slowly catalysed by 
light (approximately 55 minutes), marker compounds must reduce the silver ions in times 
ideally less than 20 minutes to obtain clear results. A successful marker/marker substrate 
system must fulfil all of the above criteria.
Previous research in this area identified the potential of platinum complexes of 
bidentate phosphines and platinum and palladium complexes of both meso- 
tetraarylporphyrins and 4’-aryl-2,2, :6,,2”-terpyridines as suitable markers. The Pt and Pd 
complexes of functionalised tetraphenyl porphyrin were all shown to rapidly reduce silver 
ions in a Timm’s type reaction. Our findings initially appeared to be in agreement with this. 
However, it was found that following extensive purification the metal complexes no longer 
displayed any redox activity. This suggests that the previously tested samples contained 
trace impurities and it was these that catalysed the reduction of silver. The metal salts 
(PtCl2 , P dC y  rapidly reduce the silver ions in the physical developer forming an 
immediate black colouration.
4 ’ -(4-Hydroxyphenyl)-2,2 ’: 6 ’ ,2”-terpyridine, 4 ’ -(4-diethylphosphatopheny 1)-
2,2’:6’,2”-terpyridine and 4’-(4-phosphatophenyl)- 2,2’:6’,2”-terpyridine and the platinum 
iodide and palladium chloride square planar complexes were previously shown to catalyse 
the reduction of silver ions in 2-3 minutes. Whereas, the platinum chloride complexes 
reduce the silver ions more slowly (20 minutes). The free ligands displayed surprising 
catalytic activity. The proposed explanation for this was that the ligand may form a silver 
complex with the silver ions present in the physical developer. This silver complex may 
then catalyse the reduction of silver. The platinum complexes [Pt(4.5)Cl]+ and 
[Pt(4.12)Cl]+ catalysed the reduction of silver in 20 and 24 minutes respectively which is in 
agreement with previous findings. None of the free terpyridine ligands prepared displayed 
any redox activity. This suggests that this earlier proposal was incorrect and the reduction 
of silver was caused by an unknown substance. This highlights the need for the marker
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compounds to be rigorously purified to ensure it is indeed the marker and not some other 
entity catalysing the reduction of silver ions.
During the course of this research many problems associated with solubility were 
encountered. We therefore turned our attention to preparing water soluble marker 
compounds bearing a reactive group to allow conjugation directly to a secondary antibody. 
Unfortunately the work undertook was unsuccessful to this end, never-the-less this appears 
to be the most logical direction for future research in this project area.
A major downfall of this project is the reliability of the physical developer solution. 
The performance of the solutions varies depending on the supplier of the Tris base (a 
component of the silver stock solution). We were informed that optimal performances of 
the developer solution are obtained when using Tris base purchased in 1991! This will have 
an effect on obtaining reproducible results. From our own experience we have found that 
minor changes in pH and temperature of the physical developer solution alters the rate of 
silver reduction. The age of the solutions also has a similar effect. Ideally the developer 
solution should be freshly prepared before use although this is time consuming and the 
stock solutions are best prepared on a larger scale.
To conclude, since very little is known about the silver reduction mechanism it has 
proved difficult to design markers that catalytically reduce silver ions present in the 
developer solution. We have shown that altering the coordinated ligands (e.g in the 
compounds [Pt(dppe)Cl2 ], [Pt(dppe)l2 ], [Pt(dppe)S4 ] etc) alters the redox activity towards 
the reduction of silver in a Timm’s type reaction. Although at present we do not understand 
why. We have also shown that the markers need to be of high purity as any impurity may 
be responsible for the reduction of silver.
